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Restrictive annuloplasty rings are a standard mitral valve repair procedure for 
ischemic mitral regurgitation (MR), however there is a high incidence of recurrent MR. 
With this recurrent MR, there is a need to understand the restrictive effects from an 
annuloplasty on the MV leaflets. The first goal of this dissertation is to study the effects of 
annular dynamics on the mitral leaflets and its restriction. To accomplish this, an MV in 
vitro model with a dynamically contracting annulus will be designed and used to compare 
leaflet strain between varying contractile states. These, now, high-risk patients with failed 
MV repairs and replacements created a demand for percutaneous MV interventions. With 
no dedicated devices currently on the market, clinicians have resorted to placing 
transcatheter aortic valves (TAV) into mitral annular calcification (valve-in-MAC), failing 
mitral bioprosthetic valves (valve-in-valve), and failing mitral annuloplasty rings (valve-
in-ring). Currently, there are no official clinical guidelines, and no quantitative engineering 
studies have been conducted to better understand performance and risks. Percutaneous 
laceration of the anterior mitral leaflet (LAMPOON) is a proposed proactive solution to 
the risk of left ventricular outflow tract (LVOT) obstruction. The second goal of this 
dissertation includes designing and performing in vitro experiments to evaluate and 
quantify benefits of LAMPOON on LVOT obstruction and thrombosis. These goals will 
provide insight into potential causes of recurrent MR with annuloplasty rings, and an in-
depth quantitative assessment of the benefits of LAMPOON with transcatheter mitral valve 
replacements. These will better inform procedural guidelines and medical device design, 
as well as provide further insight into MV biomechanics and advanced platforms for future 
 xxvi 
MV in vitro studies. In Specific Aim 1, a novel dynamically contracting annulus was 
developed for in vitro studies. It was subsequently found that healthy contraction provided 
lower strains on the anterior mitral leaflet (AML) than diseased contraction and static 
conditions. The findings suggested that maintaining annular dynamics during MV repair 
procedures could improve loading on the AML. In Specific Aim 2, a novel LAMPOON 
model was incorporated into a modified LV phantom for in vitro studies. Results found 
that LAMPOON can lower velocities in the LVOT, lower maximum VSS in the LV, and 
increase flow into the anterior neo-sinus during diastole. Combined, the findings suggested 
that LAMPOON could aid in preventing LVOT obstruction and reduce the risk of 
thrombosis in the anterior neo-sinus.
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CHAPTER 1. INTRODUCTION 
The heart is the central part of the cardiovascular system, consisting of a left and 
right side acting as two pumps in series. Each side has two chambers (atrium and ventricle) 
and two valves. The smaller right side of the heart receives blood from the body into the 
right atrium with the right ventricle pumping it to the lungs for reoxygenation. The larger 
left side receives blood from the lungs into the left atrium and pumps to the body via the 
left ventricle. Between the left atrium and left ventricle there is a bi-leaflet valve known as 
the mitral valve. The mitral valve’s purpose is to maintain unidirectional flow between the 
left atrium and ventricle and consists of four major components: annulus, leaflets, chordae 
tendineae, and papillary muscles. The mitral valve’s complex structure allows it to operate 
under the highest loading in the heart, with any changes in its four major components 
leading to failure. 
Two major endpoints of failure are mitral stenosis (MS) and regurgitation (MR). 
Stenosis is when the valve cannot completely open during filling (diastole), while 
regurgitation is when the valve cannot completely close during ejection (systole). Stenosis 
and regurgitation can be induced through primary/tissue and secondary/structural diseases. 
Stenosis is usually caused through valvular calcification, but the more prevalent 
regurgitation is caused by a host of primary and secondary diseases. Primary MR stems 
from tissue related conditions such as congenital, degenerative, or bacterial diseases 
creating suboptimal coaptation from changes in the valve itself. Secondary MR is created 
when the surrounding structures of the otherwise healthy valve are altered creating 
improper coaptation, e.g. ischemia or a myocardial infarction thinning the left ventricular 
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wall causing the papillary muscles and the annulus to dilate resulting in ischemic mitral 
regurgitation (IMR). 
In order to correct these pathophysiologic conditions, clinicians have developed 
surgical and interventional, repair and replacement procedures. One surgical repair 
commonly done to correct mitral regurgitation is the insertion of a mitral annuloplasty ring. 
The annuloplasty ring attempts to addresses the issue of improper leaflet closure 
(coaptation) by restructuring the mitral annulus into a shape that would induce better 
coaptation. For IMR, this is typically done by downsizing the annulus into a smaller orifice 
using a rigid annuloplasty ring, thus bringing the leaflets closure together and keeping the 
annulus that new size and shape. Implantation of an annuloplasty ring restricts the motion 
of the mitral valve throughout the cardiac cycle, with stiffer rings imparting more severe 
restriction. Although this surgical repair is an effective treatment, studies have shown MR 
recurrence as high as 30% in patients with IMR within the first 6 months after operation.1, 
2 Assessment of annular dynamics and its effect on the MV leaflets could help in further 
understanding the incidence of recurrent MR and long-term MV repair outcomes of the 
annuloplasty procedure. 
A surgeon may also opt to replace the mitral valve with a bioprosthetic or mechanical 
valve. These replacement mitral valves are sutured into the annulus to take over the 
function of the diseased valve. These surgical repairs and replacements are initially done 
on low-risk patients,3 however, these procedures can result in recurrent MR or MS that 
need further treatment with patients that are likely now at high-risk for surgery. These 
patient groups created a pertinent demand for percutaneous MV interventions. With no 
dedicated devices currently on the market for transcatheter mitral valves, clinicians have 
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resorted to placing transcatheter aortic valves (TAV) into mitral annular calcification 
(valve-in-MAC),4-7 mitral bioprosthetic valves (valve-in-valve),7-9 and mitral annuloplasty 
rings (valve-in-ring).10-12 
Left ventricular outflow tract (LVOT) obstruction and leaflet thrombosis are 
potential risks from transcatheter valve replacement in the MV.13-17_ENREF_12 This is 
due to the anterior mitral leaflet (AML) being permanently displaced into the LVOT by the 
stent of the transcatheter valve. Additionally, the AML also covers the stent frame creating 
a neo-sinus between the AML and TAV leaflets in danger of flow stasis. One way to 
proactively relieve these risks is through prior surgical resection of the A2 scallop during 
placement of a surgical prosthetic MV.18 Another is through a new percutaneous laceration 
of the A2 scallop known as LAMPOON.19 Both the use of transcatheter prosthetic valves 
in the mitral position and the idea to relieve LVOT obstruction to at risk patients are 
developing areas. Assessment of how laceration of the AML affects the flow in the LV, 
LVOT, and neo-sinus with a transcatheter mitral valve could help in further understanding 
their effects and long-term outcomes. 
The overall objectives of the present research were to develop new in vitro simulators 
to better understand the effects of annular dynamics on the AML as well as laceration of 
the AML with a transcatheter valve replacement on LV flow. Once developed, experiments 
were conducted to measure how annular contraction plays a role in AML strain and how 
AML laceration can affect the flow in the LV, LVOT, and neo-sinus with the transcatheter 
valve. The results from these experiments may help guide annuloplasty ring design and 
clinical procedure standards, as well as provide a better physiologic understanding of the 
mitral valve.  
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CHAPTER 2. BACKGROUND 
2.1 The Cardiovascular System and the Heart 
2.1.1 The Cardiovascular System 
The cardiovascular system is an organ system of the human body. It is designed to circulate 
blood throughout the body permitting transport of oxygen, hormones, blood cells, and 
nutrients. This helps maintain the body’s homeostasis by providing nourishment, 
stabilizing temperature and pH, and fighting diseases. The cardiovascular system consists 
of the heart, blood vessels (arteries, capillaries, and veins), and blood. The heart pumps 
blood away from it through arteries which exchanges nutrients at capillaries and returns to 
the heart via veins (Figure 2-1). The blood is reoxygenated by the lungs (pulmonary loop) 
and sent to the rest of the body (systemic loop). 
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Figure 2-1. Diagram of the circulatory system highlighting the systemic loop and 
capillary exchange between arteries and veins (modified from Iaizzo et al.20). 
 
2.1.2 The Heart 
The heart is comprised of four chambers: the right atrium, right ventricle, left atrium, and 
left ventricle. The chambers are each separated by a valve: tricuspid valve (right 
atrium/ventricle), pulmonary valve (right ventricle/pulmonary artery), mitral valve (left 
atrium/ventricle), and aortic valve (left ventricle/aorta). The right and left side of the heart 
act as two pumps in series. The right side pumps to the lungs (pulmonary loop), returning 
to the left side, while the left side pumps to the body (systemic loop), returning to the right 
side (Figure 2-2).  
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Figure 2-2. Four chamber and four valve anatomical view of the heart (modified 
from medlineplus.com and Carpentier et al.21). 
 
Each valve helps maintain unidirectional flow. The mitral valve opens during 
diastole to allow the left ventricle to fill with reoxygenated blood and closes during systole 
as the left ventricle ejects the blood to the body (Figure 2-3).  
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Figure 2-3. Mitral valve open during diastolic filling and closed during systolic 
ejection of the left ventricle (modified from Carpentier et al.21). 
 
In order to pump blood to the whole body, the left ventricle is the largest chamber of 
the heart with the thickest muscular wall. This creates a powerful contraction resulting in 
the highest pressures in the heart. Thus, the mitral valve experiences the highest forces and 
is prone to the highest incidence of disease of any heart valve.20, 22 
 
2.2 The Mitral Valve 
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In order to experience the high systole pressure and open seamlessly during diastole, the 
mitral valve is comprised of a complex structure of annulus, leaflets, and subvalvular 
apparatus (chordae tendineae and papillary muscles)(Figure 2-4). 
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Figure 2-4. Detailed diagram of mitral valve leaflet, annular plane, and 
subvalvular apparatus (chordae tendineae and papillary muscles) (modified from 
Carpentier et al.21). 
 
2.2.1 The Mitral Leaflets 
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The MV leaflets are the functioning valve mechanism that opens and closes to provide 
unidirectional flow between the left atrium and ventricle. The MV is a bicuspid valve 
consisting of two major leaflets: anterior and posterior (Figure 2-4). The anterior leaflet 
and posterior leaflet are similar in surface area, but different in size and shape. The surface 
area of the leaflets is roughly twice that of the orifice area providing redundancy for 
coaptation during closure.23 In a healthy valve, it is this coaptation that provides the seal 
between leaflets and prevents retrograde flow into the left atrium during systole (Mitral 
Valve Regurgitation).  
The MV leaflets share the same free-edge and meet at two points known as 
commissures. They are attached at the base to the MV annulus (2.2.2) and supported by 
the subvalvular apparatus along the leaflet surface and edge (2.2.3). The leaflets themselves 
are made of four layers: atrialis, spongiosa, fibrosa, and ventricularis (in order from atrium 
to ventricle) (Figure 2-5). The atrialis and ventricularis encompass the leaflet with 
endothelial cells with the addition of collagen and elastin fibers for structure and elasticity. 
The fibrosa is the thickest layer of the leaflets and is comprised of densely organized 
collagen fibers (type I, II, and IV). With most of the collagen content in the leaflet, the 
fibrosa provides the majority of load-bearing support. The spongiosa is made up of elastin, 
glycosaminoglycans (GAGs), and proteoglycans and acts as a support layer that helps 
lubricate and distributes loading.23 
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Figure 2-5. Histological cross-section of mitral leaflet.23 
 
These combinations of materials give the MV leaflets nonlinear, viscoelastic, 
anisotropic material properties. The major axis of alignment of leaflet collagen fibers are 
in the circumferential direction with cross-fiber directionality and heterogeneity changing 




Figure 2-6. Diagram illustrating the stress-strain relationship and fiber 
orientation of the mitral valve leaflets (modified from Toma et al.24). 
 
2.2.2 The Mitral Annulus 
The mitral annulus is a region of myocardium between the left atrium and ventricle from 
which the MV leaflets hinge. The annulus is generally described as having a saddle and D-




Figure 2-7. Three dimensional representation of the mitral valve annulus 




Figure 2-8. Normalized in vivo human measurements of annular motion 
throughout the cardiac cycle (modified from Levack et al.25). 
 
The annulus is not well defined and is simply viewed as the ring of tissue that the 
base of the leaflets attaches to.28 The material properties of the annulus vary greatly around 
the perimeter of the annulus and between hearts with different densities of collagen and 
elastin (Figure 2-9).29 
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Figure 2-9. Diagram showing variety of annular structure between patients 
(modified from Angelini et al. 28). 
 
2.2.3 The Mitral Subvalvular Apparatus 
The mitral subvalvular apparatus consists of the chordae tendineae and the papillary 
muscles (PMs) (Figure 2-4). The chordae insert into both the MV leaflets and PMs and act 
as tensile pillars for the MV leaflet during systole and help control leaflet mobility 
throughout the cardiac cycle. There are three classification for chordae: marginal (primary), 
intermediary (secondary), and basal (tertiary) (Figure 2-10). 
 
Figure 2-10. Diagram of chordae tendineae classification with papillary muscles: 




Marginal chordae insert into the leaflet free edge, the intermediary chordae insert 
into the belly of the leaflets, and the basal chordae insert closest to the annulus (furthest 
away from the apex of the heart). It is worth noting that the there are two larger and distinct 
intermediary chordae called strut chordae that insert into the belly of the anterior leaflet 
and carry the majority of the systolic loading. From a biomechanical standpoint, the 
chordae tendineae are primarily composed of collagen and elastin and show nonlinear 
viscoelastic behavior under tensile loading.23 
 There are two PMs to which both the anterior and posterior leaflet chordae insert 
into: anterolateral and posteromedial (Figure 2-10). The PMs are denoted as the anchor 
point of the chordae into the LV and are distinct myocardial appendages along the LV wall. 
Their primary role is to help stabilize loading between the chordae and leaflets. This is 
done through a combination of factors: LV wall motion, chordal insertion pattern, and the 
material property and structure of the PMs (myocardium) that acts as a foundation for the 
chordae (Figure 2-11).21, 23 
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Figure 2-11. Illustration of selected morphologies of papillary muscles and chordal 
insertions (modified from Carpentier et al.21). 
 
2.3 Mitral Valve Pathophysiology 
The MV has been identified as the most common heart valve to experience 
hemodynamically significant disease in the United States of America.30 This section details 
the two forms of MV dysfunction: mitral regurgitation (MR) and mitral stenosis (MS). 
 
2.3.1 Mitral Valve Regurgitation 
In MV disease, poor valve geometry or degeneration, creates incomplete valve closure that 
results in MR (Figure 2-12).21 This regurgitation creates systolic back flow resulting in a 
fraction of the oxygenated blood in the ventricle getting returned to the left atrium, rather 
than being pumped to the body. This flow inefficiency also leads to an increased load on 
the lungs due to elevated atrial pressure during ventricular systole. 
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Figure 2-12. Illustrations of mitral regurgitation examples (modified from 
Carpentier et al.21). 
 
There are two types of mitral regurgitation classifications: primary and secondary. 
Primary MR involves the valvular tissue whereas secondary MR involves the supporting 
structures, e.g. the ventricle.21 Common cases of primary MR are congenital 
malformations, inflammatory or degenerative diseases, bacterial endocarditis, and 
calcification.21 Common cases of secondary MR are myocardial infarction, dilated or 
hypertrophied cardiomyopathies, and endomyocardial fibrosis.21 Secondary MR lends 
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itself to in vitro and in vivo studies, because of the ability to manipulate MV geometry with 
a disease having healthy tissue. In contrast, it is hard to control for the differences in 
diseased tissue of primary MR as well as acquire the samples for experimental studies. 
 If left untreated, mitral regurgitation can lead to patient death.31 With at least 
moderate MR occurring at a frequency of 1.7% in US adult population,22 there is a demand 
for treatment. MR is most commonly treated with mitral valve repair (2.4.1, 2.5.1), but is 
also treated with mitral valve replacement (2.4.2, 2.5.2). 
 
2.3.2 Mitral Valve Stenosis 
In MV disease, valve dysfunction can prevent the valve from opening completely, resulting 
in mitral stenosis (MS). This stenosis creates an increased pressured gradient across the 
MV and leads to poor valve function and ventricular filling and elevated atrial pressure. A 
few causes include leaflet thickening (calcification, congenital, or degenerative), 
commissure fusion, and chordae thickening/fusion (Figure 2-13).21 If left untreated, mitral 
stenosis can lead to patient death.32, 33 Although there is a smaller prevalence of only 0.1% 
in US adult population,22 it is still a surgically treated disease. MS is most commonly 
treated with a mitral valve replacement (2.4.2, 2.5.2), but can also be treated with mitral 
valve repair (2.4.1, 2.5.1). 
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Figure 2-13. Illustration of mitral stenosis examples  (modified from Carpentier et 
al.21). 
 
2.4 Mitral Valve Surgical Corrections 
In order to help patients with mitral valve disease, clinicians and engineers began making 
medical devices for surgical treatments. These surgical treatments can be broken down to 
two major categories: repair or replacement. This section highlights common surgical MV 
repairs and replacements. 
 
2.4.1 Surgical Repair 
Mitral valve surgical repair typically encompasses any procedure that augments the native 
MV and requires the patient to be on a cardio-pulmonary bypass. 
To help treat both primary and secondary MR, implantation of a mitral valve 
annuloplasty ring (MVAR) is a standard surgical repair.21, 34, 35 The MVAR is used to 
restore proper annular geometry and prevent any further changes. MVAR implantation is 
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typically undersized, bringing the leaflets closer together to improve MV leaflet coaptation 
and reduce MR (Figure 2-14).35 Additionally, clinicians can attempt to revascularize the 
left heart for secondary MR, or augment the MV with pseudo-chordae and leaflet 
resection/modification with primary and secondary MR.21, 31, 36-40 These are typically done 




Figure 2-14. Diagram of surgical mitral annuloplasty repair. (A) Suturing rigid 
ring into a dilated annulus, (B) resulting downsized annulus with proper leaflet 
coaptation (modified from Carpentier et al.21). 
 
Although this surgical repair has been proven to be effective, studies have shown MR 
recurrence as high as 30% in patients with ischemic MR.1, 2  
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2.4.2 Surgical Replacement 
Surgical mitral valve replacements (SMVR) typically encompasses any procedure that 
replaces the native MV and requires the patient to be on a cardio-pulmonary bypass.  
This replacement can either be a bioprosthetic or a mechanical valve (Figure 2-15). 
Bioprosthetic heart valves (BHV) are made of porcine or bovine pericardium and require 
less to no anticoagulation therapy, whereas mechanical heart valves (MHV) are made from 
an assortment of metal polymers and require varying degrees of anticoagulation therapies. 
BHVs typically have a shorter lifespan of ~10 years and MHVs a longer lifespan of ~30 
years.41 
 
Figure 2-15. Surgical On-X mechanical heart valve (CryoLife, Atlanta, GA) and 
Magna Mitral Ease bioprosthetic heart valve (Edwards Lifesciences, Irvine, CA), 
and diagram of a bioprosthetic mitral valve replacement being sutured into the 
mitral annulus. 
 
The SMVR is sutured into the mitral annulus replacing the function of the native 
valve. The native valve can either be spared or resected at the surgeon’s discretion. 
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Resection can encompass the entire MV leaflets and chordae tendineae or as little as the 
A2 scallop.18 Chordal sparing is typically done to maintain LV structure and increase 
ejection performance with SMVR.42 
 
2.4.3 Surgical Repair vs Replacement 
Mitral repair is the most recommended surgical approach for MR.43 Mick et al.43 states that 
“the well-accepted advantages of mitral valve repair consist of lower operative mortality,44-
48 improved preservation of left ventricular function, and greater freedoms from prosthetic 
valve-related complications such as thromboembolism, anticoagulant-related hemorrhage 
and endocarditis.45, 46, 49-52” However, patient anatomy and pathophysiology plays the 
largest role in deciding the optimal correction.43 
 
2.5 Mitral Valve Interventional Corrections 
Mitral valve intervention is a growing market with only one device, MitraClip repair 
(Abbott, Lake Bluff, IL), currently approved by the FDA for commercial use. This medical 
device area stems from the need for minimally invasive approaches for high-risk surgical 
patients with new or recurrent disease and the desire to treat all patients as minimally 
invasive as possible. This section details emerging therapies in both intervention mitral 
valve repairs and replacements. 
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2.5.1 Interventional Repair 
Most MV interventional repair devices are for patients with MR and aim to recreate a 
similar surgical repair procedure, but with a minimally invasive approach. Three main 
anatomical targets of transcatheter mitral valve repairs (TMVr) are the mitral leaflets, 
mitral annulus, and chordal apparatus. Currently, the mitral leaflet approaches recreate the 
edge-to-edge repair clipping leaflet edges together, the mitral annulus approaches recreate 
an annuloplasty repair by adjusting the annular shape and size, and the chordal approaches 
recreate the insertion of a pseudo-chordae to fix leaflet motion. Patient indications and 
current approval statuses vary widely in this growing market; Figure 2-16 summarizes 
leading interventional MV repair therapies that have been CE marked for European use.53 
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Figure 2-16. Overview of current transcatheter mitral valve repair (TMVr) devices 
that have been CE marked (modified from Saccocci et al.53). 
 
  
2.5.2 Interventional Replacement 
Stemming from the success of transcatheter aortic valve replacement (TAVR) as a 
minimally invasive alternative to surgical aortic valve replacement (SAVR),54-60 medical 
professionals have been exploring the possibilities of transcatheter mitral valve 
replacement (TMVR).53 These TMVs are dedicated devices for the MV and are designed 
to meet the complexity of the MV anatomy and physiology (2.2). Patient indications and 
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current approval statuses vary widely in this growing market; Figure 2-17 summarizes 
leading interventional MV replacement therapies that have been implanted in human.53 
 
Figure 2-17. Overview of current transcatheter mitral valve replacement (TMVR) 
devices that have been implanted in humans (modified from Saccocci et al.53). 
 
2.5.3 Interventional Repair vs Replacement 
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The MVs complex anatomy and physiology make for a challenging target to treat. 
Accessibility and ease-of-use limits the capabilities of a transcatheter approach for mitral 
repair in contrast to an open-heart surgery. This has restricted current TMVr designs to 
target single objectives (e.g. edge-to-edge clip) in as simple deployment as possible. These 
restricted designs have also led to the quicker development and implementation of TMVr. 
In contrast, a TMVR must replace the entire function of the MV without embolizing or 
migrating due to the high pressures of the LV and address the possibility of paravalvular 
MR due to the shape of the nonuniform, contracting annulus, among other issues. These 
design hurdles have led to a slower development and implementation of TMVRs. 
As it currently stands, there are no FDA approved TMVR devices and only one FDA 
approved TMVr device (MitraClip). This is soon to change in the coming years with the 
more than just the examples of TMVr in Figure 2-16 and TMVR in Figure 2-17 in 
development and early clinical use. The MitraClip has shown that TMVr can provide good 
clinical outcomes for patients with MR and has a strong hold on the interventional MV 
market having been implanted in over 30,000 people.61-64 However, the Tendyne valve 
(Abbott, Lake Bluff, IL) and Intrepid valve (Medtronic, Minneapolis, MN) have shown 
encouraging results for TMVR and both have entered into pivotal randomized trials.65-67 
At the end of the day, safety, efficacy, and patient outcomes/quality of life will have to be 
weighed between TMVr and TMVR, not just feasibility. 
 
2.6 Transcatheter Aortic Valves in the Mitral Valve 
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Some patients who undergo MV repair or replacements have recurrent MR or MS over 
time.68-71 With these patients having already undergone open-heart surgery and are 
typically elderly with multiple comorbidities, they are often at high-risk for surgery. In 
response to this high-risk assessment, a non-surgical solution is necessary. However, some 
patients are not candidates for transcatheter repair and there are currently no dedicated 
transcatheter mitral valve replacements on the market. 
Due to the need for a minimally invasive replacement solution for people these 
patients, clinicians have begun implanting transcatheter aortic valves (TAV), off-label, in 
mitral annular calcification (valve-in-MAC),4-7 mitral bioprosthetic valves (valve-in-
valve),7-9 and mitral annuloplasty rings (valve-in-ring).10-12 This can be viewed in Figure 




Figure 2-18. Graphical drawings of transcatheter mitral valve approaches.72 
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Figure 2-19. Example of mitral valve-in-valve deployment using a Sapien XT 
transcatheter aortic valve (Edwards Lifesciences, Irvine, California) and Carpentier 




Figure 2-20. Example of mitral valve-in-ring deployment using a Sapien XT 
transcatheter aortic valve (Edwards Lifesciences, Irvine, California) and semi-rigid 
Physio mitral annuloplasty ring (Edwards Lifesciences). 
 
Normally, a TAV would not work in the mitral position, due to the dynamic contraction of 
the MV annulus and the inability to anchor the TAV in place. However, the MVAR, 
SMVR, and MAC provide rigid constructs to hold the transcatheter valve in position. 
Studies have shown successful use of the TAV in the MV;74-76 however, it is currently not 
an indicated use of the TAV and companies are still developing dedicated TMVs to be used 
instead. It is important to note, that the SAPIEN family (Edwards Lifesciences, Irvine, CA) 
are the only TAVs currently being deployed into the MV due to their low-profile design. 
 
2.7 Transcatheter Mitral Valve Complications 
2.7.1 Left Ventricular Outflow Tract Obstruction 
A prominent concern with TMVR is the potential obstruction of the left ventricular outflow 
tract (LVOT) by the TAV and native anterior MV leaflet. Three factors related to TMVR 
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LVOT obstruction include: device protrusion, aorto-mitral angulation, and septal bulging 
(Figure 2-21).13, 14 The TAV protrusion into the LV causes the anterior MV leaflet to be 
propped open into the LVOT causing obstruction. In addition, compounding with the 
deployment of the TAV into the MV and LV, the aorto-mitral angulation is a geometric 
concern that influences the amount of protrusion into the LVOT. The septal bulging can 




Figure 2-21. Selected risks of LVOT obstruction from Blanke et al.14 (risk 
increases from green to red).  
 
2.7.2 Thrombosis 
Thrombosis is the formation of a blood clot inside the circulatory system. Thrombosis is a 
problem for prosthetic heart valves, especially for those in the mitral position.15, 77, 78  
Mechanical prosthetic MVs have a thrombosis prevalence of 0.3% to 1.3% in developed 
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countries and as high as 6.1% in undeveloped countries.77, 78 In addition, bioprosthetic MVs 
with native MV leaflets intact have shown to have a thrombosis prevalence as high as 
24%.22 Major factors contributing to thrombosis as outlined by Virchow’s Triad are blood 
coagulability (blood cell damage), prosthetic heart valve surface interactions, and blood 
flow (stasis and turbulence). In this study we will be investigating thrombosis risk due to 
the changes in blood flow.  
 Thrombosis with TAVR has been observed79-82 with recent studies focusing on the 
flow stasis in a region known as the neo-sinus.83 The neo-sinus is the region between the 
native AV leaflets and the TAV leaflets and is formed by the native AV leaflets wrapping 
around the deployed TAV preventing flow through the open cells of the stent frame. 
Additionally, the AML also covers the stent frame creating a neo-sinus in danger of 
flow stasis between the AML and TAV leaflets. Thrombosis in the mitral position and in 
TAVs have been independently observed.16, 17, 84-86 In addition, the major occurrence of 
thrombosis from patients that underwent a bioprosthetic MV replacement were from those 
with their native leaflets preserved22. It then stands to reason that a TAV in an MV with its 
native leaflets preserved, would be under similar risks. Overall, these factors need to be 
considered when performing transcatheter mitral valve replacement. 
 
2.8 Percutaneous Laceration of Anterior Mitral Leaflet (LAMPOON) 
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In order to proactively prevent LVOT obstruction for TMVR caused by the AML, 
clinicians have begun intentionally lacerating the AML in a minimally invasive approach 
known as LAMPOON prior to transcatheter valve deployment (Figure 2-22).19, 87, 88 
 
Figure 2-22. Diagram of LAMPOON procedure from Babaliaros et al.: (A) TMV 
inserted displacing AML, (B) post-LAMPOON AML separation, (C-E) Guidewires 
inserted into LV via aorta, electrified to puncture AML and ensnared, then 
electrified and pulled to lacerate AML (modified from Babaliaros et al.19). 
 
Guided by fluoroscopy and echocardiography, LAMPOON first involves placing a 
guidewire at the A2 insertion of the AML and placing a second guidewire with a snare into 
the atrium via retrograde approach. The first guidewire is electrified to puncture and burn 
through the AML. The second guidewire the ensnares the first on the other side of the 
AML. Lastly, the first guidewire is electrified a second time and both wires pulled, burning 
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and lacerating the AML. This effectively creates a larger LVOT by allowing the TMVR 
stent frame and chordae to spread the AML apart post-LAMPOON. The LVOT is increased 
even more with open cell stent frame designs, as blood can now flow through the cells of 
the stent frame that were originally blocked by the AML. 
 
2.9 Mitral Valve In Vitro Modeling 
Mitral valve in vitro modeling is used to study the MV in a controlled environment with 
the ability to acquire metrics that are unable to be obtained in vivo. In current rigid in vitro 
models, the structural complexity of the excised MV is preserved and can be studied 
(Figure 2-23).89 
 
Figure 2-23. Basic schematic of in vitro rigid chamber left heart model.90 
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However, these models rely on certain simplifications, one being that the MV is 
mounted to a static, rigid annulus (leaflet attachment to the myocardium). This 
simplification of the annulus is justified when looking to control factors that are separate 
from a study’s interest, e.g. investigating chordal forces. However, in order to study, for 
example, how the motion of the MV annulus affects the biomechanics of the MV (e.g. MV 
leaflets), a more physiological model with dynamic contraction is needed. 
In addition to the rigid wall in vitro model, our lab has developed a flexible wall in 
vitro model (Figure 2-24).90 In current flexible wall models, the LV is made of a 
deformable material that is able to change shape under pressure. This provides a more 
anatomic and contractile motion of the LV wall when compared to the rigid wall. This 




Figure 2-24. Basic schematic of in vitro flexible chamber left heart model.90 
 
2.10 Significance 
There are currently no in vitro simulators that incorporate dynamic MV annular 
contraction. This simplification of MV motion provides a limitation for complete 
assessment of the MV and its annulus focused medical devices (e.g. annuloplasty ring) in 
an in vitro environment. Specific Aim 1 will provide an in vitro means of studying the effects 
of annular contraction to further understand valvular biomechanics. The new simulator 
could also help in advancing complex MR quantification techniques, computational 
simulations, and medical devices by providing a moving boundary condition and a means 
to exert force on MV devices in a left heart simulator. In addition, there are currently no 
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official guidelines for LAMPOON with TMVR (valve-in-ring, valve-in-valve, and valve-
in-MAC) as TMVR is an off-label use of the TAV and LAMPOON is an investigational 
procedure. Clinicians are relying on personal experience/intuition and selected case reports 
when making decisions during TMVR and LAMPOON procedures. There have been no 
quantitative analyses on the performance and safety of TMVR or LAMPOON. Thus, 
information of this nature could help create new evidence-based guidelines and 
recommendations for LAMPOON procedures. The results from Specific Aims 2 will 
provide insights into the benefits of LAMPOON on LV flow and help create the first 
evidence-based guidelines for TMVR and LAMPOON procedures. 
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CHAPTER 3. OBJECTIVE AND SPECIFIC AIMS 
The mitral valve (MV) is an intricate anatomical structure that undergoes complex 
conformational changes due to its dynamic loading environment. The contractile motion 
of the annulus has been omitted from previous in vitro models due to the added level of 
complexity that was deemed unnecessary for the studies being pursued at the time. 
However, with the recent innovations in the MV space24, 93, 94 a dynamic annulus is 
necessary to fully understand the interactions between MV anatomy and repair or 
replacement options. 
For patients at high-risk for surgical repair and replacement, transcatheter mitral 
valve replacement (TMVR) are now being performed. Cardiologists have begun 
implanting transcatheter aortic valves (TAVs) into mitral annular calcification (valve-in-
MAC),4-7 mitral bioprosthetic valves (valve-in-valve),7-9 and mitral annuloplasty rings 
(valve-in-ring)10-12 in order to correct recurrent mitral regurgitation (MR). With these being 
new, off-label procedure, no evidence-based deployment guidelines or recommendations 
exist outside isolated experiences reported in clinical case reports.95-97 Hence, in order to 
better guide and inform TMVR, there is a need for quantitative analysis of TMVR efficacy. 
The complex geometries of the left ventricle (LV) and MV present significant 
challenges to TMVR. The most critical periprocedural decision is the TAV position within 
the MV. In order to maximize expansion of the device, it is generally preferred to implant 
the TAV further into the LV. However, if implanted too far into the LV, the native anterior 
mitral leaflet held open by the TAV, could obstruct systolic flow through the aortic valve 
(AV) via the left ventricular outflow tract (LVOT), thus resulting in a sub-aortic stenosis.13, 
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14, 98 In addition, the TAV implantation in the mitral position introduces a new structure 
into the MV and LV that can disrupt the natural flow of the LV. This can result in an 
increased risk of thrombosis as seen on the LV side of bioprosthetic valves in the mitral 
position.84 One way to proactively relieve these problems is through prior surgical resection 
of the A2 scallop of the anterior mitral leaflet (AML) during placement of a surgical 
prosthetic MV18 or through a new percutaneous laceration of the AML known as 
LAMPOON.19, 28, 29 
The main objective for this study is to better understand the biomechanical 
challenges facing mitral valve repair and intervention replacement procedures. The central 
hypothesis for Specific Aim 1 is that healthy mitral valve (MV) annular contraction 
minimizes MV leaflet strain. To evaluate leaflet strain, leaflet marker tracking will be 
measured. The central hypothesis for Specific Aim 2 is that increasing AML laceration 
(LAMPOON) will positively impact AV and TMVR performance and safety. To 
evaluate TMVR performance, velocity fields of the LV will be acquired. The flow field of 
the LV and MV will be acquired to assess risk of left ventricular outflow tract (LVOT) 
obstruction and thrombosis. 
 
Specific Aim 1: Assess the impact of healthy and pathophysiological dynamic MV 
annulus contraction on MV leaflet strain.  Building on an existing in vitro left heart 
simulator99, a novel dynamically contracting annulus (DCA) will be used to compare how 
dynamic contraction impacts MV leaflet strain. This will be done by first comparing the 
healthy contraction with ischemic MV disease condition, and subsequently the healthy with 
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static-systolic and diastolic states. Leaflet strain will be measured via marker tracking from 
images acquired using stereophotogrammetry. 
 
Specific Aim 2: Evaluate how LAMPOON affects LVOT obstruction and the risk of 
TAV thrombosis as a function of TAV implantation heights, AML lengths, and 
LAMPOON lengths.  A previously validated in vitro left heart phantom91 will be adapted 
to provide a more physiologic LVOT geometry for quantitative assessment of TMVR 
procedures. Rigid MV leaflets with different AML lengths and degrees of LAMPOON will 
be made for the LV phantom. With the newly modified LV phantom, the aortic 
transvalvular pressure gradient and LV velocity fields will be studied using pressure 
transducers and 2-D high-speed particle image velocimetry (HSPIV). Favorable 
performance will be defined as maximizing AV effective orifice area and minimizing flow 
obstruction and maximizing neo-sinus washout as seen and quantified by pressure 
transducers and HSPIV, respectively. In addition, flow in the entire LV will be captured to 
further study LAMPOON. From the flow velocities we will calculate viscous shear stress 
(VSS), principal Reynolds shear stress (pRSS), and turbulent kinetic energy (TKE). These 
metrics have shown to be indicators of flow stagnation and turbulence. Unfavorable results 
will be increased stagnation, VSS, pRSS, and TKE.  
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CHAPTER 4. MATERIALS AND METHODS – SPECIFIC AIM 1 
4.1 Materials 
4.1.1 Pulsatile Left Heat Simulator 
The pulsatile left heart simulator (LHS)(Figure 4-1) consists of a left heart chamber for 
studying the mitral valve, flow probes and pressure transducers to tune to and record left 
heart hemodynamics, a piston pump to drive fluid, and piping, a reservoir, and 
compliance/resistance devices to create a flow loop.100, 101 
 
Figure 4-1. Schematic of left heart simulator complete flow loop with cylindrical 
chamber for ovine valves. 
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The left heart chamber (Figure 4-2; Figure 4-3) is made of clear acrylic left atrium, 
ventricle, and aorta sections, an annulus plate (4.1.2) between the atrium and ventricle, and 
papillary muscle (PM) rods within the left ventricle. The annulus plate is used for mounting 
the excised MV (4.1.4) with the PM rods securing and positioning the valve’s PMs within 
the left ventricle from the exterior of the left heart chamber. Lastly, a bi-leaflet mechanical 
valve is placed inside aorta section and used as the working aortic valve for the outlet flow. 
For SA1, two left heart chambers were used: 1) ovine (Figure 4-2) and 2) porcine (Figure 
4-3). These separate chambers were used in order to accommodate the difference in size 
between ovine and porcine MVs. 
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Figure 4-2. Ovine left heart chamber. 
 
Figure 4-3. Porcine left heart chamber. 
 
4.1.2 Annulus Plates 
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A dynamically contracting MV annulus (DCA) was designed to fit within an existing 
modular left heart simulator (4.1.1) to maintain the current imaging capabilities. A spring 
was embedded within a Dacron cuff to which the MV annulus is sutured. A wire was fed 
through the center of the spring and attached to the piston heads of two linear actuators 
(Figure 4-4). The wire facilitated contraction of the annulus using the motors, while the 
spring provided an improved means for relaxation. Two different annulus plates were 
fabricated; a larger to better accommodate the size of porcine MVs (porcine DCA) (Figure 
4-5) and a smaller for ovine (ovine DCA) (Figure 4-6). Both annulus plates were designed 
in SolidWorks (Dassault Systemes; France) and 3-D printed (Proto Labs; Maple Plain, 
MN) using Accura Xtreme White as the material. See APPENDIX H for computer-aided 
design (CAD) drawings and materials used to assemble. 
 
Figure 4-4. Simplified diagram of the ovine dynamically contracting annulus 
(DCA) setup with the ovine annulus plate centered between the wire attachments at 





Figure 4-5. Porcine dynamically contracting annulus (DCA) plate. (A) atrial side. 
(B) ventricular side. 
 
 
Figure 4-6. Ovine dynamically contracting annulus (DCA) plate. (A) atrial side. 
(B) ventricular side. 
 
4.1.3 Motors and Controllers 
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The linear actuators (HAD2-2, RobotZone; Winfield, KS) were displacement driven and 
controlled individually using a proportional-integral-derivative (PID) controller with the 
addition of a feed-forward loop written in LabVIEW (2015, National Instruments; Austin, 
TX). With the LabVIEW controller, H-bridge controllers (1015B, DeviceCraft; Fitchburg, 
MA) with power supplies (RS-100-12, Meanwell Power Supplies; Taiwan) provided 
voltage to the motors. The positions of the motors were measured using their built-in 
potentiometers. A full wiring diagram (A.1), controller settings (A.2), PID tuning methods 
(A.3), and input waveforms (A.4) can be found in APPENDIX A. 
All displacement waveforms used for the motors were derived from the mean MV 
annular circumference data from prior human, in vivo 3-D echocardiography work on 
mitral annular dynamics.25 From the raw images from the paper, the figure data was 
extracted using a custom MATLAB code (APPENDIX K). This data was scaled to match 
the same mean percent areal change for the different annular area sizes of the DCAs. 
Tuning of the motors for accuracy and precision of the waveform tracking was done before 
MV experiments were performed. This was tested in LabVIEW (APPENDIX J) by 
comparing the actual position of the motors using their potentiometer to the desired 
position being output by the controller. 
 
4.1.4 Mitral Valves 
Healthy mitral valves were excised from fresh, never frozen ovine hearts (Superior Farms; 
Denver, CO) and porcine hearts (Holifield Farms; Atlanta, GA). The excision left both the 
valvular (annulus and leaflets) and subvalvular (chordae tendineae and papillary muscles) 
apparatuses preserved (Figure 4-7). 
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Figure 4-7. Excision and mounting of the full mitral valve apparatus. 
 
Each valve was sized to their respective annulus plate suture cuff dimensions; the 
inter-trigonal distance and total annular perimeter of the annulus were primary 
measurements used in selection criteria. In addition, the chordal insertion points were a 
secondary criterion used in excluding mitral valves. It was necessary for the MV to have 
distinct grouping of chordal insertions into each papillary muscle with minimal spreading, 
and no primary chordal insertions into the wall of the ventricle. 
 
4.1.5 Echocardiography 
To image the MV in the LHS over the cardiac cycle, 4-D echocardiography via ie33 
xMatrix ultrasound system and x7-2 probe (Philips Healthcare; Andover, MA) was used. 
The echocardiography was then assessed in QLAB (Philips Healthcare; Andover, MA) 
where the geometry of the MV was measured. Although not used for this study, DICOMs 
can be exported for 3-D segmentation. 
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4.1.6 High-Speed Imaging 
To image the anterior mitral leaflet over the cardiac cycle, two high-speed A504k cameras 
(Basler Inc.; Exton, PA) and XCAP video acquisition software (EPIX, Inc.; Buffalo Grove, 
IL) were used. The cameras were placed as close as possible to the LHS, en face of the MV 
from the atrial side, and approximately 15° apart. Additional lighting was used to illuminate 
the MV from the atrial side, and the aperture of the lenses were opened to the minimal 
amount that provided good visibility with the best possible focal depth. 
 
4.1.7 Instrument Calibration 
4.1.7.1 Flow Probe Calibration 
A gain value of 1 was given to the channel of the electromagnetic flow probe (Carolina 
Medical Electronics; East Bend, NC). A reservoir with a controllable valve was attached 
upstream of the probe with an extended hose attached downstream to orderly flow into a 
large graduated cylinder. With LabVIEW running and reading the voltage from the flow 
probe, the reservoir valve was opened, and fluid poured into the graduate cylinder. Next, 
flow was cut off by closing the valve. In order to calculate the flow rate, the volume of 
fluid through the probe was measured with the graduated cylinder and the amount of time 
the valve was opened was measured with LabVIEW or a timer. This was repeated for 
multiple flow rates by the resistance of the reservoir valve. The time vs voltage plot was 
 52 
exported from LabVIEW and the curve integrated to calculate the flow probe constant 
necessary to match the volume measure with the graduated cylinder. 
 
4.1.7.2 Pressure Transducer Calibration 
A gain value of 1 was given to the channel of the Deltran pressure transducer (Model# 
DPT-100, Utah Medical Products; Midvale, UT). A Delta-Cal transducer 
calibration/verification device (Model# 650-950, Utah Medical Products; Midvale, UT) 
was then attached to the transducer and flow valve opened to its channel. Before acquiring 
readings, the pinch valve was squeezed to equilibrate the transducer. With LabVIEW 
running and reading the voltage from the pressure transducer, the Delta-Cal was adjusted 
to varying pressure values (-50 to 200 mmHg), imposing those known pressure values onto 
the transducer. The pressure transducer voltage was recorded along with the corresponding 
pressure from the Delta-Cal to make a plot. The slope of the linear fit line (should be R2 = 
0.99) for voltage vs pressure was used as the new gain value, so that the voltage from the 
transducer was scaled to match the pressure in LabVIEW. 
 
4.2 Methods 
4.2.1 Experimental Conditions 
Changes in anterior leaflet strain between physiological and pathophysiological annulus 
conditions were investigated using the porcine DCA plate (Experiment A). Two states of 
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annular function were tested: 1) healthy and 2) diseased. To isolate the effects of the 
annular contraction on leaflet strain, only the annulus size/motion was changed between 
healthy and diseased states, and papillary muscles were left in-place. This consisted of 
increasing its diastolic area from 11.4 cm2 to 13.0 cm2 to simulate annular dilation and 
using a contractile waveform consistent with ischemic MR patients. The percent change of 
contraction from diastole to systole of averaged healthy and ischemic annular area data25 
was used for scaling (-13.2 ± 2.5% and -5.4 ± 1.9% change, respectively). 
Changes in anterior leaflet strain between a rigid annuloplasty (static annulus) and 
a dynamic annulus were investigated using the ovine DCA plate (Experiment B). Three 
states of annular function were tested: 1) healthy contractile, 2) static-min, and 3) static-
max. The minimum and maximum static states were sized to be the systolic and diastolic 
annular area (4.5 cm2 and 5.5 cm2, respectively) of the healthy dynamic contraction used 
as the healthy state. Differing from the porcine study, 2-D annular area fraction change as 
defined by Levack et al.25 was used for scaling of the healthy contraction (-19.02 ± 4.94% 
change). This was done to simulate a healthy contraction for a worst-case comparison of 
differences due to changes made by a rigid annuloplasty. To isolate the effects of the 
annular contraction on leaflet strain, only the annular variables were changed between 
states and the papillary muscles remained stationary. 
 
4.2.2 Experimental Protocol 
Healthy mitral valves were excised from fresh ovine hearts and porcine hearts (N=8 for 
each). The valves were sized to match the healthy, diastolic annular area of their respective 
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annulus plate (4.1.4). During excision, the annuli and subvalvular structures (i.e. chordae 
tendineae and papillary muscles) were preserved. The MVs were then mounted into the left 
heart chamber by suturing the MV annulus to the annulus cuff and attaching the PMs to 
the PM positioning rods (Figure 4-2; Figure 4-3). 
A marker grid was applied to the MV leaflets using tissue dye (Mark-It Tissue 
Marking Dye, Fisher Scientific; Hampton, NH). Stereophotogrammetry was used to track 
a 3x3 grid on the central A2 scallop (Figure 4-8) of the MV using two high-speed cameras 
at 250 Hz (4.1.6).  
 
Figure 4-8. Ovine mitral valve leaflet marked with tissue dye for 
stereophotogrammetry. 3x3 grid used for strain measurements highlighted. 
 
Before camera acquisition, the LHS was run for multiple cardiac cycles to remove 
any initial transients in the MV dynamics and flow due to start-up. A cube of known side-
length (1 cm) was placed in the same field-of-view (FOV) of the cameras where, in the 
paired 2-D camera frames, the same 7 corners of the cube were in their FOV. Using those 
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7 corners and the known length and shape of the cube, we defined a 3-D coordinate system 
between the two cameras using direct linear transformation. 4-D echocardiography was 
used for measuring annular area and leaflet midline coaptation length (4.1.5). 
Normal left heart pressures and flows (5 liters/min, 100 mmHg peak MV gradient, 
70 beats/min, 35/65 systole/diastole ratio) were replicated within the simulator. A custom 
LabVIEW code was used to control the pulsatile pump (Vivitro Labs, Victoria, BC, CA), 
and record hemodynamics from a flow probe (4.1.7.1) and wall-tapped pressure 
transducers (4.1.7.2). The pressure transducers were placed in the left atrium and left 
ventricle with the flow probe placed within the inlet of the left atrium as shown in Figure 
4-1. 
 
4.2.3 Data Analysis 
Green areal strain between peak systole and diastole for each state of annular function was 
computed over one cardiac cycle using a custom code written in MATLAB (R2016a, 
MathWorks, Natick, MA). In preliminary analysis, it was seen that there was minimal cycle 
to cycle variation in strain measurements, thus one was used to cut down on processing 
time. Midline leaflet coaptation for each state was measured with QLAB (Philips 
Healthcare, Andover, MA) using 4-D echocardiography. In addition, annular area change 
was measured with QLAB to ensure proper annular contraction for each experiment. 
The Wilcoxon signed-ranked test was used for paired-group statistics using IBM 
SPSS Statistics (v24, IBM Corp., Armonk, NY). 
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CHAPTER 5. MATERIALS AND METHODS – SPECIFIC AIM 2 
5.1 Materials 
5.1.1 Pulsatile Left Heart Simulator w/ Left Ventricular Phantom 
Based on the extensively studied Georgia Tech left heart simulator,100, 101 a novel 
and more comprehensive left ventricle simulator was designed by the Cardiovascular Fluid 
Mechanics Laboratory (Figure 5-1 and Figure 5-2).91, 102, 103  
 




Figure 5-2. Complete LV box chamber assembly with LV phantom. 
 
This realistic left heart simulator (RLHS) was comprised of an LV phantom 
complete with bioprosthetic aortic and mitral valves. The silicone LV phantom (5.1.2) is 
compliance-matched (diastolic) to a healthy myocardium and is housed in an acrylic 
chamber. The pulsatile piston pump (PPP) controls the pressure within the acrylic housing 
causing expansion and contraction of the LV, resulting in flow through the simulator. The 
peripheral resistance and compliance were used to help maintain proper hemodynamics of 
the LV. Wall-tapped pressure transducers were placed in the left atrium, left ventricle, and 
aorta, while a catheter extension was placed in the LVOT. The flow probes were placed 
upstream of the MV and downstream of the AV to measure both MV and AV flow curves. 
A 36% glycerin, 64% water solution was used in the loop in order to match the dynamic 
viscosity of blood (3.5 cP). LabVIEW was used to control the pulsatile piston pump as well 
as record and monitor the hemodynamics of the RLHS. 
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 For the purposes of this study (CHAPTER 3) and future studies, the RLHS was 
redesigned to achieve a more anatomically correct LVOT and the ability to add MV leaflets 
inside the LV. This was done externally by moving the MV inlet and AV outlet as close 
together as possible within the LV box chamber, and then further accomplished internally 
with an LV insert (5.1.3). A 29 mm GT-TAV (5.1.5) was placed inside the MV leaflets 
(5.1.4), while a 23 mm PERIMOUNT BHV (Edwards Lifesciences; Irvine, CA) will be 
used as the AV. See APPENDIX B for a detailed assembly guide for the LV box chamber. 
See APPENDIX I for CAD drawings and materials used in making the LV box chamber. 
 
5.1.2 Left Ventricle Phantom 
The silicone LV phantom (Figure 5-3) used for this study was previously studied by Okafor 
et al.91, 102 and cast by a third-party company (VenAir; Terrassa, Spain). The healthy LV 
phantom specifications used in this study were an aorto-mitral angle of 125°, a sphericity 
index of 0.598 (width of 40 mm), stiffness of 1.169 mmHg/mL, and shore A hardness of 
23. The silicone phantom provided the optical clarity necessary for high-speed particle 
image velocimetry (HSPIV). Details behind the development and design of the LV 
phantom from patient data can be found in the thesis of Okafor.103 
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Figure 5-3. Schematic of the LV phantom and dimensionality of the sphericity 
index (modified from Okafor103). 
 
5.1.3 Left Ventricle Insert 
The LV insert (Figure 5-4) served three important purposes: 1) provided a modular 
attachment for different MV leaflet geometries, 2) moved the aorto-mitral plane further 
into the LV, putting the whole LV in FOV of the high-speed camera, and 3) created an 
even better LVOT geometry by bringing the AV outlet and MV inlet closer together. 
 60 
 
Figure 5-4. 3-D printed LV insert with Long AML, 0% LAMPOON 3-D printed 
MV glued in place. 
 
 The LV insert was designed using SolidWorks and made to fit securely into the 
MV inlet of the LV box chamber. It was then 3-D printed using stereolithography (SLA) 
at a resolution of 0.010 in., solid density, and ABS-P430 material. See APPENDIX I for 
CAD drawings used in the making of the LV insert. 
 
 
5.1.4 Mitral Valve Leaflets 
 61 
The transparent MV leaflets (Figure 5-5) were 3-D printed (CIDEAS, Crystal Lake, IL) 
using SLA at a resolution of 0.0040 in., solid density, and Accura ClearVue material. The 
MV leaflet geometry was acquired from micro-computed tomography (µCT) images of an 
excised porcine valve and exported as an .STL file for printing. 
 
Figure 5-5. 3-D printed, transparent MV leaflets modeling three LAMPOON 
geometries (0%, 50%, and 100%) with Short AML. 
 
Prior to µCT, a porcine MV was sized for a 29 mm SAPIEN 3 and excised keeping 
the native valvular anatomy intact. The excised valve was then mounted onto an annulus 
plate with a circular suture cuff sized to a 29 mm SAPIEN 3. During µCT, a cylinder with 
the dimensions of a 29 mm SAPIEN 3 was inserted into the valve to provide the correct 
leaflet geometry for when we place a TAV inside the rigid, printed leaflets of the simulator 
(FIGURE XXX). 
After µCT, the valve and cylinder were segmented using 3D Slicer and the cylinder 
insert and annulus plate removed in SolidWorks. The chordae and papillary muscles were 
then removed in Geomagic Studio (3D Systems, Morrisville, NC) leaving just the MV 
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leaflets. The MV leaflet surface was then smoothed in Geomagic Studio/Design X for 
better optical clarity during printing. Next, simulated AML flail into the LVOT (Long 
AML) was done in SolidWorks and Geomagic Studio at the hinge point where the TAV 
stent frame ends and the leaflet would no longer be taut. The Long AML (XXX mm) was 
within the extreme of human lengths while the Short AMl (XXX mm) was in the norm of 
human lengths (XXX). Lastly, different size sections of the A2 scallop of the AML were 
cut away in SolidWorks to mimic the resultant geometry from different lengths of 
LAMPOON (Figure 5-6). 
 
Figure 5-6. Models of three LAMPOON geometries (0%, 50%, and 100%) with 
Long AML geometry and an image of 100% LAMPOON with porcine MV and 
SAPIEN 3 deployed at 80/20 ventricle/atrium ratio. The A2 scallop is lacerated 
allowing the AML to be pulled open by the TAV stent frame and the AML chordae. 
 
5.1.5 Georgia Tech – Transcatheter Aortic Valve 
The TAV model used for this study was made in-house (GT-TAV) to replicate the 
geometry of a 29 mm SAPIEN 3 (Edwards Lifesciences, Irvine, CA) (Figure 5-7). The GT-
TAV has previously been validated for hemodynamic performance in the AV position.83 
The stent frame is made of a clear acrylic sheet that has been laser cut to the SAPIEN 3 
internal dimensions and the leaflets are made of bovine pericardium. This provided a 
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transparent stent frame for better optical access into the AML neo-sinus during high-speed 
particle image velocimetry (HSPIV). A complete manufacturing protocol of the GT-TAV 
can be found in APPENDIX C. Part drawings and CAD of the GT-TAV can be found in 
APPENDIX I. 
 
Figure 5-7. Open 29mm GT-TAV without retaining ring alongside closed 29mm 
SAPIEN 3. The extra length at the bottom of the GT-TAV is for assembly purposes 
and is accounted for with regards to deployment height. 
  
5.1.6 High-Speed Particle Imaging Velocimetry (HSPIV) 
HSPIV was used to measure the 2-D, time-resolved velocity field of the LV and neo-sinus. 
A 2W, 532nm diode-pumped continuous wave solid-state laser (Shenzhen Optlaser, 
Shenzhen, China) emitting a 2 mm beam was used as the light source. The laser beam was 
converted to a high frequency pulsed laser sheet by using a scanning mirror (rotating mirror 
array) setup provided by LaVision (GmbH, Goettingen, Germany). This frequency was 
manually controlled and its sensor reading shown in DaVis (by LaVision). The flow was 
seeded with fluorescent polymeric rhodamine-B particles (Dantec Dynamics; Denmark) 
with a mean diameter of approximately 10μm. A CMOS camera (Phantom VEO 340L, 
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Vision Research; Wayne, NJ) was used to image the particles in the central long-axis plane 
of the LV (Figure 5-8).  
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Figure 5-8. Diagram showing anatomical orientation of the PIV image plane. The 
image plane is the LV central long-axis which slices down from the A2-P2 of the 
MV. 
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The particle size in the camera image ranged from 2 to 4 pixels. The camera was 
fitted with a macro lens system of focal length 60 mm and the aperture was set at f/4. To 
improve the signal-to-noise ratio of the acquired data, a high-pass lens filter (cut-off 
wavelength of 580 nm) was used to minimize laser reflections from the sinus region. 
Detailed hardware configuration protocols can be found in APPENDIX D. 
 
5.1.7 Instrument Calibration 
5.1.7.1 Flow Probe Calibration 
See Section 4.1.7.1. 
 
5.1.7.2 Pressure Transducer Calibration 
See Section 4.1.7.2. 
 
5.1.7.3 Viscosity Tuning 
A U-tube viscometer was used to measure the viscosity of the water/glycerin solution 
(Figure 5-9). This was done by drawing 6.8 mL of fluid to the top red line using a pipette. 
The amount of time it took to drain from the bulb to the bottom red line was then measured. 
The drainage time was then used to calculate the viscosity of the 36% glycerin, 64% water 
solution. For this study, a time of 480 seconds achieved a dynamic viscosity of 3.5 cP. 
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5.2.1 Experimental Conditions 
For both Specific Aims 2A and 2B, three conditions were varied: 1) AML length, 2) 
LAMPOON length, and 3) TAV deployment height (Table 5-1). 
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Short 3 (0, 50, 100) 1 (50/50) 3 (2.5, 5.0, 6.5) 9 
27 
Long 3 (0, 50, 100) 2 (50/50, 80/20) 3 (2.5, 5.0, 6.5) 18 
SA2B Long 3 (0, 50, 100) 1 (80/20) 3 (2.5, 5.0, 6.5) 9 9 
 
A Short AML and a Long AML were used to study how different sized AMLs, and 
by relation LVOTs, affect the flow in the LV (SA2A) and neo-sinus (SA2B). Each AML 
condition was given three different lengths of LAMPOON: 0%, 50%, and 100% AML 
length. This was done in order to study the changing effects that an optimal LAMPOON 
(100%) or suboptimal LAMPOON (50%) would have on the flow in the LV (SA2A) and 
AML neo-sinus (SA2B) when compared to the intact AML (0%). 
 For the Short AML condition, a 50/50 ventricular/atrial ratio deployment height 
was used, and for the Long AML condition, 50/50 and 80/20 deployment heights were 
used.  The 50/50 condition was used to mimic a generic deployment of the TAV in a valve-
in-ring or valve-in-MAC case. However, in order to get further expansion of the TAV to 
provide better hemodynamic performance, clinicians deploy the TAV further into the LV. 
The 80/20 condition was used to mimic the more optimal TAV deployment in conjunction 
with the worst-case AML length (Long AML condition). The 50/50 deployment provided 
a comparative variable between Short and Long AML conditions. For SA2A, a control 
condition with no MV leaflets and the GT-TAV placed upstream of the MV annular plane 
was also done to help better characterize native systole. 
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5.2.2 Experimental Protocol 
The LV box chamber was assembled and GT-TAV (5.1.5) placed into the LV insert at its 
experimental deployment height condition. A different LV insert (5.1.3) was used inside 
the chamber for each AML length and LAMPOON condition (6 total). Once the LV box 
chamber was assembled, the RLHS was configured. 
The RLHS was tuned and run for multiple cardiac cycles to remove any initial 
transients in the LV flow due to start-up. Normal left heart hemodynamics (100 mmHg 
peak MV gradient, 70 beats/min, 35/65 systole/diastole ratio) with varying cardiac output 
of 2.5, 5.0, and 6.5 liters/min were replicated within the simulator. A previously written 
custom LabVIEW code was used to trigger the HSPIV controller, control the pulsatile 
pump (Vivitro Labs, Victoria, BC, CA), and record hemodynamics from a flow probe 
(4.1.7.1) and pressure transducers (4.1.7.2). 
 Following the tuning of each cardiac output, HSPIV was performed (5.1.6). The 
high-speed laser was adjusted to ≈700 Hz for SA2A and ≈400 Hz for SA2B to optimize 
frame rate and light intensity in the regions of interest (ROI) (Figure 5-10). The camera 
was initially positioned and focused on the SA2A ROI (the LV). For each LAMPOON 
length and TAV deployment condition, SA2A HSPIV data was acquired in order of 2.5, 
5.0, and 6.5 liters/min cardiac outputs. Immediately following SA2A data acquisition, the 
camera would be moved closer and focused on the SA2B ROI (the neo-sinus) to maximize 
image resolution (Figure 5-11). Using the same experimental condition as SA2A, SA2B 
HSPIV data was then acquired in order of 6.5, 5.0, and 2.5 liters/min cardiac output. For 
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Figure 5-10. Raw camera image from SA2A showing SA2A (orange) and SA2B 




Figure 5-11. Raw camera image from SA2A with raw camera image from SA2B. 
The camera is moved closer between SA2A and SA2B to focus on the MV neo-sinus 
(outlined in green) while maximizing resolution. 
 
5.2.3 Data Processing and Analysis 
DaVis 8.4 and 10 (LaVision) were used to process HSPIV data for SA2A and SA2B, 
respectively. In order of operation, a mask was made to isolate the ROI (LV for SA2A or 
neo-sinus for SA2B) from the raw images, a background subtraction filter was used to 
remove background noise from the masked images, sequential cross-correlation was used 
for velocity vector calculation, and vector post-processing was used to remove erroneous 
vectors and smooth the velocity field. 
 Once the velocity field was calculated in DaVis, custom MATLAB code was used 
to bin-average, phase-average, and calculate velocity magnitude. Viscous shear stress 
(VSS; Equation 5-1), principal Reynolds shear stress (pRSS; Equation 5-2), and turbulent 
kinetic energy (TKE; Equation 5-3) were subsequently calculated from the phase- averaged 
 73 
velocity fields. Lastly, instantaneous streamlines and pathlines were calculated using 
Tecplot 360 (Tecplot, Bellevue, WA) and MATLAB was used to better articulate particle 
tracking in the LV and neo-sinus. 
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For SA2B, the maximum and average velocity magnitudes experienced at each grid 
location over the cardiac cycle were computed in MATLAB as a means of identifying and 
comparing regions of flow stasis. Velocity fields during diastole and systole were then 
investigated to better understand the maximum and average velocity magnitudes. The 
average velocity as well as the maximum velocity within the neo-sinus was then computed 
for each velocity field: 1) cycle average 2) cycle maximum, 3) diastole, and 4) systole. 
Particle tracking was seeded at 200 ms into diastole to calculate washout of the neo-sinus 
during diastole. 
Detailed DaVis, MATLAB, and Tecplot processing settings used for this study can 
be found in APPENDIX E. All MATLAB and Tecplot processing codes used for this study 
can be found in APPENDIX L and APPENDIX M, respectively.  
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CHAPTER 6. RESULTS AND DISCUSSION – SPECIFIC AIM 1 
6.1 Specific Aim 1 Results 
Raw Specific Aim 1 results can be found in APPENDIX F. 
Motor position showed strong agreement with the target waveforms (Figure 6-1; Table 
6-1). In addition, tracking annular area showed similar agreement with the desired in vivo 
percent areal change (Figure 6-2; Table 6-2). 
 
Figure 6-1. Comparison of desired and measured displacements of a single linear 
actuator starting with systole for plate type - waveform. 
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Table 6-1. Resultant accuracy of measured motor displacements compared to 




Figure 6-2. Echocardiographic image showing annular contraction from diastole 
to systole (see Table 6-2 for results). 
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Table 6-2. Measured mean ± SEM annular area of contractile states from 4-D 
echocardiography compared to the desired annular area. 
 
 
The mean ± standard error (SEM) anterior leaflet strain of the healthy and diseased 
states from Experiment A were 0.64 ± 0.06 and 0.70 ± 0.06, respectively (Figure 6-3; 
Figure 6-4). The healthy state significantly reduced leaflet strain when compared to the 
diseased state (p < 0.05). There was no significant difference in coaptation length between 
the two states. 
The mean ± SEM anterior leaflet strain of the healthy, static-min, and static-max 
states from Experiment B were 0.32 ± 0.06, 0.37 ± 0.06, and 0.41 ± 0.05, respectively 
(Figure 6-5; Figure 6-6). The healthy state significantly reduced leaflet strain versus both 
static states (each p < 0.05). There was no significant difference in anterior leaflet strain 
between static states, or coaptation length between the three states. 
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Figure 6-3. (Experiment A) Anterior leaflet resultant mean ± SEM Green areal 




Figure 6-4. (Experiment A) Anterior leaflet resultant Green areal strain map 
between annular contractile states: healthy and diseased. 
 
Figure 6-5. (Experiment B) Anterior leaflet resultant mean ± SEM Green areal 




Figure 6-6. (Experiment B) Anterior leaflet resultant Green areal strain map 
between annular states: healthy, static-min, and static-max. 
 
6.2 Specific Aim 1 Discussion 
In pursuit of a mitral valve simulator that more completely represents the dynamic motion 
of the full valvular apparatus, this study demonstrated the successful operation of a 
dynamically contracting mitral annulus. Motor accuracy was shown to be in good 
agreement with the desired waveforms for both the porcine and the ovine annulus plates. 
It was confirmed that this translated to proper annulus area change during experiments 
using 4-D echocardiography. With the DCAs shown to reproduce the scaled in vivo 
geometries, it was necessary to show that the MV leaflet mechanics were also reproduced. 
When investigating the reproduction of MV leaflet mechanics of the new simulator 
in Experiment A, it was seen that the diseased contractile state increased anterior leaflet 
strain compared to the healthy state. In our study, strain in the center of the A2 scallop was 
evaluated, as that is where the highest strains are seen.104  Previous porcine in vitro studies 
have seen comparable areal strain magnitudes (70-75% stretch) when only focusing on the 
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central A2 scallop and using stereophotogrammetry.105 Our results are also in agreement 
with previous in vivo and in vitro study trends that IMR increases anterior leaflet strain.101 
It is noted that our results have a greater magnitude of strain compared to the in vivo 
measurements; this is believed to be primarily due to differences seen between in vivo and 
in vitro models, using porcine and ovine valves, and the selected area being measured on 
the leaflet. Previous review articles have highlighted the increased MV leaflet strains seen 
with porcine compared to ovine as well as in vivo compared to in vitro.23 Overall, our 
results highlight the ability of the simulator to not only reproduce in vivo MV annular 
dynamics, but also MV leaflet mechanics. 
In Experiment B, it was also shown in vitro that simulated rigid annuloplasty 
increased mitral anterior leaflet strain compared to a healthy contraction. Previous in vivo 
animal studies have shown similar results where rigid true-sized annuloplasty rings 
increase anterior mitral leaflet strains.106 Our work specifically shows that sizing an 
annuloplasty ring to an MV’s diastolic and systolic annular area leads to increased strain 
in the anterior leaflet. This implies that rigid annuloplasty rings, regardless of size, can lead 
to increased strain in the anterior leaflet. Additional in vivo animal studies have also 
reported that altering the MV geometry using restrictive annuloplasty rings alters strains in 
the MV anterior leaflet107. Amini, et al.107 postulates that this annular restriction may affect 
long-term leaflet durability due to changes in the leaflet’s mechanobiological homeostasis. 
Clinical studies are needed to investigate if anterior leaflet strain is increased in patients 
with restrictive annuloplasty rings, and, if so, how it impacts repair failure. 
Additionally, there was no significant difference seen in coaptation length between 
states of both experiments. This is believed to be predominantly due to the use of healthy 
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MVs and the annulus being the only variable changed between experiments. Previous 
studies have highlighted the effects of isolated annular dilation and papillary muscle (PM) 
displacement on decreasing leaflet coaptation.108, 109 Their results show a much larger 
increase in annular area (greater than 75%), not representative of the 14% increase from 
the in vivo human data used in this study, is needed to have a significant decrease in 
coaptation. In addition, they also show that PM displacement has an even larger effect on 
decreasing leaflet coaptation, of which was not changed in this study. 
 
6.2.1 Clinical and Engineering Implications 
The work of SA1 provides the first in vitro MV simulator with a dynamically contracting 
annulus. This new left heart simulator will serve as a platform for future studies in MV 
biomechanics and repair procedures as well as percutaneous replacement device testing. 
Additionally, this work suggests that striving to maintain the MV annular dynamics during 
MV repair procedures is beneficial to the loading of the anterior leaflet. It may then 
beneficial for future annuloplasty devices to have some component of flexibility rather than 
be completely rigid. 
 
6.2.2 Limitations 
The main limitation of this new annular design is that the annulus is flat and its contraction 
is limited to 2-D, planar motion derived from 2-D projections of 3-D geometry. 
Physiologically, the MV annulus has a 3-D contractile motion over the cardiac cycle, 
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changing between a saddle-shape and a more flat-shape. It has been previously shown that 
the saddle-shape of the MV does minimize leaflet strain;110 it could then be hypothesized 
that adding this 3-D shape to our study would have presented even greater differences 
between a saddle-shaped healthy state and the flatter-shaped diseased and annuloplasty 
states. However, for our study, it was deemed that having a 2-D, planar motion allowed for 
more use of data as contractile inputs (annular metrics commonly presented as 2-D, planar 




CHAPTER 7. RESULTS AND DISCUSSION – SPECIFIC AIM 2 
7.1 Specific Aim 2 Results 
Raw Specific Aim 2 results for plots can be found in APPENDIX G. 
7.1.1 Specific Aim 2A: LV Flow with LAMPOON 
 
Figure 7-1. Diagram of Long AML raw image for better anatomical reference 
when looking at Specific Aim 2A PIV results. Orange is the PIV ROI and the AML 
and GT-TAV are masked out. 
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During peak systole, the average LVOT velocity measured was 0.46 m/s occurring with 
0% LAMPOON at 6.5 L/min. Holding cardiac output constant across conditions, the 
average LVOT velocity showed a decreasing trend as LAMPOON length increased for 
80/20 and 50/50 Long AML conditions, but not for the 50/50 Short (Figure 7-2; Figure 
7-3; Figure 7-4; Figure 7-5; Figure 7-6). 
 Maximum VSS measured over the cardiac cycle peaked at 1.4 N/m2 occurring with 
0% LAMPOON at 6.5 L/min. Holding cardiac output constant across conditions, the 
maximum VSS showed a decreasing trend as LAMPOON length increased for all 
deployment and AML lengths (Figure 7-7; Figure 7-8; Figure 7-9; Figure 7-10; Figure 
7-11). 
 Maximum principal RSS measured over the cardiac cycle peaked at 71.2 N/m2 
occurring with 0% LAMPOON at 6.5 L/min. No trend was seen with maximum principal 
RSS between LAMPOON conditions (Figure 7-12; Figure 7-13; Figure 7-14; Figure 7-15; 
Figure 7-16). 
 Maximum TKE measured over the cardiac cycle peaked at 0.084 m2/s2 occurring 
with 0% LAMPOON at 6.5 L/min. No trend was seen with maximum TKE between 
LAMPOON conditions (Figure 7-17; Figure 7-18; Figure 7-19; Figure 7-20; Figure 7-21). 
 During mid-diastole, holding cardiac output constant across conditions, vorticity 
size and magnitude in the LV showed an increasing trend with increasing LAMPOON 
(Figure 7-22; Figure 7-23; Figure 7-24). The increased vorticity size and magnitude 





Figure 7-2. Velocity fields with instantaneous streamlines at peak systole at 2.5 




Figure 7-3. Velocity fields with instantaneous streamlines at peak systole at 5.0 




Figure 7-4. Velocity fields with instantaneous streamlines at peak systole at 6.5 








Figure 7-6. Average LVOT velocities at peak systole averaged across both Long 




Figure 7-7. Frames containing maximum VSS in the cardiac cycle at 2.5 L/min 




Figure 7-8. Frames containing maximum VSS in the cardiac cycle at 5.0 L/min 




Figure 7-9. Frames containing maximum VSS in the cardiac cycle at 6.5 L/min 








Figure 7-11. Maximum VSS in the LV over the cardiac cycle averaged across all 




Figure 7-12. Frames containing maximum principal RSS in the cardiac cycle at 2.5 




Figure 7-13. Frames containing maximum principal RSS in the cardiac cycle at 5.0 




Figure 7-14. Frames containing maximum principal RSS in the cardiac cycle at 6.5 
L/min for each condition. 
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Figure 7-16. Maximum principal RSS over the cardiac cycle averaged across all 




Figure 7-17. Frames containing maximum TKE in the cardiac cycle at 2.5 L/min 




Figure 7-18. Frames containing maximum TKE in the cardiac cycle at 5.0 L/min 




Figure 7-19. Frames containing maximum TKE in the cardiac cycle at 6.5 L/min 













Figure 7-22. Vorticity fields with instantaneous streamlines at mid-diastole at 2.5 




Figure 7-23. Vorticity fields with instantaneous streamlines at mid-diastole at 5.0 




Figure 7-24. Vorticity fields with instantaneous streamlines at mid-diastole at 6.5 







7.1.2 Specific Aim 2B: Neo-Sinus Flow with LAMPOON 
 
Figure 7-25. Diagram of Long AML raw image for better anatomical reference 
when looking at Specific Aim 2B PIV results. Blue is the PIV ROI, red is anterior 
mitral neo-sinus, and the AML and GT-TAV leaflet is masked out. 
 
All LAMPOON conditions at all cardiac outputs showed a maximum velocity magnitude 
of at least 0.1 m/s in the neo-sinus over the cardiac cycle (Figure 7-26; Figure 7-27; Table 
7-1). The majority of the maximum velocities in the neo-sinus were shown to have occurred 
during systole (Figure 7-28; Figure 7-29; Table 7-2). The 100% LAMPOON condition 
showed a higher average velocity magnitude in the neo-sinus over the cardiac cycle 
compare to the 0% and 50% LAMPOON conditions (Figure 7-30; Figure 7-31; Table 7-3). 
This was shown to be a result of the 100% LAMPOON condition having higher velocity 
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in the neo-sinus during diastole compared to the 0% and 50% LAMPOON conditions 
(Figure 7-32; Figure 7-33; Table 7-4). The 100% LAMPOON was subsequently shown to 
have better washout of the neo-sinus during diastole compared to the 0% and 50% 
LAMPOON conditions from particle tracking (Figure 7-34; Figure 7-35). 
 
Figure 7-26. Cycle-maximum velocity magnitudes in the neo-sinus (highlighted by 
red box) of different LAMPOON conditions (0, 50, and 100%) at different cardiac 




Figure 7-27. Average velocities within the neo-sinus for the cycle-maximum 
velocity magnitudes. Helps quantify Figure 7-26. 
 
Table 7-1. Average and maximum velocities within the neo-sinus for the cycle-




Figure 7-28. Mid-Systolic velocity fields in the neo-sinus (highlighted by red box) 
of different LAMPOON conditions (0, 50, and 100%) at different cardiac outputs 




Figure 7-29. Average velocities with the neo-sinus for the mid-systolic velocity 
fields. Helps quantify Figure 7-28. 
 
Table 7-2. Average and maximum velocities within the neo-sinus for the mid-




Figure 7-30. Cycle-average velocity magnitudes in the neo-sinus (highlighted by 
red box) of different LAMPOON conditions (0, 50, and 100%) at different cardiac 




Figure 7-31. Average velocities within the neo-sinus for the cycle-average velocity 
magnitudes. Helps quantify Figure 7-30. 
 
Table 7-3. Average and maximum velocities within the neo-sinus for the cycle-














2.5 0.031 0.038 0.026 0.031 0.080 0.100
5.0 0.043 0.050 0.034 0.043 0.056 0.075




0% LAMPOON 50% LAMPOON 100% LAMPOON
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Figure 7-32. Mid-Diastolic velocity fields in the neo-sinus (highlighted by red box) 
of different LAMPOON conditions (0, 50, and 100%) at different cardiac outputs 




Figure 7-33. Average velocities within the neo-sinus for the mid-systolic velocity 
fields. Helps quantify Figure 7-32. 
 
Table 7-4. Average and maximum velocities within the neo-sinus for the mid-















2.5 0.015 0.035 0.005 0.019 0.121 0.182
5.0 0.014 0.027 0.013 0.024 0.103 0.141




0% LAMPOON 50% LAMPOON 100% LAMPOON
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Figure 7-34. 20 particle pathlines in the neo-sinus (highlighted by red box) of 
different LAMPOON conditions (0, 50, and 100%) at different cardiac outputs (2.5, 
5.0, and 6.5 L/min). 
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Figure 7-35. Particle washouts between LAMPOON conditions at different flow 
rates. Particles were seeded 200 ms into diastole. 
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7.2 Specific Aim 2 Discussion 
7.2.1 Specific Aim 2A: LV Flow with LAMPOON 
Left ventricular outflow tract (LVOT) obstruction is a risk for patients with transcatheter 
mitral valve replacements (TMVR).13, 14, 111 This is primarily caused by current TMVs, off-
label TAVs or dedicated TMVs, extending into the LVOT once deployed and 
consequentially propping the anterior mitral leaflet (AML) into the LVOT. The main goal 
of the LAMPOON procedure is to proactively prevent this transcatheter valve induced 
LVOT obstruction by lacerating the AML prior to implantation.19, 88, 112, 113 This laceration 
increases the size of the post-TMVR LVOT by allowing the AML to splay around the stent 
frame as the transcatheter valve expands with help from the chordae pulling the AML apart. 
 Specific Aim 2A investigated how differing degrees of LAMPOON with different 
AML lengths and TAV deployment heights would affect flow in the LV.  While studying 
systolic flow, it was found that both deployment heights for the Long AML (80/20 and 
50/50 ventricle/atrial) showed decreased systolic velocity magnitude in the LVOT with 
increased LAMPOON (Figure 7-5; Figure 7-6). This was due to LAMPOON creating a 
larger LVOT (a larger cross-sectional area) for systolic flow to go through. This decrease 
in LVOT velocity with LAMPOON could translate to a decrease in LVOT obstruction with 
an effective lower pressure gradient across the AV. The Short AML (50/50 ventricle/atrial) 
showed no clear differences in systolic velocity magnitude in the LVOT with increased 
LAMPOON. This was believed to be due to the already small length of the Short AML 
condition with no large changes in LVOT cross-sectional area, given the geometry of the 
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LV and Short AML. Overall the velocity magnitude in the LVOT during peak systole were 
low, even with the Long AML. This was believed to be due to the size of the LVOT still 
being large, and the resultant shape of the LVOT in our model resembling a horseshoe 
shape with 0% LAMPOON, allowing flow to go around the side AML and not just the 
central, A2 plane (Figure 7-36).  
 
Figure 7-36. Cross-sectional view of the LVOT between 0% and 100% 
LAMPOON. Red, dashed line is the cross-sectional cut of the LVOT and the orange, 
dashed line is the central, long-axis plane at which we imaged. 
 
Going forward, this work suggests that when measuring the estimated LVOT size 
post-TMVR pre-operatively, other planes beside the central long-axis plane should be 
investigated for measurements and the entire shape of the LVOT be taken into 
consideration for LVOT obstruction. 
 Upon investigating the effects on flow in the LV with LAMPOON, it was found 
that the largest magnitudes of VSS, TKE, and pRSS occurred during diastole. The 
maximum VSS occurred during the start of the E-wave with the highest velocity inlet jet. 
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The maximum TKE and pRSS occurred after the E and A-waves and were predominantly 
found in the same region and time point with the same experiment and showed the same 
trends. The maximum VSS decreased with increased LAMPOON across all conditions 
(Figure 7-10; Figure 7-11), however the magnitudes themselves were small (high of 1 N/m2 
with 0% LAMPOON and 6.5 L/min). There were no distinguishable differences between 
pRSS and TKE at all cardiac output conditions (Figure 7-15; Figure 7-16; Figure 7-20; 
Figure 7-21). Throughout the LV, pRSS and TKE values were generally small with only 
intermittent cells of intensity due to the flow fluctuations in the LV after the E and A-
waves. It was found that Long AML, 0% LAMPOON at 6.5 L/min reached pRSS of over 
70 N/m2; this was in range of platelet activation levels (32 N/m2 at 70 ms and 170 N/m2 at 
7 ms exposure),114-116 but not near blood damage levels (400-800 N/m2 at 1 ms exposure 
time-scale).117, 118 The smaller time scales (1-7 ms) were used as a conservative approach, 
because we looked at instantaneous shear rates, with our acquisition having 7 ms between 
frames, without any temporal tracking along pathlines. If we were to track shear stress 
exposure of platelets throughout the cardiac cycle, not the assumption of a single frame, 
we could look at lower shear stress thresholds for longer exposure time-scales (Figure 
7-37).116 These lower thresholds could potentially show increased levels of platelet 
activations, however further studies are needed to confirm this. 
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Figure 7-37. “Hellums’ shear stress-exposure time threshold required to activate 
platelets, with some additional data.” (Taken from Fraser et al.)116 
 
From these results, it is postulated that hemolysis may not be a factor in a valve-in-
valve, valve-in-MAC, or valve-in-ring with average LV geometry and normal flow 
waveforms, but platelet activation may occur. Our experiments used a symmetrically 
expanded TAV with an aligned deployment, the best case clinical scenario. Future studies 
should look to quantify how eccentricity and alignment in valve deployment (e.g., 
deployment into calcium deposits) and irregular flow waveforms (e.g. atrial fibrillation) 
could affect VSS, pRSS, and TKE in the LV, as no implantation is perfect and valve 
eccentricity has already been shown to increase these values in bicuspid AVs and TAVs.119, 
120 
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Upon investigating the effects on diastolic flow in the LV with LAMPOON, 
interestingly, it was also found that a larger vortical structure was produced with increasing 
LAMPOON for all conditions (Figure 7-22; Figure 7-23; Figure 7-24). In addition, the 
vortical core was able to move more apically into the LV with increased LAMPOON for 
all conditions. This larger vortical structure increased flow into the LVOT and the anterior 
side of the GT-TAV during mid-diastole. These mid-diastolic LV flow characteristics 
helped better explain our Specific Aim 2B findings. 
Further clinical studies are needed to confirm these results. Additionally, further in 
vitro and clinical studies are needed to validate the postulations and hypotheses made from 
these results. 
 
7.2.2 Specific Aim 2B: Neo-Sinus Flow with LAMPOON 
Thrombosis has been seen clinically and subclinically with TAVR.81, 121-124 This has led to 
recent investigations into the AV neo-sinus where the native AV leaflets wrap around the 
stent frame creating a cavity of flow stasis between the TAV leaflets and the native AV 
leaflets.83, 125-127 With the implantation of TAVs in the MV, thrombosis has now been seen 
clinically and subclinically with mitral valve-in-ring, valve-in-valve, and valve-in-MAC.15, 
16, 128-132 Previous studies had shown that resecting the AML during SMVR had a lower 
incidence of thrombosis than those with intact AML.84 In the same vein as with TAVR, it 
was hypothesized that an anterior mitral neo-sinus was formed between the TAV leaflets 
and the AML wrapped around the stent frame with TMVR, thus creating stagnation leading 
to thrombosis. Furthermore, like the surgical AML resection with SMVR, the use of 
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LAMPOON with TMVR could offer similar benefits with the potential to lower the risk of 
thrombosis with TMVR. 
Specific Aim 2B studied how differing degrees of LAMPOON would affect the 
flow in the anterior mitral neo-sinus. All LAMPOON conditions at all cardiac outputs 
showed a maximum velocity magnitude of at least 0.1 m/s in the neo-sinus over the cardiac 
cycle which would indicate adequate washout (Figure 7-27). The largest area of high 
velocities occurred during systole when the GT-TAV closed, and the fluid was pushed into 
the neo-sinus due to the LV ejection (Figure 7-29). 100% LAMPOON showed higher 
average velocity in the neo-sinus (from the GT-TAV leaflet edge up to the skirt line) than 
0% and 50% LAMPOON at all cardiac outputs (Figure 7-31). This was due to LAMPOON 
relieving stagnation in the neo-sinus during diastole when the GT-TAV was open (Figure 
7-33). 
This was further characterized through washout simulation via particle tracking 
from pathlines (Figure 7-34; Figure 7-35). When the region of the neo-sinus from the leaflet 
edge to the stent skirt was seeded during diastole (at 200 ms), it was shown that 100% 
LAMPOON had complete washout within ≈50 ms while the 0% and 50% had to wait until 
systole for full washout. This systolic washout is most evident in the 0% and 50% 
LAMPOON conditions at 2.5 L/min due to it being the lowest flow conditions. 
Combining the post-TMVR findings of possible stress inducing platelet activation 
levels (from SA2A) with the AML creating flow stagnation in the neo-sinus during diastole 
(from SA2B) creates a plausible mechanism for TMVR thrombosis. In addition to its 
mitigation of LVOT obstruction, the benefit of LAMPOON to relieve anterior neo-sinus 
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stagnation, hindering that pathway of thrombosis, warrants further clinical consideration 
and discussion. 
It was important to note that the laceration in the 50% LAMPOON condition did 
not reach the TAV leaflet edge, which could explain why there was little difference 
between 0% and 50% LAMPOON in the neo-sinus. It was postulated from these results 
that LAMPOON that reaches the TAV leaflet edge could provide increased stagnation 
relief compared to anything shorter, and that this relief would increase the closer the 
laceration got to the mitral annulus (100% LAMPOON). However, these results show 
limited stagnation relief below the skirt line of the TAV, and thus the benefits of 
LAMPOON for the neo-sinus may be limited to the skirt line (Figure 7-38). 
 
Figure 7-38. Velocity contour of the neo-sinus with 50% LAMPOON with Long 
AML at 80/20 deployment highlighting the minimum point you may need to lacerate 
for washout benefits (leaflet edge) and the limiting point for washout (skirt line). 
 
From these results, it was hypothesized that 100% LAMPOON should still be 
preferred over a shorter length that still reaches the skirt line, because 100% LAMPOON 
allows for increased splaying of the AML around the stent frame, thus creating a larger 
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opening into the neo-sinus in 3-D space. Additionally, complete chordal sparing AML 
resection would create an even larger opening into the neo-sinus than 100% LAMPOON 
and could be the preferred method if percutaneously feasible. It was further hypothesized 
that LAMPOON will have minimal impact on the flow in the neo-sinus of a closed-cell 
TMV. 
Further clinical studies are needed to confirm these results. Additionally, further in 
vitro and clinical studies are needed to validate the postulations and hypotheses made from 
these results. 
No significant differences were found in the hemodynamics between LAMPOON 
conditions at the same cardiac outputs. This is believed to be mainly caused by the lack of 
a large LVOT obstruction from our experimental design (healthy size LV, average aorto-
mitral angle, etc.). Additionally, the functioning AV was not directly in the aorto-mitral 
plane, positioned further upstream. The AML and LVOT were thus believed to be far 
enough away from the AV that there was plenty of distance for pressure recovery. The lack 
of a true LVOT obstruction and the AV being placed upstream allowed us to tune each 
experiment to the same hemodynamic conditions mitigating any changes we would have 
seen with an induced sub-aortic stenosis from obstruction. 
 
7.2.3 Clinical and Engineering Implications 
The work of Specific Aim 2 provides the first in vitro simulation of the LAMPOON 
procedure. This new experimentation platform will serve as a means for future fluid 
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mechanics studies involving the LV, LAMPOON, and TMVRs. Additionally, this work 
suggests that the LAMPOON procedure can be beneficial by increasing flow in the neo-
sinus, increasing diastolic mixing in the LV, and decreasing velocity in the neo-LVOT. 
These findings could lead to the laceration of the AML with TMVR and the removal of the 
AML with SMVR becoming a standard of care, provided that it becomes easier to do with 
regards to TMVR. This also poses a question of whether future TMVR devices should 
incorporate open-cell or differently shaped stent frames in order to receive the full benefits 
of the LAMPOON or any leaflet resection procedure, as the relief through LAMPOON 
may only go as far as the closed enclosure of the transcatheter valve (e.g., sealing skirt, 
closed-cell stent, etc.). 
 
7.2.4 Limitations 
A limitation of Specific Aim 2 was the use of rigid mitral valve leaflets. This was necessary 
in order to make a transparent anatomically accurate model that could be seamlessly 
incorporated into the LV phantom. Although when a TAV is deployed into the MV, most 
of the MV leaflets are wrapped around the TAV stent frame and tethered by the chordae 
into a static state, the dynamics of the excess leaflet, i.e. the AML edge, is lost in the rigid 
model. 
Another limitation was the use of the LV phantom previously made by Okafor.103 
It was a patient-averaged model of a healthy LV with healthy geometry and stiffness. This 
was a good starting point for a controlled study looking at the general fluid mechanics of 
the LAMPOON procedure, however most patients currently receiving LAMPOON have 
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smaller than average LVs with atypical aorto-mitral angulations, hence the risk of LVOT 
obstruction and use of LAMPOON. It was believed that the use of a smaller LV and 
irregular aorto-mitral angulation would have helped to induce LVOT obstruction in the 0% 
LAMPOON condition and shown greater differences in the results. 
A limitation with the particle tracking in Tecplot was that the pathlines and seeding 
were based solely on velocity field data in the ROI with no physical boundary conditions 
and no velocity data surrounding the ROI. This primarily means that we could not track 
particles that leave and reenter the ROI due to the small oscillations in the observed neo-
sinus flow caused by the small undulations of the TAV leaflets during diastole. A better 
method would be to enforce a wall boundary condition at the AML and use a velocity field 
larger than the ROI with the ability to only seed the ROI. For the 0% and 50% LAMPOON 
cases it was believed that washout would have been even worse if we could have tracked 
a particle momentarily leaving and reentering the neo-sinus. 
A final limitation was the power of the laser used for HSPIV. It’s strength and the 
distance away from the ROI hindered the images’ light intensity that limited the quality of 
the data. This was partially remedied by lowering the acquisition rate for SA2B, because 
the neo-sinus was furthest away from the laser, but at the cost of a larger time interval 
between frames. For both SA2A and SA2B, the posterior LV region close to the posterior 
leaflet had the least light intensity and the worst data. 
 An overall limitation was that 2-D PIV was used to characterize a 3-D flow field. 
Neighboring planes within small distances (2-4 mm) of the central plane were studied and 
showed only small differences in the flow field in that planar direction. However, both the 
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neo-sinus and the neo-LVOT are irregular 3-D shapes and the use of stereographic, 
plenoptic, or tomographic PIV would provide even better characterization of their flow 
regions.  
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CHAPTER 8. CONCLUSIONS AND FUTURE WORK 
8.1 Specific Aim 1 
8.1.1 Conclusions 
This work provides the first in vitro MV simulator with a dynamically contracting annulus. 
The linear actuators in combination with the annular plate designs provided MV annular 
contraction and reproduced the annulus area change of previous in vivo studies and MV 
leaflet mechanics of previous in vitro studies. It was found that ischemic contraction leads 
to increased AML strain compared to healthy contraction. Additionally, it was seen that a 
static annulus, mimicking restrictive annuloplasties that are sized to systolic and diastolic 
sizing increased AML strain. This work suggests that striving to maintain the MV annular 
dynamics during MV repair procedures is beneficial to the loading of the anterior leaflet. 
 
8.1.2 Future Work 
This new left heart simulator will serve as a platform for future studies in MV biomechanics 
and repair procedures as well as percutaneous replacement device testing. In particular, the 
addition of annular contraction with TMV deployment in an in vitro setting could provide 
a more robust comprehension of flow characteristics and paravalvular leak. 
 
8.2 Specific Aim 2 
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8.2.1 Conclusions 
In Specific Aim 2A, the results showed that LAMPOON decreased average LVOT velocity 
magnitude at peak systole, lowered VSS, and increased diastolic flow into the LVOT. 
SA2A also showed pRSS magnitudes close to platelet activation levels. This suggests that 
LAMPOON could help mitigate LVOT obstruction and that there could be a risk of platelet 
activation in the LV with TMVR. 
In Specific Aim 2B, the results showed that 100% LAMPOON decreased 
stagnation in the neo-sinus during diastole and that all conditions had adequate neo-sinus 
flow during systole. This suggests that LAMPOON could lower the risk of thrombosis in 
the anterior MV neo-sinus. SA2B also leads to postulation that to have any neo-sinus 
benefits from LAMPOON the laceration must reach the transcatheter valve’s leaflet edge 
(edge of the neo-sinus) at a minimum. 
 
8.2.2 Future Work 
Future work in this area could work on improving the current LV model by making new 
LV phantoms that are smaller with varying aorto-mitral angulations. Additionally, with 
advances in silicone 3-D printing or the use of a silicone mold/casting, a flexible and 
transparent MV leaflet model could replace the current rigid model. Future studies should 
focus on the effects of eccentricity and irregular flow waveforms on the shear stresses and 
neo-sinus washout as well as different length and different shaped AML cuts. The length 
in regard to confirming whether or not the TAV leaflet edge and the skirt line are indeed 
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the boundaries of neo-sinus relief, and the shape to more accurately detail the AML A2-
resection from SMVR for valve-in-valve. Lastly, given that we have time-resolved flow 
fields of the LV over the cardiac cycle, additional work should be made to investigate the 
shear exposure of platelets and blood cells over the cardiac cycle.  
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APPENDIX A. ASSEMBLY GUIDE – DYNAMICALLY 
CONTRACTING ANNULUS MOTOR AND CONTROLLER 
Summary 
This assembly guide outlines how to connect all parts of the dynamically contracting 
annulus and contains a table of materials used. 
 
A.1 Motor and Controller Wiring 
 














A +V ADJ Turn Screw Used to adjust the voltage output of 
the power supply 
0 L/N/Gnd White/Black
/Green 
Computer cord taken apart; 
provides power from wall to power 
supply 
1 -V Black Negative voltage between power 
supply (-V) and H-Bridge 
controller (Gnd) 
2 +V Red Positive voltage between power 






1 Gnd (9) Black Negative voltage between power 
supply (-V) and H-Bridge 
controller (Gnd) 
2 +V (8) Red Positive voltage between power 
supply (+V) and H-Bridge 
controller (+V) 
3 M- (12) Black Negative voltage between H-Bridge 
controller (M-) and motor 
4 M+ (11) Red Positive voltage between H-Bridge 
controller (M+) and motor 
5 Vset or 
Iset (1) 
Blue Voltage magnitude from DAQ NI-
9269 to H-Bridge controller used to 
control motor speed (voltage 
magnitude via M) 
6 F/R (2) Orange Binary voltage DAQ NI-9269 to H-
Bridge controller used to control 
motor direction (voltage charge via 
M) 
7 +5v (5) White Voltage magnitude from H-Bridge 
to motor for motor potentiometer to 
normalize to (0-5 V) 
 136 
8 Gnd (6) Yellow Ground from H-Bridge to motor for 
motor potentiometer to normalize 
to (0-5 V) and DAQ NI-9239 





3 - Black Negative voltage between H-Bridge 
controller (M-) and motor 
4 - Red Positive voltage between H-Bridge 
controller (M+) and motor 
7 - White Voltage magnitude from H-Bridge 
to motor for motor potentiometer to 
normalize to (5 V max) 
8 - Yellow Ground from H-Bridge to motor for 
motor potentiometer to normalize 
to (0V min) 
10 - Blue Motor potentiometer voltage output 





5 Ch0-0 Blue Voltage magnitude from DAQ NI-
9269 to H-Bridge controller used to 
control motor speed (voltage 
magnitude via M) 
6 Ch1-0 Orange Binary voltage from DAQ NI-9269 
to H-Bridge controller used to 
control motor direction (voltage 
charge via M) 
9 Ch0-1/ 
Ch1-1 






10 Ch0-0 Blue Motor potentiometer voltage output 
to DAQ NI-9239 (0-5 V) 

















Figure A-5. DAQ wiring figure. NI 6269 – Voltage Output; NI 9239 – Voltage 
Input. See for Table A-1 details. 
 
A.2 H-Bridge Controller Settings 
H-Bridge Controller is the Device Craft 1015B-50V/30A with a Prolific PL2303HX-A 
serial board. Aside from changing default settings, it is most important to note that Mode 
3 was used to operate in a 1-4 V Ain range with the F/R line active (Figure A-6). This is 
so that any voltage below 1 V is stop and above 4 V is full speed (range 0-5 V), and so you 
can control directionality.  
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Figure A-6. List of settings for the H-Bridge Controller. 
 
A.3 PID+ Controller Tuning 
To help inform, a PID controller is a controller that uses a control loop feedback of the 
proportional, integral, and derivative terms of the system error (Equation Error! R
eference source not found.). 
 









The proportional term outputs a value that is proportional to (multiplied by) the 
current value and is used to correct the current error. However, the integral term outputs a 
value that is used to correct the offset of the system with the value being relative to the sum 
of the error over time. Furthermore, the derivative term outputs a value that is used to 
predict future error of the system by calculating the change of the error over time. Some 
effects of individually increasing the specified gain values can be seen in Table A-2. 
Table A-2. Effects of increasing each respective gain value. 
Gain Rise Time Overshoot Settling Time 
Steady-State 
Error 
Kp Decrease Increase - Decrease 
Ki Decrease Increase Increase Decrease 
Kd - Decrease Decrease - 
 
For the motor/H-Bridge controller configuration in this thesis, manually tuning 
your PID gains by trial-and-error is reasonable given the system, however, that is not 
always the case and the Ziegler-Nichols tuning method can yield better results. The 
Ziegler-Nichols tuning method is a tuning method that utilizes the system’s determined 
ultimate gain and the period of oscillation at the ultimate gain to calculate the proportional, 
integral, and derivative values for the controller using heuristic equations (Table A-3). 
Using only the proportional controller, the ultimate gain is found by tuning the proportional 
gain value and manually manipulating the system until its response creates an oscillation 
with a constant magnitude. The time between those oscillations is the period of oscillation 
used for calculation. 
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Table A-3. Ziegler-Nicholas tuning method equations to calculate gain constants 
with ultimate gain and period of oscillation. 
Control Type Gain Values 
Kp Ki Kd 












 Next, the resultant velocity versus voltage curve was used to determine the pulse 
width modulation (PWM) offset voltage. A linear best fit line was made for both directional 
velocities and the average y-intercept between both directions was used. Note: subtract 1 
V from the y-intercept, due to that being the starting point of the PWM output voltage. 
Also, a feed-forward controller is a controller that accounts for errors before they 
occur and affect the system, thus reducing the error without the slowness of a feedback 
loop. This was tuned last based on the resultant error left in the controller. Given the used 
motor/H-Bridge controller system, this was also easily tuned manually by trial-and-error. 
 
A.4 Input Waveform Data and Graphs 
The input waveforms were derived by Levack et al._ENREF_3725 human annulus 
circumferential data (Figure A-7). A matlab code was written to wrip the data from image 
based on the plot lines and axis scales (K.1).  
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Figure A-7. Average circumferential motion of the annulus over the cardiac cycle 
normalized to size at the beginning of diastole. Black = Normal, Blue = Ischemic, 
Red = Myxomatous.25 
 
The raw data was then scaled to a 35/65% systole/diastole cardiac cycle, scaled to the size 
of the annulus plates, and divided by two (using two motors) to be used as the displacement 
curve of the motors (Table A-4; Table A-5; Table A-6). These can be rescaled to match 
different sized plates. These displacement curves are used in LabVIEW (J.1) to tune the 
motors and get a tuned voltage output for each one. 
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Table A-4. Healthy inputs for DCA code, scaled to max displacement of 0.5 cm. 
Note: the first column is time (ms), second is displacement (cm), and third through 
fifth are inputs for a spline fit function in LabVIEW over 856 ms cardiac cycle. 
0 -0.23405 0 1 856 
9.822951 -0.25676 
   
23.7388 -0.28153 
   
43.3847 -0.31757 
   
58.9377 -0.34459 
   
72.85355 -0.36712 
   
91.68087 -0.39865 
   
107.2339 -0.42342 
   
126.8798 -0.45721 
   
140.7956 -0.48423 
   
157.1672 -0.5 
   
173.5388 -0.49324 
   
187.4546 -0.47973 
   
208.7377 -0.4482 
   
224.2907 -0.41892 
   
238.2066 -0.38288 
   
253.7596 -0.33784 
   
267.6754 -0.29955 
   
285.6842 -0.25676 
   
299.6 -0.23187 
   
334.565 -0.21396 
   
371.0503 -0.20721 
   
401.4546 -0.20045 
   
427.2984 -0.1982 
   
462.2634 -0.18018 
   
491.1475 -0.15766 
   
520.0317 -0.12613 
   
542.835 -0.09685 
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577.8 -0.03411 
   
617.3257 -0.00225 
   
647.7301 0 
   
675.094 -0.01351 
   
707.0186 -0.04054 
   
738.9432 -0.07432 
   
770.8678 -0.11712 
   
802.7923 -0.15991 
   
856 -0.23405 
   
 
Table A-5. Ischemic inputs for DCA code, scaled to max displacement of 0.2 cm. 
Note: the first column is time (ms), second is displacement (cm), and third through 
fifth are inputs for a spline fit function in LabVIEW over 856 ms cardiac cycle. 
0 -0.11574 0 1 856 
5.123119 -0.11863 
   
23.1565 -0.12972 
   
40.37018 -0.14082 
   
58.40356 -0.14822 
   
75.61724 -0.15931 
   
92.83092 -0.16671 
   
110.0446 -0.17781 
   
128.078 -0.1889 
   
142.0129 -0.1963 
   
158.4068 -0.2 
   
177.2599 -0.1963 
   
191.1948 -0.1889 
   
209.2282 -0.17226 
   
226.4419 -0.15376 
   
242.8358 -0.12972 
   
258.4101 -0.10753 
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275.6238 -0.08719 
   
299.6 -0.06237 
   
320.5316 -0.0539 
   
355.5445 -0.04465 
   
382.9458 -0.0391 
   
414.9141 -0.0317 
   
443.8378 -0.02246 
   
478.8506 -0.01506 
   
509.2966 -0.00581 
   
544.3094 -0.00026 
   
577.8 0 
   
608.246 -0.00951 
   
640.2142 -0.02246 
   
672.1825 -0.04095 
   
704.1508 -0.05575 
   
737.6413 -0.07239 
   
772.6542 -0.08164 
   
804.6224 -0.09458 
   
856 -0.11574 
   
 
Table A-6. Myxomatous inputs for DCA code, not scaled to any particular 
displacement. Note: the first column is time (ms), second is displacement (cm), and 
third through fifth are inputs for a spline fit function in LabVIEW over 856 ms 
cardiac cycle. 
0 -0.2737 0 1 856 
7.5822 -0.2860 
   
25.6156 -0.3058 
   
42.8293 -0.3217 
   
59.2233 -0.3317 
   
76.4369 -0.3436 
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93.6506 -0.3674 
   
110.0446 -0.3932 
   
124.7992 -0.4230 
   
133.8159 -0.4647 
   
141.1932 -0.5025 
   
147.7508 -0.5462 
   
156.7674 -0.5799 
   
168.2432 -0.5998 
   
182.1781 -0.5839 
   
196.9327 -0.5422 
   
208.4085 -0.5045 
   
218.2449 -0.4588 
   
225.6222 -0.4250 
   
235.4585 -0.3813 
   
243.6555 -0.3396 
   
251.8525 -0.2999 
   
260.8692 -0.2582 
   
269.8859 -0.2125 
   
278.9026 -0.1708 
   
288.7390 -0.1251 
   
299.6000 -0.0778 
   
320.5316 -0.0457 
   
347.9330 -0.0139 
   
382.9458 -0.0020 
   
413.3918 0 
   
448.4047 -0.0119 
   
480.3729 -0.0338 
   
509.2966 -0.0576 
   
538.2202 -0.0715 
   
577.8000 -0.0726 
   
617.3798 -0.1033    
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650.8703 -0.1251    
682.8386 -0.1490    
713.2845 -0.1748    
743.7305 -0.1946    
777.2211 -0.2185    
807.6670 -0.2383    




APPENDIX B. ASSEMBLY GUIDE – LEFT VENTRICLE BOX 
CHAMBER 
Summary 
This assembly guide details the step-by-step instructions for assembling the LV Box 
Chamber. Note: each change in LV insert or retrieval of the GT-TAV required complete 
disassembly and reassembly of the LV box chamber. 
 
B.1 Assembly LV Box Chamber 
This part involves mounting the left ventricle phantom (bag) into the box chamber that will 
pressurize the surrounding space causing it to contract and relax. 
Step 1: Pick which left ventricle (LV) phantom you want to use. They vary in sphericity 
index and stiffness. 




Figure B-1. (A) Gasket on box chamber side; (B) gasket on inside; (C) LV 
disassembled, (D) LV phantom placed onto LV box. 
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Step 3: Lay down a line of dental glue around the edges of the aorto-mitral top plate (Figure 
B-2A). Place the aorto-mitral LV insert into the top plate; smoothen the dental glue at the 
seam after compression, then trim off any excess for a good seal (Figure B-2B). 
 
Figure B-2. Placement of LV insert into the aorto-mitral top plate. (A) laying 
down dental glue and (B) finished placement. 
 
Step 4: Place the aorto-mitral top plate of the LV box over the LV phantom making sure 
that the ridge of the phantom fits in its groove (Figure B-3A). Be sure not to block the 
external wall tap for the pressure transducer with the black gasket. Once in place, screw 
(10-32’s) the mitral valve (MV) side into place starting from the center hole and working 
your way towards the aorto-mitral septum (Figure B-3B). Next, screw the aortic valve (AV) 
side into place working from the septum down to the center hole (Figure B-3C). For both 
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side, with each order of screws, the plate will compress down and align the next set of 
holes. 
 
Figure B-3. (A) Top placed over phantom; (B) Order of screwing MV side, from 
green to red; (C) Order of screwing AV side, from green to red. 
 
Step 5: Perform the leak test by attaching AV/MV leak-plates and gaskets to the box. 
Screw into place using the 10-32 screws with washers (Figure B-4). One creates a wall 
while the other is tapped. Add fluid to the LV phantom through the wall tap using a syringe 
until the LV begins to expand from built up pressure. Check for leaks. If leaking, 
reassemble, if not, continue to B.2. 
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Figure B-4.  Set-up for leak test. 
 
B.2 Assemble AV/Aorta and MV/Atrium and Deploy GT-TAV 
This part involves mounting the aortic valve and mitral valve into place in their respective 
aorta and atrium chambers. 
Step 1: Place circular spacers into the atrium for uniform internal diameter (Figure B-5A).  
Step 2: Lay down a line of dental glue on both sides of the larger block spacer and sandwich 
between the atrium and the MV/atrium plate. Orientate the block and plate, so that the cut-
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outs of the plate’s flat-edge and the block face the aorto-mitral septum and the pressure tap 
of the atrium does not face opposite of it (Figure B-5B). Remove excess dental glue from 
inside and outside. The cut-outs prevent interference with the LV pressure port on the 
aorto-mitral top plate. If the atrium pressure tap faces opposite of the cut-out, it will face 
into the table when finished and thus unusable. 
Step 3: Lastly, screw the MV/atrium plate into place with four 10-32 countersunk screws 
(Figure B-5C).  
 
Figure B-5. (A) Circular spacers placed into atrium; (B) Block spacer placed 
between atrium and MV/atrium plate; (C) MV/atrium plate screwed onto the block 
spacer and atrium. 
 
Step 4: Unlike the MV where you place the spacers first, first place the AV BHV into the 
aorta with the leaflets facing into the chamber. Make sure the commissure/stent-post is 
aligned with the slots in the chamber, so that the leaflets are also aligned with the sinuses. 
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You may need to loosen screws on the AV end of the chamber to make it easier to put in 
(Figure B-6A/B). 
Step 5: Place spacers on top on the AV BHV to make a flush surface with the edge of the 
aorta chamber (Figure B-6C). 
Step 6: Squeeze out dental glue onto a usable surface and mix together quickly. Spread 
dental glue over the face of the aorta chamber with the spacers. Be sure to get into the 
cracks between the spacers and the chamber to provide a proper seal. This needs to be done 
timely, so that the glue does not dry in the middle of it. Once finished applying dental glue, 
place the gasket on top of the face followed by the LV/aorta plate (Figure B-6D). 
Step 7: Screw four 10-32 countersunk screws into place attaching the AV/aorta plate to 
the aorta chamber. Be sure to orient the plate with the flat edge facing the aorto/mitral 
septum and the round edge facing away (Figure B-6E). 
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Figure B-6. (A) Showing the stent posts and aortic sinuses of the aorta chamber; 
(B) AV BHV in position; (C) spacers inserted; (D) dental glue applied and gasket 
covering it; (E) AV/aorta plate screwed down to aorta chamber. 
 
Step 8: Insert the pressure catheter down the aorta from the lure lock and through the AV, 
so that it will go directly into the LV when assembled (Figure B-7). It is much easier to do 
this now instead of while the system is running. 
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Figure B-7. Insertion of catheter through AV from Aorta before assembly to 
chamber. 
 
**At this point B.1 needs to be completed** 
Step 9: Take the GT-TAV and place it into the LV insert orientated such that a stent post 





Step 10: Take the correct deployment height spacer for the experiment and push it in 
behind the GT-TAV until the spacer is flush with the LV insert (Figure B-8B). This ensures 
accurate and precise deployment of the GT-TAV between experiments and also prevents 
migration. 
 
Figure B-8. (A) Showing orientation and direction to insert GT-TAV into the LV 
insert; (B) Showing resultant deployment of GT-TAV with deployment spacer 
pushed in behind it. 
 
Step 11: Take remaining 10-32 screws with washers and attach AV/Aorta and MV/Atrium 




Figure B-9. Assembly of AV/aorta and MV/atrium to the LV box. 
 
B.3 Electrical Wiring 
This part involves proper wiring/connections of the motor, pressure and flow probes, their 
respective power supplies and input boxes, and the cDAQ system. 
**At this point B.2 needs to be completed** 
Step 1: Attach pressure probes to wall taps. Take the other ends and plug them in the rear 
of the pressure probe box’s individual conditioner/amplifier boards. For ease of use, 
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configure so that on the pressure probe box, Channel 1 = LV Box; Channel 2 = LV 
Chamber; Channel 3 = Aorta. (Figure B-10) 
 
Figure B-10. Rear of pressure transducer conditioner/amplifier. 
 
Step 2: Connect the BNC cables from the analog-out BNC splitter to the analog-in BNC 
cDAQ module (Figure B-11). For ease of use, connect the channels to their respective 
selves, i.e. 1-to-1, 2-to-2, etc. (BNC splitter has numbers on it corresponding to the probes). 
**We currently use probes 5, 6, and 7 for channels 1, 2, and 3, respectively** 
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Figure B-11. (A) Notice the respective numbering on the BNC analog-out cords; (B) 
Analog-in channels on the cDAQ. 
 
Step 3: Attach flow probes into the flow loop. One upstream of the MV, just before the 
atrium chamber, and the other downstream of the AV, just after the aorta chamber. Make 
sure the positive arrow on the probe is facing in the direction of the flow. If not, you can 
correct by multiplying by a negative one in LabVIEW. 
Step 4: Plug flow probes into “flow box” (power supply and conditioner/amplifier). For 
ease of use, configure so that the MV inlet is in Channel 1 and AV out is in Channel 2. 
Connect BNC analog out channel from flow box to the BNC analog-in cDAQ module. For 
ease of use, configure so that the flow BNC input is in Channel 4 of the cDAQ module 
(Figure B-12). 
**We currently use probe 207 for MV inlet and 208 for AV outlet** 
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Figure B-12. (A) Flow probe conditioner/amplifier; (B) Analog-in channels on 
cDAQ. Orange = flow probe inputs, Green = connection between flow box and 
cDAQ. 
 
B.4 Add Fluid and Tune Phantom 
Here you will add your fluid and tune the loop for pressure and flow. 
**At this point B.3 needs to be completed** 
**Make sure that the pressure transducers are on and that all pipes are closed off, so that 
there is no leaking** 
Step 1: Add fluid to flow loop reservoir and check for leaks. If leaks, stop and reassemble, 
otherwise continue. 
Step 2: Slowly add fluid to LV box using the funnel. Make sure the top wall top is open 
for air to escape the box. Once full blead the hose line to the pump of air using the tap on 




Figure B-13. Funnel goes above vertical tube to fill pump line. Air comes out of the 
tap (circled in yellow) at the top of the box. 
 
Step 3: Run the flow loop. Once the LV phantom and box are full of liquid you can 
add/remove liquid to ensure proper contraction of the phantom. 
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APPENDIX C. MANUFACTURING GUIDE – GEORGIA TECH 
TRANSCATHETER AORTIC VALVE 
**Parts of Appendix C were modified from Prem Midha125** 
Summary 
This manufacturing guide details the step-by-step instructions for creating a clear GT-
TAVR valve. This includes material selection, tissue treatment, and suture technique. The 
current model is roughly based on the Edwards SAPIEN 3 design; however, this technique 
can be altered slightly to create models of other transcatheter heart valve designs. 
 
Parts Utilized 
• 1/32” Acrylic Sheet: purchased from ZLazr 
• Aluminum Rod: purchased from McMaster-Carr 
• Bend-and-Stay 316L Stainless Steel Wire: purchased from McMaster-Carr 
• Fresh Bovine Pericardium: purchased from Animal Technologies 
• Glutaraldehyde Solution: purchased from VWR 
• Phosphate Buffered Saline (PBS): purchased from VWR 
• Stainless Steel Pins: purchased from McMaster-Carr 
• Rubber Sheet: purchased from McMaster-Carr 
 
 166 
C.1 Stent Manufacturing 
This part involves fabrication of an acrylic stent pattern for the GT-TAVR. 
Step 1: Design an appropriate stent pattern. Designing a stent pattern is the most critical 
step in the manufacturing of a GT-TAVR, as the relevance of your experiment relies on 
meaningful dimensions. There are many resources that will help guide this process 
including Mano Thubrikar’s textbook “The Aortic Valve”,133 manufacturer drawings of 
their leaflet patterns, and clinical data on aortic valve dimensions as published by many 
research groups.20, 134-138 Ultimately, the design process is not something that can be 
prescribed in a protocol, but an example design is provided below. Be sure to account for 
your material thickness in the design.  
Step 2: Once you have finalized a design, export the drawing as a *.ai file, with appropriate 
line coloring (red) and line thickness (0.001 pt or similar) for laser cutting. This drawing 
stores the vector paths of your design.  
Step 3: Cut your designs into the thin acrylic sheet on a laser cutter. The resulting 
transparent stent should look similar to the Figure C-1 below. 
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Figure C-1. Example of GT-TAV stent frame post laser cut. 
 
Step 4: The flat pattern will need to be rolled into a cylindrical shape. In order to facilitate 
this process, machine both an aluminum mandrel for the desired internal stent diameter as 
well as a clamp for the desired outer stent diameter (Figure C-2). Registration features can 




Figure C-2. Machined aluminum mandrels specified to the internal diameter of 
the GT-TAV and machined clamps specified to the external diameter of the GT-
TAV. 
Step 5: While heating the oven to 180˚C, place the mandrel, O-clamp, and acrylic stents 
inside. The melting point of acrylic is 160˚C. Monitor the materials while heating to ensure 
that the acrylic does not fully melt. Overheating the materials slightly will ensure that the 
acrylic is very flexible for enough time to allow the aluminum tools to impart a consistent 
and continuous curve to the rolled acrylic stent. To avoid transference of other materials 
that may be on the bottom of the oven, place the acrylic stents on a clean metal surface.  
Step 6: Once the oven has reached 180˚C, wearing insulated gloves, quickly remove the 
stent and aluminum tools from the oven. Carefully wrap the stent around the mandrel to 
achieve a cylindrical shape. Press the stent against the mandrel to ensure that a continuous 
curve is imparted to the acrylic. The acrylic should be easily malleable at this temperature.  
Step 7: Once a general cylindrical shape is imparted to the acrylic (Figure C-3), it may be 
necessary to refine the shape further. In order to do so, place the acrylic within the O-Clamp 
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and reheat for a short period of time. The acrylic will expand and unfurl within the O-
Clamp. Once this is observed, use the insulated gloves and aluminum mandrel to press the 
acrylic into the O-Clamp to refine the cylindrical shape. It may be necessary to repeat this 
process. It is also possible to use a heat gun to gently induce flexibility of the acrylic for 
spot corrections. It is important to ensure that the vertical edges of the acrylic that are joined 
together when made into a cylinder maintain the appropriate curvature of the cylinder. 
 
Figure C-3. Example of finished GT-TAV stent frame. 
 
C.2 Retaining Ring Manufacturing 
This part details the procedure for fabrication of the retaining ring made of stainless steel 
wire that is used to model the fact that commercial valves are manufactured such that the 
leaflets are attached perpendicularly to the walls of the stent. In this model, the leaflets are 
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parallel to the walls of the stent. The retaining ring (Figure C-4) will be inserted into the 
valve to force the leaflets into the perpendicular configuration.  
Step 1: 3-D print an appropriate mold that outlines the valve leaflet outline (Figure C-4).  
 
Figure C-4. Example of GT-TAV retaining ring and the 3-D printed mold to make 
it. 
 
Step 2: Cut a section of stainless steel wire longer than you will need. 
Step 3: Using a flathead screwdriver and pliers, gently compress the wire into the mold 
one commissure at a time. Ensure that the retaining ring curvature is continuous and 
smooth.  
Step 4: Trim the excess material and finish forming the retaining ring.  
Step 5: Carefully remove the retaining ring from the mold, so as not to distort the shape. 
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C.3 Pericardium Fixation 
This part details the procedure for fixing the pericardium used to make the valve leaflets. 
Many studies and manufacturer protocols have described pericardial tissue fixation 
techniques,139-142 but most fall within the same general bounds: ~0.625% glutaraldehyde 
in phosphate buffered saline (PBS) under low pressure (~4mmHg) for approximately 36 
hours. For storage, a 0.2% glutaraldehyde in PBS solution is used.142 
Step 1: Create a large batch of 0.625% glutaraldehyde solution with PBS.   
Step 2: Place a rubber sheet at the bottom of a deep, stainless steel tray. Cut large, flat 
sections from the fresh pericardial sack and pin the edges to the rubber sheet. Try to 
minimize any wrinkles or folds in the tissue during this step of the process. 
Step 3: Pour approximately 2 inches of 0.625% glutaraldehyde solution on top to generate 
a 4mmHg pressure head. 
Step 4: Let sit in the refrigerator for 36 hours.  
Step 5: After 36 hours, rinse the tissue serially in saline and store in 0.2% glutaraldehyde 
solution. 
 
C.4 Valve Assembly 
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This part details the procedure for trimming, attaching, and suturing tissue to the acrylic 
stent to form the valve leaflets. 
**At this point C.1, C.2, and C.3 need to be completed** 
 
Step 1: Trim out a uniform section of fixed pericardium. This section of pericardium 
should be a rectangle approximately 1 cm taller than the original unrolled acrylic stent 
height and 1 cm longer than the unrolled acrylic stent width. Trimming the section of 
pericardium may be easier if the tissue is dried slightly first, however, be cautious not to 
leave the tissue in this state for more than 5 minutes. Continually rehydrate the valve in 
saline or storage solution throughout the process of assembly. 
Step 2: Insert the pericardium into the rolled stent. The tissue should be aligned such that 
the making sure to offset the tissue edge 0.25 cm from the bottom edge of the stent. The 
stent should be aligned like a crown, where the commissure posts point upward and are the 
top edge of the stent, while the continuous edge of the cylinder is the bottom (Figure C-5). 
The shorter edge of the pericardium should be aligned 0.25 cm offset from the break in the 




Figure C-5. Diagram of GT-TAV orientation. 
 
Step 3: Suture the pericardium to the stent with a back-stitch (Figure C-6). A back-stitch 
provides the best seal against leakage. Suturing should first start at the commissure near 
the seam of the acrylic, then continue across the arches. While suturing, care should be 
taken to ensure the pericardium tension is evenly distributed across the circumference of 
the stent. Rehydration of the pericardium consistently is an important factor in achieving 
an even distribution of tension. 
 
Figure C-6. Diagram of the back-stitch sewing technique. 
 
Step 4: Once the suture comes to the other side of the seam, the suture should continue 
downwards, binding both edges of the seam together with a running stitch. These stitches 
should be across two layers of pericardium, due to the original overlap.  
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Step 5: A back stitch suture should be used across the bottom of the stent to fix the 
pericardium in place. A knot should then be tied to hold the tension. This knot should be 
placed away from any delicate structures on the stent design.  
Step 6: The tissue should then be trimmed to ensure both minimum overlap across the 
seam as well as 1 cm of coaptation of the valve leaflets. It may be helpful to first close the 
leaflets, insert the retention ring, and then trim the valve leaflets to achieve adequate 
coaptation.  
Step 7: In order to test the adequate coaptation of the valves, a valve coaptation test should 
be conducted. The valve should first be placed in a clear plastic tube with a tight seal around 
the outside diameter of the plastic stent, then running water should be poured into the 
plastic tube (Figure C-7). If the valve demonstrates adequate coaptation, the running water 
will be occluded by the valve. Be sure to examine the center of the stent where the valves 
meet, as well as the stitches to ensure no leakage. 
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Figure C-7. Image of GT-TAV leak test with a plastic tube full of water and a 29 
mm GT-TAV plugging the bottom. Note: the valve shows good coaptation. 
 
Step 8: Use tissue-grade cyanoacrylate (super glue) to seal the knot of the stent.  
Step 9: Insert a retaining ring over the leaflets. The final product should look similar Figure 
C-8. A very small amount of super glue may be necessary to fix the retaining ring to the 
top of the stent posts. 
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APPENDIX D. EXPERIMENTAL PROTOCOL – HIGH-SPEED 
PARTICLE IMAGE VELOCIMETRY 
**Parts of Appendix D were modified from Prem Midha.125** 
Summary 
This experimental protocol details the describes the high-speed particle image velocimetry 
(HSPIV) hardware configuration and data collection procedure. 
 
D.1 Hardware Configuration 
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Figure D-1. High-speed PIV hardware configuration. 
 
High-Speed PIV Checklist: 
1. DO NOT turn the laser on until scanner is on and the experimental set up is ready. 
2. Turn the camera ON before launching the Davis application to ensure camera 
recognition. 
3. The band-pass filter should be installed on the camera lens to filter undesirable 
frequencies of light. 
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4. The cap of the camera should be always closed unless acquiring data to minimize risk 
of sensor damage. 
5. Turn the scanner on before turning on the laser. Failure to do so can results in damage 
to the mirror array and anything the reflected beam hits. 
6. Use the vertical traverse to place the pulsed laser sheet at the desired plane within the 
flow chamber. 
7. Focus the camera on the seeding particles within the plane of the laser sheet.  




Figure D-2. Rear of high-speed controller. 
 
High-Speed Controller: The LabView program controlling the realistic left heart 
simulator sends its trigger (external trigger in) to the high-speed controller (HSC) at the 
desired time point during a cardiac cycle (e.g. start of diastole) (Figure D-2). The controller 
augments this trigger and commands the camera to acquire (to camera trigger) at a time (to 
camera f-sync) that is near the input trigger, but also corresponds to a laser pulse. This link 
is created through the scanner clock signal (scanner clock in). sends the starting trigger and 




Figure D-3. Rear of Phantom VEO 340L camera. 
 
High-speed camera: The f-sync cable connects to the high-speed controller and provides 
the camera with the reference times when the laser is pulsing (scanner clock) (Figure D-3). 
The trigger from the HSC provides a TTL pulse which instructs the camera to begin 




Figure D-4. Primary view of high-speed scanner and laser. 
 
Scanner and Laser Source: The laser source emits a continuous wave laser beam which 
gets converted into a pulsed laser sheet via rotating mirror array (scanner) (Figure D-4). A 
portion of the reflected laser sheet hits mirror which again sends a portion of the signal 
back to an optical sensor which detects the laser pulse frequency. The frequency of laser 
pulse is adjusted by turning a potentiometer controlling the rotating mirror speed. The 
potentiometer is accessible from the top of the scanner and fits a small flathead screwdriver. 





Figure D-5. Secondary view of high-speed scanner and laser system highlighting 
adjustable traverse system and laser sensor. 
 
Scanner Accessories: The vertical traverse allows for easy adjustment of the z-position of 
the laser sheet within the flow chamber. The scanner and laser source are mounted to a 
single plate, which is adjusted by this traverse. The laser power supply has no failsafe and 
must not be turned on until the scanner is turned on or the laser will damage the mirror 
array. The high frequency spinning of the array prevents damage. 
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D.2 Data Collection – DaVis 
**Make sure the camera is plugged into the high-speed controller on the DaVis computer 
and turned on** 
**Make sure the trigger is plugged into the high-speed controller on the DaVis computer 
and a signal is coming from the LabView computer** 
 
Step 1: From the starting window, create a new PIV project (Figure D-6). After selecting 
a MyProjects folder by right-clicking a desired folder from file tree, click the New+ → 
Project name: Specify: “user defined”  → Type of project: PIV → Ok. After clicking 
okay, the project should open to the next window. 
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Figure D-6. Starting window where you create a new project. 
 
Step 2: In the new Project window (Figure D-7), click Recording to open recording 
window (Figure D-8). 
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Figure D-7. Project window for PIV where you access tasks such as recording, 
scaling/ calibration, and processing. 
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Figure D-8. Recording window for PIV acquisition. 
 
**Make sure the laser sensor is plugged into the high-speed controller on the DaVis 
computer with the laser and scanner turned on** 
 
Step 3: From recording window, configure Device Settings tab under the Devices → 
HighSpeed Recording → Timing (Figure D-9). You should see a current image rate signal 
to the right if the laser if correctly hitting the laser sensor. If it is not, adjust the laser. Set 
Time based>>Mode: to external image clock and click the refresh button next to Time 
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based>>Image rate: to sync with current image rate. Next set Image range and 
trigger>>Images: to “user defined” and Image range and trigger>>Source: to 
‘Trigger’ input. 
 
Figure D-9. Record window zoomed in on Device Settings. 
 
Step 4: In the Window Manager → Live Mode section, click on the continuous grab icon 
to get the live camera view and adjust the image exposure and focus (Figure D-10).  
 189 
 
Figure D-10. Recording window zoomed in on Intensity Calibration and Live 
Mode. 
  
Step 5: To fix any noise patterns in the image you must do an intensity calibration. This 
step must be performed each time you start the system or any time you change the area of 
interest.  
While leaving DaVis open, go to PSS 2.8 to restore camera to factor defaults by 
selecting Manager Tab (top right corner) → Phantom Nucleus (bottom right corner) → 
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Restore Settings → Reload factory Settings → Ok (Figure D-11). Note: make sure to 
select the correct camera ID.  
 
Figure D-11. Manager tab in PCC 2.8 for resetting camera to factory defaults. 
 
Next, close the camera shutter to provide a black image for intensity calibration. 
Do this by selecting Live tab (top right corner) → Cine Settings → Close Shutter (Figure 
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D-12). Note: make sure to select the correct camera ID. An icon will appear saying the 
shutter is closed with a new button to open it (don’t click this yet). 
 
Figure D-12. Live tab in PCC 2.8 for opening and closing the camera shutter. 
 
Lastly, go back to DaVis and click the Intensity Calibration button and then max 
out the Exposure (Figure D-10). Once the intensity calibration is done you can click the 
Open Shutter button in PCC to proceed with image acquisition (Figure D-12). 
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Step 6: Acquire HSPIV images. To acquire the images, go to Window Manager → 
Recording tab and click the Record Icon (Figure D-13). The file name can be left default 
to capture the information displayed below and modified later if needed. 
 
Figure D-13. Recording window zoomed in on Intensity Calibration and Recording. 
 
Upon completion of the recording, check the images by scrolling through the acquired 
sequence. If satisfied save the images to the computer; specify the acquisition name via 
Recording → Storage → Name: → Specify → “user defined” and then click the Save 
Icon in the Window Manager (Figure D-13). 
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APPENDIX E. PROCESSING PROTOCOL – SPECIFIC AIM 2 
E.1 High-Speed Particle Image Velocimetry – DaVis 
E.1.1 HSPIV – DaVis 8.4 – Specific Aim 2A 
Step 1: Mask Out Image (Figure E-1). This operation was used to mask out areas outside 
the ROI and solid objects inside the ROI (e.g. the AML or GT-TAV) from the raw image. 
The geometric mask was used for the AML, GT-TAV, aorto-mitral plane, and give a 
boundary for the maximum LV size in the 6.5 L/min condition. The algorithmic mask was 
used to account for the moving LV wall throughout the cardiac cycle. Variables for the 




Figure E-1. Example of a Mask Out Image operation for Specific Aim 2A. 
Geometric and algorithmic masks were used. 
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Step 2: Subtract Time Filter (Figure E-2). This operation was used to subtract background 
noise from the masked images. For SA2A, a minimum intensity subtraction with a 
symmetric filter length of 5 images was used. 
 
Figure E-2. Example of Subtract Time Filter operation for Specific Aim 2A. 
 
Step 3: PIV Time-Series (Figure E-3). This operation encompasses the calculation of 
velocity fields via cross-correlation from the masked and filtered images. Details include: 
• The previous result as a reference shift for the Time series cross-correlation 
• Sequential cross-correlation with a data source of 0+1, 1+2, 2+3… as a vector 
calculation parameter with a multi-pass interrogation window of decreasing size 
and variable shape (64x64/square to 32x32/circle) with 50% overlap and 2 passes 
for each size. A high accuracy mode was also used for the final pass 
• Default values were used for Multi-pass options and Multi-pass postprocessing. 
• Image preprocessing, Define mask, and Vector postprocessing were not used. 
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Figure E-3. Example of PIV Time-Series operation for Specific Aim 2A. 
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Step 4: Vector Post-processing (Figure E-4). This operation was used to remove erroneous 
vectors and smooth the field. Details include: 
• Deleting a vector if its peak ration Q< 1.3 
• 2x Median filter: strongly remove & iteratively replace (if average differs by 2 and 
but less than 3 standard deviations from neighboring group, respectively) 
• Removing groups with <5 vectors 
• 1x Smoothing by a 3x3 grid 
• Note: no interpolation or extrapolation was done. 
 
Figure E-4. Example of Vector Postprocessing for Specific Aim 2A. 
 
E.1.2 HSPIV – DaVis 10 – Specific Aim 2B 
Step 1: Mask Out Image (). This operation was used to mask out areas outside the ROI and 
solid objects inside the ROI (e.g. the AML or GT-TAV) from the raw image. The geometric 
mask was used for the AML, GT-TAV, aorto-mitral plane, and give a boundary for the 
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maximum opening of the GT-TAV leaflet size in the 6.5 L/min condition. For the 0% 
LAMPOON condition, the algorithmic mask was used to account for the moving GT-TAV 
leaflet throughout the cardiac cycle instead of the static geometric mask at the maximum 
opening. 
 
Figure E-5. Example of Mask Out Image operation with only geometric mask for 




Figure E-6. Example of Mask Out Image operation with geometric and 
algorithmic masks for Specific Aim 2B. 
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Step 2: Subtract Time Filter (Figure E-7). This operation was used to subtract background 
noise from the masked images. For SA2B, a minimum intensity subtraction with a 
symmetric filter length of 5 images was used for 0% and 100% LAMPOON, and a filter 
length of 7 images was used for 50% LAMPOON. 
 
Figure E-7. Example of Subtract Time Filter operation for Specific Aim 2B. 
 
Step 3: PIV (Particle Image Velocimetry) (Figure E-8). This operation encompasses the 
calculation of velocity fields via cross-correlation from the masked and filtered images. 
Details include: 
• Use of GPU for the Method: cross-correlation for time resolved 2D-PIV (2D2C). 
• Vector calculation was used with a multi-pass interrogation window of decreasing 
size and variable shape (64x64/square to 32x32/square to 16x16/circle) with 50% 
overlap for each, and 3 passes for 64x64 and 32x32 and 5 passes for 16x16. 
• Default values were used for Multi-pass postprocessing. 
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• Image pre-processing and define mask in Main Settings as well as Vector post-
processing were not used. 
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Figure E-8. Example of PIV operation for Specific Aim 2B. 
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Step 4: Vector Post-processing (Figure E-9). This operation was used to remove low 
sample groups (<5 vectors) and smooth the field (1x smooth 3x3). Less is done here than 
in SA2A, because the use of the GPU produces already corrected results for cross-
correlation. 
 
Figure E-9. Example of Vector Post-processing operation for Specific Aim 2B. 
 
E.2 High-Speed Particle Image Velocimetry – MATLAB and Tecplot 360 
Step 1: Bin-Average (BinAVG.m). This MATLAB code averaged neighboring frames into 
one, knowing to start at the beginning of each cycle. For the purposes of this study, the bin-
size was between 3-5 frames depending on the acquisition frame rate. This resulted in a 
time of 7-8 ms between bin-averaged frames. Note: it is important to use the correct 
number of frames per cycle for the acquisition rate used for each condition (399 Hz ≈ 342 
frames and 401Hz ≈ 343 frames at 856 ms a cycle); if you do not, the beginning of each 
 204 
subsequent cycle used for calculations will be displaced by the error, thus affecting the 
results. This code exported x (m), y (m), u (m/s), v (m/s). 
 
Step 2: Scale (ScalingData.m). The Scaling operator in DaVis assumed the camera is 
perpendicular to the flow and scaled both the x and y direction equally. This MATLAB 
code scaled the resultant data by an x and y component to calibrate for a non-perpendicular 
single camera. These calibration constants needed to be calculated by measuring pixel 
distances and the x/y distances in DaVis used for calculations with the known x/y distances. 
This code exported x (m), y (m), u (m/s), v (m/s). 
 
Step 3: Reorganize Bin-Averaged or Scaled data (PIV_Organizing_final_v1.m). In order 
for the following fluid mechanics calculations code to work, the frames of each time point 
in all cycles had to be filed together. This MATLAB code copies and reorganizes the 
sequentially acquired data into folders with all cycle frames at each time point, i.e. there 
were the same number of folders as bin-averaged time points in a cycle and each folder 
contained the same number of files as cycles. This code exported x (m), y (m), u (m/s), v 
(m/s). 
 
Step 4: Calculating Velocity Magnitude, VSS, pRSS, and TKE 
(Master_PIV2_TFE_new.m). This MATLAB code calculates the velocity magnitude, 
viscous shear stress, Reynolds shear stress, and turbulent kinetic energy from the 
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reorganized file structure of the bin-averaged or scaled data. This code exported x (m), y 
(m), z (m), u (m/s), v (m/s), vel_mag (m/s), du/dx (s-1), du/dy (s-1), dv/dx (s-1), dv/dy (s-1), 
ωz (s-1), VSS (N/m2), ρu’u’ (N/m2), ρv’v’ (N/m2), ρu’v’ (N/m2), TKE (m2/s2), pRSS (N/m2). 
 
Step 5: Phase-Averaging (PhaseAvgBinnedData.m). The images were acquired 
sequentially over multiple cardiac cycles. This MATLAB code averaged each time point 
in the bin-averaged or scaled data over all cycles. Although this was already done in Step 
4, the file sizes are much smaller (only velocity) and formatted for Step 6. This code 
exported x (m), y (m), u (m/s), v (m/s). 
 
Step 6: Calculate Minimum, Maximum, and Average Velocity 
(Extract_min_max_avg_vel_TFE.m). This MATLAB code calculated the minimum, 
maximum, and average velocity magnitude and time at which they occured of each spatial 
location over the cardiac cycle. This code exported min_vel (m/s), min_time (ms), max_vel 
(m/s), max_time (ms), avg_vel (m/s). 
 
Step 7: Reorganizing Phase-Average (PIV_Renaming_v1.m). This MATLAB code copied 
and renamed the phase-averaged data files to start at whatever time-point in the cycle 
desired. For this study the data was made to start at 200 ms. This was done in order to start 
the particle seeding and pathline calculation in Tecplot at the time of interest. 
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Step 8: Export Pathlines. In Tecplot, ask to make 350 streamlines, calculate pathlines at a 
minimum of 0.001 s time steps with no particle mass, and export the resultant data as a 
space delimited .txt file with X and Y positions for only the particles. 
 
Step 9: Calculate Particle Tracking (ParticleTrackingTecplotToExcelAndEPS_TFE.m). 
This MATLAB code took the resultant pathlines from Tecplot and made a particle tracking 
video as an *.avi and exported an *.xls spreadsheet of the particles for residency time 
calculations. 
 
Step 10: Calculate Residency Time (ParticleTrackingWashout.m). This MATLAB code 




APPENDIX F. RAW DATA – SPECIFIC AIM 1 
F.1 Motor Tracking Raw Results 
Table F-1. Specific Aim 1 raw motor tracking results pertaining to Figure 4-1. 
Porcine - Healthy Porcine - Diseased Ovine - Healthy 
Time Desired Measured Time Desired Measured Time Desired Measured 
0 -0.23241 -0.241776 0 -0.11519 -0.111481 0 -0.21232 -0.206626 
2.002 -0.23524 -0.243172 2.001 -0.11598 -0.111494 2.001 -0.21885 -0.207307 
5.004 -0.24251 -0.247498 4.003 -0.11678 -0.112685 4.003 -0.22517 -0.210612 
7.005 -0.24725 -0.250247 6.005 -0.1179 -0.113388 6.004 -0.23108 -0.212353 
9.007 -0.25184 -0.255375 8.018 -0.11903 -0.114497 9.005 -0.23871 -0.213803 
11.008 -0.25622 -0.25739 10.019 -0.12017 -0.116762 11.008 -0.24269 -0.216868 
13.01 -0.26033 -0.261027 12.02 -0.12132 -0.116892 14.01 -0.24705 -0.220158 
15.011 -0.26418 -0.264505 14.022 -0.12248 -0.118128 16.011 -0.24908 -0.226213 
17.012 -0.26783 -0.268008 16.022 -0.12367 -0.12023 18.012 -0.25055 -0.226932 
19.014 -0.27132 -0.273078 18.013 -0.12488 -0.121929 20.014 -0.25161 -0.230622 
21.015 -0.27472 -0.277618 20.014 -0.12611 -0.121995 23.006 -0.2527 -0.232177 
23.017 -0.27808 -0.279403 22.027 -0.12737 -0.123218 25.008 -0.25329 -0.235245 
25.018 -0.28146 -0.282442 24.017 -0.12866 -0.124497 27.009 -0.25393 -0.240112 
27.02 -0.28491 -0.286493 26.019 -0.12998 -0.126954 29.01 -0.25475 -0.241476 
29.021 -0.28844 -0.28969 28.02 -0.13134 -0.127492 31.024 -0.25588 -0.246445 
31.022 -0.29205 -0.29441 30.021 -0.13273 -0.129847 33.026 -0.25746 -0.250114 
33.024 -0.29571 -0.29769 32.023 -0.13413 -0.130281 36.028 -0.26087 -0.253105 
35.025 -0.29942 -0.303919 34.024 -0.13552 -0.129982 39.03 -0.26535 -0.256478 
37.027 -0.30315 -0.305959 36.025 -0.13688 -0.131059 42.032 -0.27049 -0.260543 
39.028 -0.30689 -0.309264 38.027 -0.1382 -0.132626 44.033 -0.27409 -0.264487 
41.03 -0.31064 -0.312876 40.04 -0.13945 -0.134197 46.035 -0.2777 -0.267993 
43.031 -0.31436 -0.316273 42.042 -0.14061 -0.13395 48.036 -0.28121 -0.272037 
45.032 -0.31805 -0.321787 44.044 -0.14167 -0.136229 50.038 -0.28449 -0.274865 
47.034 -0.3217 -0.325896 46.044 -0.14262 -0.137851 52.039 -0.28754 -0.275988 
49.035 -0.3253 -0.327342 48.034 -0.14346 -0.138322 54.04 -0.29035 -0.278247 
51.037 -0.32885 -0.330972 51.046 -0.1446 -0.139248 56.042 -0.29294 -0.280704 
53.038 -0.33235 -0.335185 53.047 -0.14532 -0.14011 58.043 -0.2953 -0.282595 
55.039 -0.3358 -0.339146 55.049 -0.14604 -0.142697 60.045 -0.29746 -0.288553 
57.041 -0.33921 -0.344553 57.05 -0.1468 -0.143558 62.046 -0.29942 -0.289562 
59.042 -0.34257 -0.348395 59.051 -0.14762 -0.145731 64.045 -0.30119 -0.292867 
61.044 -0.34589 -0.350506 61.053 -0.14854 -0.149594 66.046 -0.30277 -0.295147 
 208 
63.045 -0.34916 -0.353957 63.054 -0.14958 -0.150287 68.047 -0.30419 -0.298198 
65.047 -0.3524 -0.356882 66.057 -0.15139 -0.150361 70.049 -0.30549 -0.302402 
67.049 -0.35562 -0.36047 68.058 -0.15271 -0.152705 72.05 -0.30671 -0.304907 
69.063 -0.35883 -0.364952 70.059 -0.15408 -0.153177 74.052 -0.3079 -0.308631 
71.063 -0.36205 -0.368109 72.061 -0.15547 -0.153833 76.053 -0.30912 -0.315772 
73.052 -0.36528 -0.37407 74.062 -0.15685 -0.154563 78.055 -0.3104 -0.315287 
75.053 -0.36855 -0.381448 76.064 -0.15818 -0.154745 80.056 -0.31179 -0.317569 
77.055 -0.37185 -0.385153 78.065 -0.15942 -0.158601 82.057 -0.31334 -0.320673 
79.056 -0.37519 -0.389089 80.066 -0.16056 -0.158214 85.06 -0.31607 -0.323056 
81.058 -0.37856 -0.390647 82.068 -0.16156 -0.158582 87.061 -0.31821 -0.325904 
83.059 -0.38193 -0.394696 84.07 -0.16246 -0.161042 89.063 -0.3206 -0.331089 
85.06 -0.38532 -0.398079 86.061 -0.16329 -0.161763 92.065 -0.32459 -0.333653 
87.062 -0.3887 -0.402027 88.062 -0.16407 -0.163839 94.066 -0.32747 -0.337338 
89.063 -0.39206 -0.407488 90.076 -0.16483 -0.164533 96.068 -0.33048 -0.338646 
91.065 -0.39541 -0.410366 92.077 -0.16561 -0.166371 99.07 -0.3352 -0.341556 
93.066 -0.39872 -0.414967 94.079 -0.16644 -0.168371 102.072 -0.34006 -0.34531 
95.068 -0.40199 -0.416464 96.078 -0.16734 -0.169781 104.073 -0.34332 -0.345722 
97.069 -0.40523 -0.419921 98.079 -0.16836 -0.170515 106.078 -0.34655 -0.347172 
99.084 -0.40843 -0.423058 101.081 -0.17007 -0.171835 108.079 -0.34965 -0.348762 
101.071 -0.41161 -0.429221 103.083 -0.17132 -0.173326 110.077 -0.35255 -0.351618 
103.073 -0.41478 -0.432961 106.085 -0.1733 -0.175525 112.079 -0.35515 -0.351442 
105.075 -0.41793 -0.435756 108.086 -0.17468 -0.176342 114.08 -0.35737 -0.35399 
107.076 -0.42109 -0.438223 110.087 -0.17606 -0.178927 116.084 -0.35912 -0.357615 
109.077 -0.42424 -0.442948 112.089 -0.17745 -0.180116 118.086 -0.36031 -0.359946 
111.079 -0.42742 -0.445964 114.094 -0.17882 -0.181868 120.084 -0.36099 -0.359334 
113.08 -0.43061 -0.451104 116.092 -0.18015 -0.183457 122.086 -0.36125 -0.360275 
115.082 -0.43385 -0.456578 118.093 -0.18144 -0.183599 124.087 -0.36119 -0.361084 
117.083 -0.43713 -0.459515 120.085 -0.18271 -0.185278 126.091 -0.3609 -0.363879 
119.085 -0.44048 -0.461427 122.086 -0.18395 -0.185592 129.093 -0.36028 -0.363525 
121.086 -0.44391 -0.464466 124.088 -0.18517 -0.188505 131.095 -0.35988 -0.364276 
124.088 -0.44922 -0.468751 127.089 -0.18696 -0.19023 133.097 -0.35961 -0.36575 
127.102 -0.45477 -0.471342 129.091 -0.18814 -0.190736 135.097 -0.35957 -0.365687 
129.092 -0.45863 -0.477297 131.092 -0.18931 -0.192131 137.1 -0.35982 -0.365082 
131.093 -0.46262 -0.477821 133.094 -0.19048 -0.195234 139.1 -0.36031 -0.365523 
133.095 -0.46667 -0.483439 135.095 -0.19165 -0.195053 141.102 -0.36094 -0.366236 
135.096 -0.47074 -0.484875 137.097 -0.19279 -0.194295 143.103 -0.36161 -0.365886 
137.097 -0.47474 -0.489148 139.098 -0.1939 -0.195974 145.105 -0.36225 -0.364888 
139.098 -0.47863 -0.491948 141.099 -0.19496 -0.196773 148.107 -0.36293 -0.365452 
141.1 -0.48232 -0.494779 143.113 -0.19597 -0.196844 150.096 -0.36306 -0.365237 
143.101 -0.48576 -0.497317 145.117 -0.1969 -0.197734 152.107 -0.36283 -0.365819 
145.103 -0.4889 -0.498696 148.117 -0.19814 -0.197528 155.099 -0.36178 -0.364749 
 209 
147.104 -0.49172 -0.499003 150.117 -0.19884 -0.19913 157.102 -0.3607 -0.363265 
149.106 -0.4942 -0.501814 152.119 -0.19946 -0.196829 159.102 -0.35936 -0.367663 
151.107 -0.49633 -0.502955 155.119 -0.20019 -0.198974 161.103 -0.35784 -0.365266 
153.108 -0.4981 -0.502847 157.122 -0.20056 -0.198432 163.105 -0.35617 -0.362497 
155.11 -0.49951 -0.50631 159.124 -0.20082 -0.198798 165.106 -0.35443 -0.362053 
157.111 -0.50053 -0.504871 161.126 -0.20099 -0.198948 167.108 -0.35265 -0.359267 
159.113 -0.50116 -0.506037 163.127 -0.20105 -0.199525 170.11 -0.35006 -0.356911 
161.114 -0.50138 -0.506 166.117 -0.20094 -0.198615 172.111 -0.34839 -0.356223 
163.115 -0.50124 -0.505409 168.13 -0.20075 -0.198304 174.112 -0.34674 -0.354252 
165.117 -0.50077 -0.507661 170.132 -0.20046 -0.198699 177.116 -0.34426 -0.352547 
167.118 -0.5 -0.506722 172.133 -0.20009 -0.198164 179.116 -0.34258 -0.350678 
169.12 -0.49899 -0.50659 174.134 -0.19963 -0.198824 181.117 -0.34085 -0.347565 
171.121 -0.49777 -0.506189 177.125 -0.1988 -0.1981 183.12 -0.33905 -0.344273 
173.123 -0.49638 -0.507638 179.126 -0.19815 -0.197457 185.12 -0.33715 -0.34205 
175.124 -0.49486 -0.507328 181.128 -0.19744 -0.199224 187.122 -0.33515 -0.338357 
177.126 -0.49325 -0.506451 183.129 -0.19666 -0.198048 189.124 -0.33302 -0.333852 
179.139 -0.49156 -0.506006 185.131 -0.19581 -0.195674 191.124 -0.33076 -0.334361 
181.131 -0.48977 -0.501911 187.132 -0.19487 -0.195269 193.126 -0.32836 -0.330549 
183.13 -0.48787 -0.502778 189.133 -0.19385 -0.19352 195.127 -0.32581 -0.327176 
185.143 -0.48586 -0.500992 191.135 -0.19271 -0.191209 197.13 -0.3231 -0.327292 
187.145 -0.48373 -0.499452 193.136 -0.19146 -0.189625 199.13 -0.32023 -0.320504 
190.144 -0.48027 -0.496464 195.137 -0.19008 -0.189448 201.132 -0.31718 -0.319185 
192.146 -0.47778 -0.495579 197.139 -0.18857 -0.186701 203.133 -0.31395 -0.314956 
194.147 -0.47516 -0.488048 199.14 -0.18694 -0.18564 205.135 -0.31057 -0.308833 
196.148 -0.47241 -0.493279 201.142 -0.18519 -0.18204 207.148 -0.30706 -0.306503 
198.15 -0.46955 -0.487975 203.143 -0.18336 -0.180777 210.151 -0.30162 -0.303098 
200.152 -0.46658 -0.48499 205.145 -0.18146 -0.180554 212.152 -0.29792 -0.299089 
202.153 -0.46353 -0.48081 207.146 -0.17951 -0.177867 214.153 -0.2942 -0.292527 
204.154 -0.4604 -0.477441 209.147 -0.17753 -0.174648 216.155 -0.29047 -0.288622 
206.156 -0.45719 -0.476168 211.149 -0.17553 -0.175632 218.156 -0.28678 -0.284666 
208.157 -0.45393 -0.468612 213.15 -0.17353 -0.170871 220.157 -0.28312 -0.277593 
210.159 -0.45062 -0.466439 215.152 -0.17154 -0.168969 222.156 -0.27949 -0.274944 
212.16 -0.44727 -0.459676 217.153 -0.16956 -0.167954 225.159 -0.27401 -0.267681 
214.161 -0.44387 -0.45645 219.155 -0.16756 -0.165514 228.164 -0.26843 -0.265775 
216.162 -0.44039 -0.454421 221.156 -0.16553 -0.162897 230.164 -0.26461 -0.26039 
218.165 -0.4368 -0.450137 223.157 -0.16344 -0.160728 232.166 -0.26067 -0.253269 
220.165 -0.43307 -0.446916 225.159 -0.16127 -0.156898 234.168 -0.25659 -0.250257 
222.167 -0.42918 -0.441246 228.161 -0.15782 -0.153737 236.169 -0.25234 -0.247925 
224.169 -0.42508 -0.431828 230.162 -0.15537 -0.150937 239.171 -0.24561 -0.243052 
226.169 -0.42076 -0.426536 232.164 -0.15277 -0.147073 241.172 -0.24091 -0.238307 
228.171 -0.41619 -0.426153 234.165 -0.15003 -0.144537 243.173 -0.23612 -0.233894 
 210 
230.172 -0.41137 -0.421324 236.167 -0.14718 -0.141004 245.175 -0.23132 -0.229089 
232.175 -0.40635 -0.415724 238.168 -0.14424 -0.138577 247.177 -0.22658 -0.219842 
234.175 -0.40114 -0.410355 240.169 -0.14124 -0.135543 249.179 -0.22198 -0.215934 
236.177 -0.39577 -0.400624 242.171 -0.13818 -0.133161 251.177 -0.2176 -0.216576 
238.178 -0.39027 -0.398005 244.172 -0.13511 -0.128274 253.178 -0.2135 -0.213854 
240.18 -0.38466 -0.390468 246.174 -0.13204 -0.127056 255.182 -0.20966 -0.209121 
242.181 -0.37896 -0.387012 248.175 -0.12899 -0.124348 257.184 -0.20605 -0.201731 
244.182 -0.37321 -0.381559 250.176 -0.12598 -0.121393 259.186 -0.20262 -0.19988 
246.184 -0.36741 -0.37571 252.178 -0.12301 -0.118754 261.187 -0.19934 -0.190574 
248.185 -0.36158 -0.364714 254.179 -0.1201 -0.114582 264.189 -0.19461 -0.191812 
250.186 -0.35574 -0.361308 256.181 -0.11724 -0.113174 266.19 -0.19153 -0.188278 
253.179 -0.347 -0.357794 258.182 -0.11445 -0.110598 268.192 -0.18844 -0.185429 
255.191 -0.34121 -0.352795 260.183 -0.11174 -0.107727 270.19 -0.18532 -0.182107 
257.191 -0.33548 -0.347003 262.185 -0.1091 -0.104872 272.192 -0.18214 -0.176397 
259.193 -0.3298 -0.337144 264.186 -0.10655 -0.102558 274.195 -0.17893 -0.173529 
262.185 -0.32141 -0.33126 267.188 -0.10286 -0.100226 276.194 -0.17577 -0.172439 
264.187 -0.31591 -0.326187 269.19 -0.10048 -0.096866 279.197 -0.17126 -0.170135 
266.188 -0.31049 -0.327048 271.191 -0.09814 -0.092131 281.199 -0.16851 -0.166835 
268.19 -0.30515 -0.319841 273.193 -0.09583 -0.092937 283.202 -0.16604 -0.160793 
270.192 -0.29989 -0.314421 275.194 -0.09353 -0.089831 285.201 -0.16391 -0.158111 
272.192 -0.29473 -0.308989 277.195 -0.09124 -0.088101 287.202 -0.16219 -0.158153 
274.194 -0.28967 -0.300458 279.197 -0.08895 -0.085012 289.203 -0.16087 -0.156052 
276.195 -0.28471 -0.294966 281.198 -0.08663 -0.083672 291.205 -0.15987 -0.15423 
278.197 -0.27985 -0.291143 283.2 -0.08429 -0.076535 293.207 -0.15912 -0.153156 
280.198 -0.2751 -0.286252 285.201 -0.08196 -0.075952 295.208 -0.15855 -0.150189 
282.2 -0.27046 -0.28157 287.203 -0.07964 -0.07735 297.21 -0.15809 -0.147718 
284.201 -0.26595 -0.273925 289.204 -0.07736 -0.074353 299.21 -0.15766 -0.146258 
286.203 -0.26155 -0.270658 291.205 -0.07514 -0.070698 301.212 -0.1572 -0.143842 
288.216 -0.25728 -0.264096 293.206 -0.07298 -0.06864 303.213 -0.15669 -0.143411 
290.205 -0.25315 -0.259253 295.208 -0.07091 -0.067308 305.215 -0.15613 -0.142096 
292.207 -0.24917 -0.252746 297.21 -0.06895 -0.065972 307.216 -0.15555 -0.140042 
294.208 -0.24538 -0.251941 299.211 -0.0671 -0.063373 309.218 -0.15493 -0.140566 
296.209 -0.24179 -0.248529 301.213 -0.0654 -0.061593 311.219 -0.15431 -0.138993 
298.211 -0.23844 -0.246498 303.214 -0.06385 -0.061255 313.22 -0.15367 -0.138647 
300.225 -0.23534 -0.242253 305.228 -0.06246 -0.060146 316.223 -0.15273 -0.137055 
302.213 -0.23252 -0.238103 307.217 -0.06125 -0.058684 318.224 -0.15213 -0.13634 
304.215 -0.22999 -0.232848 309.218 -0.06018 -0.056556 320.226 -0.15154 -0.135887 
306.229 -0.22775 -0.230662 311.219 -0.05924 -0.055794 322.227 -0.151 -0.134315 
308.23 -0.22576 -0.228562 313.221 -0.05841 -0.055078 324.228 -0.15049 -0.133841 
310.231 -0.22402 -0.226478 315.223 -0.05768 -0.053546 326.23 -0.15004 -0.133479 
312.233 -0.2225 -0.224615 317.224 -0.05702 -0.051979 328.231 -0.14963 -0.132638 
 211 
314.234 -0.22118 -0.219799 319.225 -0.05643 -0.050906 330.235 -0.14926 -0.132122 
316.235 -0.22006 -0.218474 321.228 -0.05587 -0.049633 332.237 -0.14894 -0.132698 
318.242 -0.21911 -0.217692 323.228 -0.05534 -0.049445 334.236 -0.14865 -0.131338 
320.244 -0.2183 -0.215118 325.229 -0.05481 -0.04909 337.239 -0.14829 -0.13076 
322.243 -0.21764 -0.21318 327.231 -0.05428 -0.047777 340.241 -0.14799 -0.130753 
324.244 -0.21709 -0.212319 329.232 -0.05374 -0.047173 342.241 -0.14783 -0.130606 
326.246 -0.21664 -0.210351 331.234 -0.0532 -0.045643 344.243 -0.14769 -0.130035 
328.247 -0.21626 -0.208186 333.235 -0.05265 -0.045521 346.244 -0.14757 -0.129951 
330.244 -0.21595 -0.205038 335.249 -0.05211 -0.043865 348.245 -0.14747 -0.129857 
333.245 -0.21557 -0.204401 337.25 -0.05156 -0.043982 350.247 -0.14739 -0.130472 
335.247 -0.21534 -0.203114 340.253 -0.05074 -0.043484 353.249 -0.14728 -0.12965 
337.249 -0.2151 -0.203193 342.253 -0.05019 -0.042415 355.25 -0.14723 -0.130216 
339.249 -0.21486 -0.200745 344.255 -0.04965 -0.041677 357.252 -0.14718 -0.130076 
342.242 -0.21446 -0.199863 346.254 -0.04911 -0.040433 359.253 -0.14713 -0.129721 
344.253 -0.21418 -0.198237 348.255 -0.04858 -0.040353 361.255 -0.14708 -0.130426 
346.254 -0.21388 -0.197241 350.247 -0.04805 -0.039799 363.256 -0.14701 -0.129933 
348.256 -0.21357 -0.196406 352.258 -0.04754 -0.039396 365.257 -0.14694 -0.130397 
350.257 -0.21324 -0.195521 354.259 -0.04703 -0.038733 367.258 -0.14684 -0.129569 
352.258 -0.2129 -0.194457 356.252 -0.04654 -0.038676 369.26 -0.14673 -0.130201 
354.26 -0.21254 -0.193774 358.253 -0.04605 -0.038491 371.262 -0.14658 -0.129883 
356.261 -0.21217 -0.192251 360.254 -0.04558 -0.037634 373.263 -0.14641 -0.129866 
358.263 -0.21178 -0.191768 362.255 -0.04513 -0.037659 375.255 -0.14619 -0.129916 
360.265 -0.21138 -0.190681 364.257 -0.04469 -0.037553 377.266 -0.14594 -0.129849 
362.265 -0.21097 -0.19034 366.258 -0.04426 -0.036068 379.268 -0.14563 -0.129371 
364.267 -0.21054 -0.189311 368.26 -0.04383 -0.036594 381.268 -0.14528 -0.128797 
366.268 -0.21009 -0.188902 370.261 -0.04342 -0.035337 383.27 -0.14487 -0.129883 
368.27 -0.20963 -0.188414 372.263 -0.04302 -0.035825 385.274 -0.1444 -0.12872 
370.271 -0.20915 -0.187983 374.264 -0.04262 -0.034913 387.275 -0.14386 -0.127763 
372.273 -0.20866 -0.187126 376.265 -0.04223 -0.035055 389.277 -0.14326 -0.127905 
374.264 -0.20816 -0.187174 378.267 -0.04185 -0.034495 391.278 -0.14259 -0.128454 
376.276 -0.20764 -0.186061 380.268 -0.04147 -0.034408 393.28 -0.14186 -0.127473 
378.277 -0.20711 -0.18504 382.27 -0.04108 -0.033605 395.281 -0.14108 -0.127612 
380.278 -0.20658 -0.185591 384.271 -0.0407 -0.033472 397.28 -0.14026 -0.126486 
382.28 -0.20605 -0.184927 386.273 -0.04032 -0.033678 399.282 -0.1394 -0.126265 
384.281 -0.20553 -0.184889 388.274 -0.03994 -0.03347 401.283 -0.13851 -0.125413 
386.283 -0.20501 -0.18447 390.275 -0.03955 -0.033504 403.284 -0.1376 -0.128402 
388.284 -0.20451 -0.184539 392.277 -0.03916 -0.032985 405.276 -0.13666 -0.122584 
390.285 -0.20403 -0.184151 394.278 -0.03877 -0.032429 407.277 -0.13572 -0.12377 
392.287 -0.20358 -0.18436 396.279 -0.03836 -0.032772 409.278 -0.13478 -0.12365 
394.289 -0.20315 -0.183725 398.281 -0.03795 -0.032875 411.28 -0.13384 -0.124021 
396.28 -0.20275 -0.184065 400.282 -0.03752 -0.031221 413.281 -0.1329 -0.123334 
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398.281 -0.20239 -0.183514 402.283 -0.03709 -0.032048 415.295 -0.13198 -0.121873 
400.283 -0.20208 -0.183781 404.285 -0.03664 -0.031371 417.297 -0.13105 -0.12164 
403.285 -0.20169 -0.183771 406.287 -0.03618 -0.031554 419.298 -0.13013 -0.120448 
405.286 -0.2015 -0.183513 408.288 -0.0357 -0.030791 421.287 -0.1292 -0.119981 
407.288 -0.20135 -0.183468 410.29 -0.0352 -0.02912 423.288 -0.12826 -0.119497 
409.289 -0.20123 -0.182529 412.29 -0.03469 -0.031138 425.29 -0.12731 -0.11874 
411.29 -0.20114 -0.182989 414.292 -0.03415 -0.029918 427.291 -0.12633 -0.115269 
413.292 -0.20106 -0.182258 416.294 -0.0336 -0.029534 429.293 -0.12533 -0.116051 
415.293 -0.20098 -0.182792 418.295 -0.03302 -0.028953 432.307 -0.12377 -0.115449 
417.295 -0.20089 -0.182392 420.296 -0.03241 -0.028582 434.308 -0.12269 -0.114021 
419.296 -0.20078 -0.182483 422.298 -0.03179 -0.028979 436.312 -0.12156 -0.11241 
421.298 -0.20063 -0.181506 424.3 -0.03114 -0.027504 438.313 -0.12039 -0.110859 
423.299 -0.20043 -0.181973 426.301 -0.03048 -0.027462 441.316 -0.11853 -0.108927 
425.3 -0.20018 -0.181099 428.302 -0.02981 -0.027795 444.315 -0.11654 -0.106348 
427.302 -0.19986 -0.180714 430.303 -0.02913 -0.027278 446.32 -0.11514 -0.105331 
429.303 -0.19946 -0.180363 432.305 -0.02845 -0.026936 448.318 -0.11368 -0.104788 
431.305 -0.19896 -0.180882 434.306 -0.02778 -0.026979 450.322 -0.11218 -0.102318 
433.306 -0.19838 -0.17994 436.308 -0.02711 -0.027054 452.321 -0.11062 -0.101183 
435.307 -0.19772 -0.179982 438.309 -0.02645 -0.026165 454.323 -0.10902 -0.0998 
437.309 -0.19697 -0.179407 440.31 -0.0258 -0.025753 457.327 -0.10655 -0.098769 
439.323 -0.19615 -0.179227 442.312 -0.02517 -0.025728 460.328 -0.10401 -0.097498 
441.325 -0.19526 -0.17772 444.313 -0.02457 -0.025773 462.331 -0.10228 -0.096903 
443.325 -0.19431 -0.17793 446.315 -0.024 -0.024926 464.333 -0.10052 -0.095127 
445.325 -0.19329 -0.177352 448.316 -0.02345 -0.02493 466.328 -0.09874 -0.093508 
447.326 -0.19222 -0.177281 450.318 -0.02294 -0.024938 468.334 -0.09695 -0.091997 
450.328 -0.19052 -0.173178 452.319 -0.02247 -0.024598 470.332 -0.09514 -0.090019 
452.329 -0.18933 -0.17454 454.332 -0.02201 -0.024911 473.324 -0.09242 -0.087424 
454.331 -0.18811 -0.174021 456.334 -0.02159 -0.024132 475.337 -0.0906 -0.086103 
457.332 -0.1862 -0.173366 459.337 -0.02098 -0.024143 477.34 -0.08878 -0.084364 
459.324 -0.1849 -0.173272 462.326 -0.0204 -0.023532 479.328 -0.08697 -0.083866 
461.326 -0.18357 -0.171639 464.337 -0.02003 -0.023145 481.344 -0.08515 -0.08141 
463.327 -0.18223 -0.170068 466.339 -0.01965 -0.023195 483.342 -0.08332 -0.079983 
465.328 -0.18087 -0.169045 468.34 -0.01928 -0.022989 485.346 -0.08148 -0.077178 
467.33 -0.1795 -0.165721 471.342 -0.01871 -0.023191 487.345 -0.07964 -0.07595 
469.348 -0.17812 -0.167671 473.344 -0.01832 -0.022333 490.346 -0.07683 -0.074182 
471.349 -0.17672 -0.166898 475.346 -0.01791 -0.022433 492.349 -0.07494 -0.072557 
473.347 -0.1753 -0.165509 478.347 -0.01727 -0.02148 494.349 -0.07302 -0.070257 
475.348 -0.17385 -0.163835 480.349 -0.01681 -0.022042 497.352 -0.0701 -0.067241 
477.349 -0.17237 -0.162628 482.351 -0.01632 -0.020263 500.353 -0.06711 -0.065418 
479.35 -0.17085 -0.164156 485.343 -0.01552 -0.020411 503.354 -0.06403 -0.064066 
481.351 -0.1693 -0.159975 487.354 -0.01495 -0.019554 506.347 -0.06087 -0.059947 
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483.351 -0.16771 -0.158763 489.355 -0.01436 -0.019754 508.348 -0.0587 -0.058591 
485.353 -0.16607 -0.157641 491.357 -0.01375 -0.018314 510.349 -0.0565 -0.057059 
487.354 -0.16438 -0.156597 493.358 -0.01312 -0.018968 513.352 -0.05312 -0.054393 
489.355 -0.16264 -0.153583 495.359 -0.01248 -0.018523 514.365 -0.05199 -0.055075 
491.357 -0.16085 -0.152787 497.36 -0.01183 -0.017864 517.354 -0.04857 -0.051384 
493.359 -0.15899 -0.151213 499.353 -0.01118 -0.016443 518.369 -0.04743 -0.047652 
495.36 -0.15707 -0.150042 501.355 -0.01053 -0.016187 520.369 -0.04515 -0.046547 
497.361 -0.15509 -0.148389 503.367 -0.00989 -0.015923 522.371 -0.04289 -0.042585 
500.363 -0.15201 -0.145767 505.357 -0.00926 -0.015433 524.372 -0.04066 -0.042765 
502.365 -0.1499 -0.142451 507.359 -0.00864 -0.015225 526.371 -0.03847 -0.04093 
505.357 -0.14666 -0.14234 509.369 -0.00805 -0.014496 528.373 -0.03632 -0.038607 
507.368 -0.14446 -0.141129 511.37 -0.00747 -0.014804 530.373 -0.03423 -0.036429 
509.37 -0.14223 -0.137913 513.362 -0.00693 -0.013799 533.366 -0.03122 -0.034261 
512.372 -0.13883 -0.136799 515.363 -0.00642 -0.013635 535.367 -0.02932 -0.033731 
514.373 -0.13655 -0.134514 517.365 -0.00594 -0.013598 537.379 -0.02751 -0.031861 
516.374 -0.13425 -0.129948 519.367 -0.00549 -0.0128 539.38 -0.0258 -0.030035 
518.376 -0.13195 -0.130433 521.367 -0.00507 -0.012998 541.381 -0.0242 -0.028216 
520.367 -0.12965 -0.129289 523.369 -0.00468 -0.01225 543.383 -0.02268 -0.025381 
522.369 -0.12735 -0.126684 525.371 -0.00431 -0.012065 545.385 -0.02125 -0.023868 
524.37 -0.12506 -0.1225 527.372 -0.00397 -0.011659 547.388 -0.0199 -0.022965 
526.372 -0.12276 -0.119652 529.373 -0.00365 -0.011297 549.39 -0.01863 -0.021227 
528.373 -0.12045 -0.116961 531.374 -0.00335 -0.010602 551.389 -0.01742 -0.019564 
530.374 -0.11809 -0.116448 533.376 -0.00306 -0.010874 553.393 -0.01628 -0.018623 
532.376 -0.11569 -0.11339 535.378 -0.0028 -0.010262 556.395 -0.01468 -0.016126 
534.377 -0.11322 -0.111076 537.379 -0.00254 -0.010479 558.396 -0.01367 -0.012574 
536.379 -0.11067 -0.107856 539.38 -0.0023 -0.009842 560.397 -0.01271 -0.013655 
538.38 -0.10802 -0.103383 541.382 -0.00208 -0.01026 562.399 -0.01178 -0.012763 
540.382 -0.10526 -0.101043 543.383 -0.00185 -0.00929 564.4 -0.01089 -0.011099 
542.383 -0.10238 -0.099186 545.386 -0.00164 -0.009072 566.399 -0.01002 -0.010257 
544.384 -0.09935 -0.095833 547.386 -0.00144 -0.009174 568.403 -0.00916 -0.007699 
546.386 -0.09616 -0.093187 549.388 -0.00123 -0.006039 570.392 -0.00833 -0.006936 
548.387 -0.09283 -0.087337 551.389 -0.00103 -0.008668 572.393 -0.00751 -0.006163 
550.389 -0.08936 -0.082843 553.39 -0.00084 -0.009176 574.395 -0.00672 -0.004385 
552.39 -0.08578 -0.08356 555.392 -0.00066 -0.009488 576.396 -0.00595 -0.004223 
554.391 -0.08211 -0.078157 557.393 -0.0005 -0.009572 578.398 -0.0052 -0.00279 
556.393 -0.07836 -0.072929 559.407 -0.00035 -0.008082 580.412 -0.00449 -0.002796 
558.394 -0.07457 -0.069918 562.409 -0.00017 -0.009177 582.413 -0.00382 -0.000339 
560.395 -0.07074 -0.068816 564.41 -8.1E-05 -0.009086 584.402 -0.00319 -0.000433 
562.397 -0.06689 -0.066089 566.399 -2.3E-05 -0.008966 586.403 -0.0026 0.001425 
564.399 -0.06306 -0.062628 568.411 0 -0.009188 588.405 -0.00207 -0.000387 
566.4 -0.05925 -0.05804 570.402 -1.3E-05 -0.00907 590.406 -0.00158 0.000277 
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568.401 -0.05549 -0.055779 572.404 -6.7E-05 -0.008824 592.408 -0.00116 0.001965 
570.402 -0.05179 -0.050352 574.405 -0.00017 -0.009327 594.409 -0.00079 0.001974 
572.404 -0.04818 -0.048331 576.407 -0.00031 -0.008887 596.41 -0.00049 0.002704 
574.405 -0.04467 -0.044352 578.408 -0.00051 -0.009236 598.412 -0.00025 0.002573 
576.407 -0.0413 -0.041118 580.409 -0.00076 -0.008685 600.413 -9.1E-05 0.002556 
578.408 -0.03806 -0.040029 582.411 -0.00107 -0.008784 602.427 -6E-06 0.003072 
580.41 -0.035 -0.03827 584.412 -0.00144 -0.009223 604.429 0 0.002905 
582.411 -0.03211 -0.035063 587.414 -0.0021 -0.009149 606.43 -6.9E-05 0.003046 
584.412 -0.0294 -0.032917 589.416 -0.00261 -0.008554 608.431 -0.00021 0.002938 
586.414 -0.02686 -0.028637 591.417 -0.00316 -0.008148 610.43 -0.00041 0.003037 
588.415 -0.02448 -0.027432 593.418 -0.00374 -0.009248 612.421 -0.00068 0.002864 
590.417 -0.02225 -0.025664 595.42 -0.00437 -0.008842 614.423 -0.001 0.00324 
592.418 -0.02018 -0.023467 597.421 -0.00502 -0.009352 616.424 -0.00136 0.002604 
594.42 -0.01825 -0.021296 599.423 -0.0057 -0.00884 618.426 -0.00178 0.002704 
596.421 -0.01646 -0.019493 601.424 -0.00641 -0.008825 620.427 -0.00223 0.003199 
599.423 -0.01401 -0.018382 603.426 -0.00713 -0.009563 622.429 -0.00271 0.002677 
601.425 -0.01253 -0.013985 605.428 -0.00786 -0.008919 624.431 -0.00322 0.002626 
603.426 -0.01117 -0.014621 607.428 -0.0086 -0.009563 626.432 -0.00375 0.002893 
605.427 -0.00991 -0.013066 609.43 -0.00935 -0.010414 629.446 -0.00458 0.003235 
607.429 -0.00875 -0.010631 611.431 -0.01009 -0.010419 631.447 -0.00514 0.003015 
609.43 -0.00769 -0.009077 613.433 -0.01083 -0.010801 633.449 -0.00571 0.0033 
611.432 -0.00671 -0.00826 615.434 -0.01156 -0.012252 635.45 -0.00628 0.001805 
613.433 -0.00582 -0.006811 617.436 -0.01228 -0.0124 637.452 -0.00685 0.001888 
615.434 -0.005 -0.006121 619.437 -0.01301 -0.012841 639.453 -0.00743 0.001708 
617.437 -0.00424 -0.005305 621.438 -0.01374 -0.012989 641.455 -0.00803 7.3E-05 
619.45 -0.00355 -0.003625 623.441 -0.01447 -0.014148 643.456 -0.00865 -0.00066 
622.452 -0.00262 -0.002871 625.442 -0.01522 -0.014571 645.457 -0.0093 -0.001839 
624.453 -0.00206 -0.001396 627.454 -0.01597 -0.015219 647.459 -0.00998 -0.003073 
627.443 -0.00135 -0.000771 630.457 -0.01714 -0.016001 649.458 -0.01071 -0.003627 
629.444 -0.00095 -0.00039 633.447 -0.01835 -0.016461 651.459 -0.01148 -0.00444 
631.446 -0.00062 9.6E-05 635.448 -0.01919 -0.017855 653.461 -0.01231 -0.006065 
633.447 -0.00035 0.001686 637.45 -0.02006 -0.018704 655.462 -0.0132 -0.007305 
635.449 -0.00016 0.002602 639.451 -0.02096 -0.020292 657.464 -0.01465 -0.010115 
637.45 -4.2E-05 0.001337 641.452 -0.0219 -0.02103 659.465 -0.01571 -0.010424 
639.451 0 0.001897 643.454 -0.02288 -0.021716 661.466 -0.01685 -0.011644 
641.453 -3.7E-05 0.002292 645.456 -0.0239 -0.022478 663.467 -0.01808 -0.012607 
643.454 -0.00016 0.002585 647.457 -0.02497 -0.023556 665.469 -0.01941 -0.014006 
645.456 -0.00036 0.002642 649.458 -0.02607 -0.024094 667.47 -0.02082 -0.016697 
647.457 -0.00065 0.002282 651.459 -0.0272 -0.024958 669.472 -0.02233 -0.017551 
649.459 -0.00103 0.002668 653.461 -0.02836 -0.027149 671.473 -0.02392 -0.019062 
651.46 -0.0015 0.002639 655.463 -0.02954 -0.027953 673.475 -0.02558 -0.020048 
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653.461 -0.00206 0.002516 657.464 -0.03074 -0.028433 675.476 -0.0273 -0.022212 
655.462 -0.00271 0.002711 659.465 -0.03195 -0.02989 677.478 -0.02907 -0.024684 
657.464 -0.00344 0.002911 661.466 -0.03316 -0.030373 679.479 -0.03088 -0.026696 
659.466 -0.00426 0.002162 663.468 -0.03438 -0.03128 681.481 -0.03272 -0.028187 
661.467 -0.00515 0.002713 665.471 -0.03559 -0.033081 683.472 -0.03458 -0.031158 
663.468 -0.00611 0.002446 667.471 -0.03678 -0.033653 685.483 -0.03645 -0.031843 
665.47 -0.00715 0.002357 669.472 -0.03796 -0.0345 687.475 -0.03832 -0.032906 
667.471 -0.00825 0.00229 671.474 -0.03912 -0.03504 689.476 -0.04019 -0.034702 
669.472 -0.00941 0.001087 673.475 -0.04026 -0.036601 691.477 -0.04204 -0.036568 
671.474 -0.01064 -4.1E-05 675.476 -0.04136 -0.03688 693.479 -0.04385 -0.037867 
673.475 -0.01192 -0.000972 677.478 -0.04242 -0.038761 695.48 -0.04563 -0.039231 
675.477 -0.01325 -0.002291 679.479 -0.04344 -0.039642 697.482 -0.04737 -0.042341 
677.478 -0.01464 -0.003766 681.48 -0.04443 -0.039732 699.483 -0.04908 -0.042227 
679.48 -0.01607 -0.005653 683.482 -0.04539 -0.040342 701.497 -0.05075 -0.045243 
681.481 -0.01754 -0.006085 685.485 -0.04633 -0.04157 703.498 -0.05238 -0.046176 
683.482 -0.01906 -0.007077 687.485 -0.04724 -0.04183 705.5 -0.05399 -0.048796 
685.484 -0.02061 -0.008931 689.486 -0.04814 -0.042682 707.501 -0.05557 -0.050457 
687.485 -0.02221 -0.009858 691.488 -0.04903 -0.044468 709.503 -0.05713 -0.052185 
689.487 -0.02384 -0.011022 693.489 -0.0499 -0.045079 711.504 -0.05867 -0.054822 
691.488 -0.0255 -0.013263 695.491 -0.05078 -0.045624 713.505 -0.06019 -0.05657 
693.489 -0.0272 -0.014135 697.491 -0.05166 -0.046636 715.507 -0.06169 -0.056414 
695.491 -0.02893 -0.015653 699.493 -0.05254 -0.048198 717.506 -0.06318 -0.058715 
697.492 -0.03068 -0.017674 701.494 -0.05343 -0.04857 719.507 -0.06466 -0.060901 
699.494 -0.03247 -0.019152 703.496 -0.05434 -0.048873 721.508 -0.06613 -0.065282 
701.495 -0.03427 -0.020464 705.498 -0.05527 -0.049681 723.51 -0.0676 -0.065025 
703.497 -0.03611 -0.023771 707.499 -0.05622 -0.051886 725.511 -0.06907 -0.066799 
705.498 -0.03796 -0.02499 709.501 -0.05721 -0.052451 727.512 -0.07054 -0.068535 
707.499 -0.03983 -0.027269 711.502 -0.05822 -0.053842 729.514 -0.07201 -0.070301 
709.501 -0.04171 -0.028171 713.503 -0.05925 -0.055786 732.516 -0.07423 -0.073967 
711.503 -0.04362 -0.030443 715.504 -0.0603 -0.055281 734.518 -0.07573 -0.074568 
713.505 -0.04554 -0.03269 717.506 -0.06137 -0.056038 736.522 -0.07725 -0.076209 
715.506 -0.04748 -0.034938 719.507 -0.06244 -0.056943 738.52 -0.07878 -0.078266 
718.52 -0.05043 -0.037427 721.509 -0.06352 -0.058395 740.523 -0.08035 -0.079677 
721.51 -0.05344 -0.038599 723.51 -0.06459 -0.060564 742.524 -0.08194 -0.083108 
723.51 -0.05548 -0.040364 725.512 -0.06565 -0.061722 744.525 -0.08358 -0.085137 
725.512 -0.05755 -0.042417 727.513 -0.0667 -0.061439 746.526 -0.08525 -0.088589 
727.514 -0.05966 -0.044432 729.514 -0.06773 -0.062012 748.528 -0.08696 -0.090725 
729.515 -0.06181 -0.047227 731.516 -0.06873 -0.063327 750.529 -0.08873 -0.091397 
731.516 -0.06399 -0.04847 733.517 -0.06971 -0.064032 752.53 -0.09055 -0.093457 
733.518 -0.06622 -0.051542 735.519 -0.07064 -0.06514 754.532 -0.09243 -0.095041 
735.519 -0.06849 -0.053038 737.52 -0.07154 -0.066065 756.538 -0.09437 -0.097699 
 216 
737.52 -0.07081 -0.055801 739.522 -0.07239 -0.066565 758.534 -0.09637 -0.10093 
739.522 -0.07317 -0.060049 741.523 -0.07319 -0.067115 761.536 -0.09952 -0.102941 
741.523 -0.07558 -0.061887 743.524 -0.07393 -0.068825 763.538 -0.10171 -0.106877 
743.525 -0.07805 -0.065566 745.526 -0.07461 -0.068715 765.54 -0.10397 -0.108219 
745.526 -0.08057 -0.066543 747.527 -0.07525 -0.069725 767.541 -0.10629 -0.11197 
747.527 -0.08313 -0.068935 749.529 -0.07584 -0.070419 769.542 -0.10866 -0.112247 
749.529 -0.08573 -0.071883 751.529 -0.07639 -0.07151 771.544 -0.11106 -0.115014 
751.53 -0.08836 -0.076334 753.532 -0.07691 -0.071866 773.546 -0.1135 -0.117759 
753.532 -0.09103 -0.078315 755.533 -0.07741 -0.072172 776.538 -0.11718 -0.1219 
755.533 -0.09373 -0.080935 757.534 -0.07788 -0.072649 779.549 -0.12088 -0.124083 
757.535 -0.09644 -0.085226 759.536 -0.07834 -0.074058 781.551 -0.12333 -0.125762 
759.536 -0.09918 -0.088262 761.537 -0.07879 -0.074018 783.542 -0.12577 -0.127871 
761.537 -0.10193 -0.089852 763.539 -0.07924 -0.074357 785.544 -0.12818 -0.131645 
763.539 -0.10469 -0.092944 765.54 -0.07969 -0.075513 787.545 -0.13055 -0.133697 
765.54 -0.10746 -0.096235 767.541 -0.08015 -0.076299 789.546 -0.13287 -0.13557 
767.542 -0.11022 -0.100132 769.543 -0.08063 -0.076579 791.548 -0.13513 -0.138102 
769.543 -0.11299 -0.101475 771.544 -0.08112 -0.077305 793.562 -0.13734 -0.141827 
771.545 -0.11574 -0.104325 773.545 -0.08164 -0.078173 795.563 -0.13948 -0.143167 
773.546 -0.11849 -0.10734 775.547 -0.08219 -0.077736 797.564 -0.14156 -0.145424 
775.547 -0.12122 -0.110585 777.549 -0.08278 -0.079641 800.567 -0.14459 -0.146875 
777.549 -0.12393 -0.112601 779.55 -0.08341 -0.079754 802.569 -0.14655 -0.148594 
779.55 -0.12664 -0.116218 781.551 -0.08408 -0.081413 804.57 -0.14846 -0.1508 
781.552 -0.12933 -0.120645 783.552 -0.08479 -0.080627 806.571 -0.15033 -0.154118 
783.553 -0.13201 -0.121891 785.555 -0.08553 -0.082419 808.573 -0.15216 -0.154911 
785.554 -0.13468 -0.125461 787.555 -0.08629 -0.083139 810.575 -0.15396 -0.157001 
787.556 -0.13735 -0.128376 789.557 -0.08709 -0.083426 812.576 -0.15572 -0.158236 
789.557 -0.14002 -0.131777 791.558 -0.0879 -0.083995 814.576 -0.15746 -0.160226 
791.558 -0.14268 -0.136308 793.559 -0.08874 -0.085149 817.579 -0.16002 -0.163129 
793.56 -0.14534 -0.139442 795.561 -0.08959 -0.086704 819.578 -0.1617 -0.165207 
795.566 -0.148 -0.142963 797.562 -0.09046 -0.086864 821.579 -0.16336 -0.165063 
797.563 -0.15067 -0.148191 799.564 -0.09134 -0.08875 823.583 -0.16502 -0.168382 
799.564 -0.15333 -0.151356 801.565 -0.09223 -0.089373 825.582 -0.16666 -0.169783 
802.566 -0.15735 -0.154118 803.567 -0.09312 -0.089277 827.584 -0.16829 -0.170556 
804.568 -0.16003 -0.158483 805.569 -0.09401 -0.090464 829.584 -0.16992 -0.175786 
806.569 -0.16273 -0.159986 807.569 -0.0949 -0.091431 832.587 -0.17235 -0.177221 
808.571 -0.16543 -0.163205 809.571 -0.09579 -0.092282 835.589 -0.17476 -0.179767 
810.572 -0.16815 -0.166559 811.572 -0.09667 -0.092955 837.593 -0.17636 -0.182689 
812.573 -0.17087 -0.169078 813.574 -0.09754 -0.092866 839.595 -0.17796 -0.183899 
814.592 -0.17361 -0.174804 815.575 -0.09841 -0.094354 841.596 -0.17955 -0.186209 
816.593 -0.17635 -0.177681 817.576 -0.09927 -0.095384 843.597 -0.18114 -0.187579 
818.595 -0.1791 -0.179262 819.578 -0.10012 -0.096159 845.599 -0.18273 -0.191317 
 217 
820.592 -0.18186 -0.182727 821.579 -0.10097 -0.097277 848.598 -0.1851 -0.194912 
822.593 -0.18463 -0.188477 823.581 -0.10182 -0.097535 850.6 -0.18668 -0.197266 
824.591 -0.1874 -0.190559 825.583 -0.10265 -0.098393 853.601 -0.18905 -0.200139 
826.594 -0.19018 -0.193977 827.584 -0.10349 -0.098732 
   
828.594 -0.19297 -0.195232 829.585 -0.10432 -0.099842 
   
830.596 -0.19576 -0.199223 831.587 -0.10514 -0.101028 
   
832.597 -0.19855 -0.202033 833.588 -0.10596 -0.102002 
   
834.599 -0.20136 -0.206473 835.589 -0.10678 -0.101785 
   
836.6 -0.20416 -0.208587 837.602 -0.10759 -0.103478 
   
838.601 -0.20698 -0.213308 840.593 -0.1088 -0.103396 
   
840.604 -0.20979 -0.215972 842.594 -0.10961 -0.105428 
   
843.605 -0.21402 -0.221286 844.596 -0.11041 -0.105343 
   
845.607 -0.21685 -0.223783 845.597 -0.11081 -0.107642 
   
847.608 -0.21967 -0.226645 847.598 -0.11161 -0.107751 
   
850.6 -0.22392 -0.230057 849.599 -0.11241 -0.1072 
   
852.602 -0.22675 -0.23266 851.665 -0.1132 -0.109305 
   
854.603 -0.22958 -0.237216 854.681 -0.1144 -0.110488 
   
856.604 -0.23241 -0.243077 856.682 -0.11519 -0.110584 
   
 
F.2 Echocardiography Tracking Raw Results 
































































































































































































































































































































































































































































































































































F.3 Bar Graph Raw Results 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































F.4 Strain Maps 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX G. RAW DATA – SPECIFIC AIM 2 
G.1 Specific Aim 2A – Peak Systolic LVOT Average Velocity 
Table G-1. 50/50 Short AML peak systolic LVOT average velocity at all 
LAMPOON and CO conditions. 
















2.5 0.273 0.247 0.262 
5.0 0.394 0.406 0.364 
6.5 0.462 0.473   
Average 0.334 0.327 0.313 
 
Table G-2. 50/50 Long AML peak systolic LVOT average velocity at all 
LAMPOON and CO conditions. 
















2.5 0.257 0.223 0.208 
5.0 0.441 0.375 0.367 
6.5 0.458 0.423 0.395 
Average 0.385 0.340 0.323 
 
Table G-3. 80/20 Long AML peak systolic LVOT average velocity at all 
LAMPOON and CO conditions. 

















2.5 0.298 0.268 0.245 
5.0 0.398 0.371 0.342 
6.5 0.409 0.409 0.380 
Average 0.368 0.349 0.322 
 
Table G-4. Combined average of Long AML peak systolic LVOT average 
velocity at all LAMPOON and CO conditions. 
















2.5 0.278 0.246 0.227 
5.0 0.420 0.373 0.355 
6.5 0.434 0.416 0.388 
Average 0.362 0.339 0.320 
 
G.2 Specific Aim 2A – Maximum VSS 
Table G-5. 50/50 Short AML maximum VSS and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.723 139 0.728 149 0.568 193 
5.0 1.002 439 1.135 99 0.734 149 
6.5 1.393 445 1.014 122     
Average 0.862 289 0.931 124 0.651 171 
 
 233 
Table G-6. 50/50 Long AML maximum VSS and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.544 121 0.452 144 0.446 173 
5.0 1.154 107 0.903 115 0.633 115 
6.5 1.381 107 1.182 94 0.655 129 
Average 1.026 112 0.845 117 0.578 139 
 
Table G-7. 80/20 Long AML maximum VSS and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.593 143 0.422 121 0.414 165 
5.0 1.065 107 0.853 121 0.720 137 
6.5 1.071 128 0.801 128 0.880 108 
Average 0.910 126 0.692 123 0.671 137 
 
Table G-8. Combined average of all deployment and AML lengths maximum 
VSS and time it occurred at all LAMPOON and CO conditions. 

















2.5 0.620 134 0.534 138 0.476 177 
5.0 1.074 218 0.963 112 0.696 134 
6.5 1.281 227 0.999 114 0.768 119 




G.3 Specific Aim 2A – Maximum Principal RSS 
Table G-9. 50/50 Short AML maximum principal RSS and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 14.15 250 5.87 342 7.25 298 
5.0 31.36 183 18.42 282 14.41 254 
6.5 23.96 233 25.62 226     
Average 22.757 217 12.147 312 10.829 276 
 
Table G-10. 50/50 Long AML maximum principal RSS and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 8.39 250 8.32 266 6.10 288 
5.0 24.73 200 20.05 173 20.02 180 
6.5 39.33 171 23.13 180 32.89 180 
Average 24.151 207 17.166 206 19.671 216 
 
Table G-11. 50/50 Short AML maximum principal RSS and time it occurred at all 
LAMPOON and CO conditions. 


















2.5 5.27 228 5.62 221 12.85 180 
5.0 21.80 200 24.83 193 41.69 144 
6.5 71.20 157 20.85 178 41.46 122 
Average 32.757 195 17.100 197 32.000 149 
 
Table G-12. Combined average of all deployment heights and AML lengths 
maximum principal RSS and time it occurred at all LAMPOON and CO conditions. 

















2.5 9.270 243 6.603 276 8.733 255 
5.0 25.964 194 21.102 216 25.373 193 
6.5 44.832 187 23.200 195 37.176 151 
Average 26.555 206 15.471 238 20.833 214 
 
 
G.4 Specific Aim 2A – Maximum TKE 
Table G-13. 50/50 Long AML maximum TKE and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.0391 245 0.0065 282 0.0073 160 
5.0 0.0340 189 0.0190 276 0.0191 226 
6.5 0.0296 233 0.0296 226     
Average 0.037 217 0.013 279 0.013 193 
 
 236 
Table G-14. 50/50 Long AML maximum TKE and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.0091 250 0.0102 259 0.0076 288 
5.0 0.0257 200 0.0201 173 0.0210 180 
6.5 0.0425 178 0.0279 173 0.0328 180 
Average 0.026 209 0.019 201 0.020 216 
 
Table G-15. 80/20 Long AML maximum TKE and time it occurred at all 
LAMPOON and CO conditions. 

















2.5 0.0068 214 0.0078 207 0.0175 187 
5.0 0.0239 200 0.0248 193 0.0404 151 
6.5 0.0834 164 0.0284 207 0.0421 122 
Average 0.038 193 0.020 202 0.033 153 
 
Table G-16. Combined average of all deployment heights and AML lengths 
maximum TKE and time it occurred at all LAMPOON and CO conditions. 

















2.5 0.018 236 0.008 249 0.011 212 
5.0 0.028 196 0.021 214 0.027 186 
6.5 0.052 192 0.029 202 0.037 151 
Average 0.033 206 0.017 228 0.022 187 
 
 237 
G.5 Specific Aim 2B – Neo-Sinus Particle Tracking 
Table G-17. 80/20 Long AML neo-sinus particle tracking results for 2.5 L/min. 

















0 0 1 0 0 1 0 0 1 
0.001 0.00117 1 0.001 0.00117 1 0.001 0.00117 1 
0.002 0.00234 1 0.002 0.00234 1 0.002 0.00234 1 
0.003 0.00350 1 0.003 0.00350 1 0.003 0.00350 0.99143 
0.004 0.00467 0.98551 0.004 0.00467 1 0.004 0.00467 0.98000 
0.005 0.00584 0.94928 0.005 0.00584 1 0.005 0.00584 0.94857 
0.006 0.00701 0.94928 0.006 0.00701 1 0.006 0.00701 0.93714 
0.007 0.00818 0.94928 0.007 0.00818 1 0.007 0.00818 0.91714 
0.008 0.00935 0.94928 0.008 0.00935 0.99578 0.008 0.00935 0.89143 
0.009 0.01051 0.94928 0.009 0.01051 0.99578 0.009 0.01051 0.87714 
0.01 0.01168 0.93478 0.01 0.01168 0.99156 0.01 0.01168 0.85429 
0.011 0.01285 0.91304 0.011 0.01285 0.98312 0.011 0.01285 0.82857 
0.012 0.01402 0.89855 0.012 0.01402 0.97468 0.012 0.01402 0.80286 
0.013 0.01519 0.89855 0.013 0.01519 0.95781 0.013 0.01519 0.78857 
0.014 0.01636 0.89855 0.014 0.01636 0.94937 0.014 0.01636 0.74286 
0.015 0.01752 0.89855 0.015 0.01752 0.94937 0.015 0.01752 0.71143 
0.016 0.01869 0.89130 0.016 0.01869 0.94515 0.016 0.01869 0.68286 
0.017 0.01986 0.86232 0.017 0.01986 0.94515 0.017 0.01986 0.64857 
0.018 0.02103 0.84783 0.018 0.02103 0.94093 0.018 0.02103 0.61714 
0.019 0.02220 0.84783 0.019 0.02220 0.93671 0.019 0.02220 0.59143 
0.02 0.02336 0.84783 0.02 0.02336 0.93671 0.02 0.02336 0.56286 
0.021 0.02453 0.84783 0.021 0.02453 0.93671 0.021 0.02453 0.52571 
0.022 0.02570 0.83333 0.022 0.02570 0.93671 0.022 0.02570 0.49714 
0.023 0.02687 0.81159 0.023 0.02687 0.93671 0.023 0.02687 0.45714 
0.024 0.02804 0.79710 0.024 0.02804 0.92827 0.024 0.02804 0.42571 
0.025 0.02921 0.79710 0.025 0.02921 0.91561 0.025 0.02921 0.41429 
0.026 0.03037 0.79710 0.026 0.03037 0.91561 0.026 0.03037 0.38857 
0.027 0.03154 0.79710 0.027 0.03154 0.91139 0.027 0.03154 0.36571 
0.028 0.03271 0.78986 0.028 0.03271 0.90717 0.028 0.03271 0.32000 
0.029 0.03388 0.77536 0.029 0.03388 0.90295 0.029 0.03388 0.29429 
0.03 0.03505 0.76087 0.03 0.03505 0.90295 0.03 0.03505 0.26286 
0.031 0.03621 0.75362 0.031 0.03621 0.90295 0.031 0.03621 0.22571 
0.032 0.03738 0.74638 0.032 0.03738 0.90295 0.032 0.03738 0.20571 
 238 
0.033 0.03855 0.74638 0.033 0.03855 0.90295 0.033 0.03855 0.18571 
0.034 0.03972 0.74638 0.034 0.03972 0.89873 0.034 0.03972 0.14857 
0.035 0.04089 0.74638 0.035 0.04089 0.88608 0.035 0.04089 0.13143 
0.036 0.04206 0.72464 0.036 0.04206 0.88186 0.036 0.04206 0.11429 
0.037 0.04322 0.71014 0.037 0.04322 0.87764 0.037 0.04322 0.10571 
0.038 0.04439 0.70290 0.038 0.04439 0.87764 0.038 0.04439 0.10000 
0.039 0.04556 0.70290 0.039 0.04556 0.87764 0.039 0.04556 0.08857 
0.04 0.04673 0.70290 0.04 0.04673 0.87342 0.04 0.04673 0.07714 
0.041 0.04790 0.69565 0.041 0.04790 0.87342 0.041 0.04790 0.07143 
0.042 0.04907 0.69565 0.042 0.04907 0.87342 0.042 0.04907 0.06286 
0.043 0.05023 0.69565 0.043 0.05023 0.86920 0.043 0.05023 0.05714 
0.044 0.05140 0.68116 0.044 0.05140 0.86498 0.044 0.05140 0.05429 
0.045 0.05257 0.66667 0.045 0.05257 0.86076 0.045 0.05257 0.04857 
0.046 0.05374 0.65942 0.046 0.05374 0.85232 0.046 0.05374 0.04571 
0.047 0.05491 0.65942 0.047 0.05491 0.85232 0.047 0.05491 0.04286 
0.048 0.05607 0.65942 0.048 0.05607 0.84810 0.048 0.05607 0.03143 
0.049 0.05724 0.65217 0.049 0.05724 0.84810 0.049 0.05724 0.02857 
0.05 0.05841 0.65217 0.05 0.05841 0.84810 0.05 0.05841 0.02000 
0.051 0.05958 0.65217 0.051 0.05958 0.84810 0.051 0.05958 0.01429 
0.052 0.06075 0.65217 0.052 0.06075 0.84388 0.052 0.06075 0.01429 
0.053 0.06192 0.64493 0.053 0.06192 0.84388 0.053 0.06192 0.00857 
0.054 0.06308 0.63768 0.054 0.06308 0.84388 0.054 0.06308 0.00571 
0.055 0.06425 0.62319 0.055 0.06425 0.84388 0.055 0.06425 0.00286 
0.056 0.06542 0.61594 0.056 0.06542 0.84388 0.056 0.06542 0.00286 
0.057 0.06659 0.61594 0.057 0.06659 0.84388    
0.058 0.06776 0.60870 0.058 0.06776 0.83966    
0.059 0.06893 0.60870 0.059 0.06893 0.83966    
0.06 0.07009 0.60870 0.06 0.07009 0.83966    
0.061 0.07126 0.60870 0.061 0.07126 0.83966    
0.062 0.07243 0.60870 0.062 0.07243 0.83544    
0.063 0.07360 0.60145 0.063 0.07360 0.83122    
0.064 0.07477 0.60145 0.064 0.07477 0.82278    
0.065 0.07593 0.60145 0.065 0.07593 0.82278    
0.066 0.07710 0.60145 0.066 0.07710 0.82278    
0.067 0.07827 0.60145 0.067 0.07827 0.82278    
0.068 0.07944 0.60145 0.068 0.07944 0.82278    
0.069 0.08061 0.59420 0.069 0.08061 0.82278    
0.07 0.08178 0.59420 0.07 0.08178 0.82278    
0.071 0.08294 0.59420 0.071 0.08294 0.81857    
0.072 0.08411 0.57971 0.072 0.08411 0.81857    
0.073 0.08528 0.57971 0.073 0.08528 0.81857    
 239 
0.074 0.08645 0.57246 0.074 0.08645 0.81857    
0.075 0.08762 0.57246 0.075 0.08762 0.81435    
0.076 0.08879 0.57246 0.076 0.08879 0.80169    
0.077 0.08995 0.56522 0.077 0.08995 0.79747    
0.078 0.09112 0.56522 0.078 0.09112 0.79747    
0.079 0.09229 0.56522 0.079 0.09229 0.78903    
0.08 0.09346 0.55797 0.08 0.09346 0.78059    
0.081 0.09463 0.55797 0.081 0.09463 0.78059    
0.082 0.09579 0.55797 0.082 0.09579 0.77637    
0.083 0.09696 0.55797 0.083 0.09696 0.77215    
0.084 0.09813 0.55797 0.084 0.09813 0.77215    
0.085 0.09930 0.55797 0.085 0.09930 0.76371    
0.086 0.10047 0.55072 0.086 0.10047 0.75949    
0.087 0.10164 0.55072 0.087 0.10164 0.75949    
0.088 0.10280 0.54348 0.088 0.10280 0.75527    
0.089 0.10397 0.54348 0.089 0.10397 0.75527    
0.09 0.10514 0.54348 0.09 0.10514 0.75527    
0.091 0.10631 0.54348 0.091 0.10631 0.75527    
0.092 0.10748 0.54348 0.092 0.10748 0.75527    
0.093 0.10864 0.52899 0.093 0.10864 0.75527    
0.094 0.10981 0.52899 0.094 0.10981 0.75105    
0.095 0.11098 0.52899 0.095 0.11098 0.74262    
0.096 0.11215 0.52899 0.096 0.11215 0.74262    
0.097 0.11332 0.52174 0.097 0.11332 0.73418    
0.098 0.11449 0.52174 0.098 0.11449 0.72574    
0.099 0.11565 0.52174 0.099 0.11565 0.72152    
0.1 0.11682 0.52174 0.1 0.11682 0.71730    
0.101 0.11799 0.52174 0.101 0.11799 0.71308    
0.102 0.11916 0.52174 0.102 0.11916 0.71308    
0.103 0.12033 0.52174 0.103 0.12033 0.70886    
0.104 0.12150 0.51449 0.104 0.12150 0.70042    
0.105 0.12266 0.51449 0.105 0.12266 0.70042    
0.106 0.12383 0.51449 0.106 0.12383 0.69620    
0.107 0.12500 0.51449 0.107 0.12500 0.69198    
0.108 0.12617 0.51449 0.108 0.12617 0.69198    
0.109 0.12734 0.51449 0.109 0.12734 0.68776    
0.11 0.12850 0.51449 0.11 0.12850 0.68354    
0.111 0.12967 0.51449 0.111 0.12967 0.68354    
0.112 0.13084 0.51449 0.112 0.13084 0.67932    
0.113 0.13201 0.51449 0.113 0.13201 0.67932    
0.114 0.13318 0.51449 0.114 0.13318 0.67932    
 240 
0.115 0.13435 0.51449 0.115 0.13435 0.67932    
0.116 0.13551 0.51449 0.116 0.13551 0.67932    
0.117 0.13668 0.51449 0.117 0.13668 0.67511    
0.118 0.13785 0.51449 0.118 0.13785 0.67089    
0.119 0.13902 0.51449 0.119 0.13902 0.66245    
0.12 0.14019 0.51449 0.12 0.14019 0.65823    
0.121 0.14136 0.51449 0.121 0.14136 0.64557    
0.122 0.14252 0.51449 0.122 0.14252 0.64557    
0.123 0.14369 0.51449 0.123 0.14369 0.64557    
0.124 0.14486 0.51449 0.124 0.14486 0.63713    
0.125 0.14603 0.51449 0.125 0.14603 0.63291    
0.126 0.14720 0.51449 0.126 0.14720 0.62869    
0.127 0.14836 0.51449 0.127 0.14836 0.62447    
0.128 0.14953 0.51449 0.128 0.14953 0.62025    
0.129 0.15070 0.51449 0.129 0.15070 0.61603    
0.13 0.15187 0.51449 0.13 0.15187 0.61603    
0.131 0.15304 0.51449 0.131 0.15304 0.60759    
0.132 0.15421 0.51449 0.132 0.15421 0.60338    
0.133 0.15537 0.51449 0.133 0.15537 0.60338    
0.134 0.15654 0.51449 0.134 0.15654 0.60338    
0.135 0.15771 0.51449 0.135 0.15771 0.60338    
0.136 0.15888 0.51449 0.136 0.15888 0.60338    
0.137 0.16005 0.51449 0.137 0.16005 0.60338    
0.138 0.16121 0.51449 0.138 0.16121 0.60338    
0.139 0.16238 0.51449 0.139 0.16238 0.59916    
0.14 0.16355 0.51449 0.14 0.16355 0.59916    
0.141 0.16472 0.51449 0.141 0.16472 0.59916    
0.142 0.16589 0.51449 0.142 0.16589 0.59916    
0.143 0.16706 0.51449 0.143 0.16706 0.59916    
0.144 0.16822 0.51449 0.144 0.16822 0.59916    
0.145 0.16939 0.51449 0.145 0.16939 0.59916    
0.146 0.17056 0.51449 0.146 0.17056 0.59916    
0.147 0.17173 0.51449 0.147 0.17173 0.59916    
0.148 0.17290 0.51449 0.148 0.17290 0.59494    
0.149 0.17407 0.51449 0.149 0.17407 0.59072    
0.15 0.17523 0.51449 0.15 0.17523 0.58228    
0.151 0.17640 0.51449 0.151 0.17640 0.58228    
0.152 0.17757 0.51449 0.152 0.17757 0.58228    
0.153 0.17874 0.51449 0.153 0.17874 0.57384    
0.154 0.17991 0.51449 0.154 0.17991 0.57384    
0.155 0.18107 0.51449 0.155 0.18107 0.57384    
 241 
0.156 0.18224 0.51449 0.156 0.18224 0.57384    
0.157 0.18341 0.51449 0.157 0.18341 0.56962    
0.158 0.18458 0.51449 0.158 0.18458 0.56540    
0.159 0.18575 0.51449 0.159 0.18575 0.56540    
0.16 0.18692 0.51449 0.16 0.18692 0.56540    
0.161 0.18808 0.51449 0.161 0.18808 0.56540    
0.162 0.18925 0.51449 0.162 0.18925 0.56540    
0.163 0.19042 0.51449 0.163 0.19042 0.56540    
0.164 0.19159 0.51449 0.164 0.19159 0.56540    
0.165 0.19276 0.51449 0.165 0.19276 0.56540    
0.166 0.19393 0.51449 0.166 0.19393 0.56540    
0.167 0.19509 0.51449 0.167 0.19509 0.56540    
0.168 0.19626 0.51449 0.168 0.19626 0.56540    
0.169 0.19743 0.51449 0.169 0.19743 0.56540    
0.17 0.19860 0.51449 0.17 0.19860 0.56540    
0.171 0.19977 0.51449 0.171 0.19977 0.56540    
0.172 0.20093 0.51449 0.172 0.20093 0.56540    
0.173 0.20210 0.51449 0.173 0.20210 0.56540    
0.174 0.20327 0.51449 0.174 0.20327 0.56540    
0.175 0.20444 0.51449 0.175 0.20444 0.56540    
0.176 0.20561 0.51449 0.176 0.20561 0.56540    
0.177 0.20678 0.51449 0.177 0.20678 0.56540    
0.178 0.20794 0.51449 0.178 0.20794 0.56540    
0.179 0.20911 0.51449 0.179 0.20911 0.56118    
0.18 0.21028 0.51449 0.18 0.21028 0.56118    
0.181 0.21145 0.51449 0.181 0.21145 0.56118    
0.182 0.21262 0.51449 0.182 0.21262 0.56118    
0.183 0.21379 0.51449 0.183 0.21379 0.56118    
0.184 0.21495 0.51449 0.184 0.21495 0.56118    
0.185 0.21612 0.51449 0.185 0.21612 0.56118    
0.186 0.21729 0.51449 0.186 0.21729 0.56118    
0.187 0.21846 0.51449 0.187 0.21846 0.56118    
0.188 0.21963 0.51449 0.188 0.21963 0.56118    
0.189 0.22079 0.51449 0.189 0.22079 0.56118    
0.19 0.22196 0.51449 0.19 0.22196 0.56118    
0.191 0.22313 0.51449 0.191 0.22313 0.56118    
0.192 0.22430 0.51449 0.192 0.22430 0.56118    
0.193 0.22547 0.51449 0.193 0.22547 0.56118    
0.194 0.22664 0.51449 0.194 0.22664 0.56118    
0.195 0.22780 0.51449 0.195 0.22780 0.56118    
0.196 0.22897 0.51449 0.196 0.22897 0.56118    
 242 
0.197 0.23014 0.51449 0.197 0.23014 0.56118    
0.198 0.23131 0.51449 0.198 0.23131 0.56118    
0.199 0.23248 0.51449 0.199 0.23248 0.56118    
0.2 0.23364 0.51449 0.2 0.23364 0.56118    
0.201 0.23481 0.51449 0.201 0.23481 0.56118    
0.202 0.23598 0.51449 0.202 0.23598 0.56118    
0.203 0.23715 0.51449 0.203 0.23715 0.56118    
0.204 0.23832 0.51449 0.204 0.23832 0.56118    
0.205 0.23949 0.51449 0.205 0.23949 0.56118    
0.206 0.24065 0.51449 0.206 0.24065 0.56118    
0.207 0.24182 0.51449 0.207 0.24182 0.56118    
0.208 0.24299 0.51449 0.208 0.24299 0.56118    
0.209 0.24416 0.51449 0.209 0.24416 0.56118    
0.21 0.24533 0.51449 0.21 0.24533 0.56118    
0.211 0.24650 0.51449 0.211 0.24650 0.56118    
0.212 0.24766 0.51449 0.212 0.24766 0.56118    
0.213 0.24883 0.51449 0.213 0.24883 0.56118    
0.214 0.25000 0.51449 0.214 0.25000 0.56118    
0.215 0.25117 0.51449 0.215 0.25117 0.56118    
0.216 0.25234 0.51449 0.216 0.25234 0.56118    
0.217 0.25350 0.51449 0.217 0.25350 0.56118    
0.218 0.25467 0.51449 0.218 0.25467 0.56118    
0.219 0.25584 0.51449 0.219 0.25584 0.56118    
0.22 0.25701 0.51449 0.22 0.25701 0.56118    
0.221 0.25818 0.51449 0.221 0.25818 0.56118    
0.222 0.25935 0.51449 0.222 0.25935 0.56118    
0.223 0.26051 0.51449 0.223 0.26051 0.56118    
0.224 0.26168 0.51449 0.224 0.26168 0.56118    
0.225 0.26285 0.51449 0.225 0.26285 0.56118    
0.226 0.26402 0.51449 0.226 0.26402 0.56118    
0.227 0.26519 0.51449 0.227 0.26519 0.56118    
0.228 0.26636 0.51449 0.228 0.26636 0.56118    
0.229 0.26752 0.51449 0.229 0.26752 0.56118    
0.23 0.26869 0.51449 0.23 0.26869 0.56118    
0.231 0.26986 0.51449 0.231 0.26986 0.56118    
0.232 0.27103 0.51449 0.232 0.27103 0.56118    
0.233 0.27220 0.51449 0.233 0.27220 0.56118    
0.234 0.27336 0.51449 0.234 0.27336 0.56118    
0.235 0.27453 0.51449 0.235 0.27453 0.56118    
0.236 0.27570 0.51449 0.236 0.27570 0.56118    
0.237 0.27687 0.51449 0.237 0.27687 0.56118    
 243 
0.238 0.27804 0.51449 0.238 0.27804 0.56118    
0.239 0.27921 0.51449 0.239 0.27921 0.56118    
0.24 0.28037 0.51449 0.24 0.28037 0.56118    
0.241 0.28154 0.51449 0.241 0.28154 0.56118    
0.242 0.28271 0.51449 0.242 0.28271 0.56118    
0.243 0.28388 0.51449 0.243 0.28388 0.56118    
0.244 0.28505 0.51449 0.244 0.28505 0.56118    
0.245 0.28621 0.51449 0.245 0.28621 0.56118    
0.246 0.28738 0.51449 0.246 0.28738 0.56118    
0.247 0.28855 0.51449 0.247 0.28855 0.56118    
0.248 0.28972 0.51449 0.248 0.28972 0.56118    
0.249 0.29089 0.51449 0.249 0.29089 0.56118    
0.25 0.29206 0.51449 0.25 0.29206 0.56118    
0.251 0.29322 0.51449 0.251 0.29322 0.56118    
0.252 0.29439 0.51449 0.252 0.29439 0.56118    
0.253 0.29556 0.51449 0.253 0.29556 0.56118    
0.254 0.29673 0.51449 0.254 0.29673 0.56118    
0.255 0.29790 0.51449 0.255 0.29790 0.56118    
0.256 0.29907 0.51449 0.256 0.29907 0.55696    
0.257 0.30023 0.51449 0.257 0.30023 0.55696    
0.258 0.30140 0.51449 0.258 0.30140 0.55696    
0.259 0.30257 0.51449 0.259 0.30257 0.55274    
0.26 0.30374 0.51449 0.26 0.30374 0.54852    
0.261 0.30491 0.51449 0.261 0.30491 0.54852    
0.262 0.30607 0.51449 0.262 0.30607 0.54852    
0.263 0.30724 0.51449 0.263 0.30724 0.54852    
0.264 0.30841 0.51449 0.264 0.30841 0.54852    
0.265 0.30958 0.51449 0.265 0.30958 0.54852    
0.266 0.31075 0.51449 0.266 0.31075 0.54852    
0.267 0.31192 0.51449 0.267 0.31192 0.54852    
0.268 0.31308 0.51449 0.268 0.31308 0.54852    
0.269 0.31425 0.51449 0.269 0.31425 0.54852    
0.27 0.31542 0.51449 0.27 0.31542 0.54852    
0.271 0.31659 0.51449 0.271 0.31659 0.54852    
0.272 0.31776 0.51449 0.272 0.31776 0.54852    
0.273 0.31893 0.51449 0.273 0.31893 0.54430    
0.274 0.32009 0.51449 0.274 0.32009 0.54430    
0.275 0.32126 0.51449 0.275 0.32126 0.54430    
0.276 0.32243 0.51449 0.276 0.32243 0.54008    
0.277 0.32360 0.51449 0.277 0.32360 0.54008    
0.278 0.32477 0.51449 0.278 0.32477 0.54008    
 244 
0.279 0.32593 0.51449 0.279 0.32593 0.54008    
0.28 0.32710 0.51449 0.28 0.32710 0.54008    
0.281 0.32827 0.51449 0.281 0.32827 0.54008    
0.282 0.32944 0.51449 0.282 0.32944 0.53586    
0.283 0.33061 0.51449 0.283 0.33061 0.53586    
0.284 0.33178 0.51449 0.284 0.33178 0.53586    
0.285 0.33294 0.51449 0.285 0.33294 0.53586    
0.286 0.33411 0.51449 0.286 0.33411 0.53586    
0.287 0.33528 0.51449 0.287 0.33528 0.53586    
0.288 0.33645 0.51449 0.288 0.33645 0.53165    
0.289 0.33762 0.51449 0.289 0.33762 0.53165    
0.29 0.33879 0.51449 0.29 0.33879 0.52743    
0.291 0.33995 0.51449 0.291 0.33995 0.52321    
0.292 0.34112 0.51449 0.292 0.34112 0.52321    
0.293 0.34229 0.51449 0.293 0.34229 0.52321    
0.294 0.34346 0.51449 0.294 0.34346 0.52321    
0.295 0.34463 0.51449 0.295 0.34463 0.52321    
0.296 0.34579 0.51449 0.296 0.34579 0.51899    
0.297 0.34696 0.51449 0.297 0.34696 0.51899    
0.298 0.34813 0.51449 0.298 0.34813 0.51899    
0.299 0.34930 0.51449 0.299 0.34930 0.51477    
0.3 0.35047 0.51449 0.3 0.35047 0.51055    
0.301 0.35164 0.51449 0.301 0.35164 0.51055    
0.302 0.35280 0.51449 0.302 0.35280 0.51055    
0.303 0.35397 0.51449 0.303 0.35397 0.51055    
0.304 0.35514 0.51449 0.304 0.35514 0.51055    
0.305 0.35631 0.51449 0.305 0.35631 0.51055    
0.306 0.35748 0.51449 0.306 0.35748 0.50633    
0.307 0.35864 0.51449 0.307 0.35864 0.50633    
0.308 0.35981 0.51449 0.308 0.35981 0.50633    
0.309 0.36098 0.51449 0.309 0.36098 0.50633    
0.31 0.36215 0.51449 0.31 0.36215 0.50211    
0.311 0.36332 0.51449 0.311 0.36332 0.50211    
0.312 0.36449 0.51449 0.312 0.36449 0.50211    
0.313 0.36565 0.51449 0.313 0.36565 0.50211    
0.314 0.36682 0.51449 0.314 0.36682 0.50211    
0.315 0.36799 0.51449 0.315 0.36799 0.50211    
0.316 0.36916 0.51449 0.316 0.36916 0.50211    
0.317 0.37033 0.51449 0.317 0.37033 0.50211    
0.318 0.37150 0.51449 0.318 0.37150 0.50211    
0.319 0.37266 0.51449 0.319 0.37266 0.50211    
 245 
0.32 0.37383 0.51449 0.32 0.37383 0.50211    
0.321 0.37500 0.51449 0.321 0.37500 0.50211    
0.322 0.37617 0.51449 0.322 0.37617 0.50211    
0.323 0.37734 0.51449 0.323 0.37734 0.50211    
0.324 0.37850 0.51449 0.324 0.37850 0.50211    
0.325 0.37967 0.51449 0.325 0.37967 0.50211    
0.326 0.38084 0.51449 0.326 0.38084 0.50211    
0.327 0.38201 0.51449 0.327 0.38201 0.50211    
0.328 0.38318 0.51449 0.328 0.38318 0.50211    
0.329 0.38435 0.51449 0.329 0.38435 0.49789    
0.33 0.38551 0.51449 0.33 0.38551 0.49789    
0.331 0.38668 0.51449 0.331 0.38668 0.49789    
0.332 0.38785 0.51449 0.332 0.38785 0.49789    
0.333 0.38902 0.51449 0.333 0.38902 0.49789    
0.334 0.39019 0.51449 0.334 0.39019 0.49789    
0.335 0.39136 0.51449 0.335 0.39136 0.49789    
0.336 0.39252 0.51449 0.336 0.39252 0.49789    
0.337 0.39369 0.51449 0.337 0.39369 0.49789    
0.338 0.39486 0.51449 0.338 0.39486 0.49367    
0.339 0.39603 0.51449 0.339 0.39603 0.49367    
0.34 0.39720 0.51449 0.34 0.39720 0.49367    
0.341 0.39836 0.51449 0.341 0.39836 0.49367    
0.342 0.39953 0.51449 0.342 0.39953 0.49367    
0.343 0.40070 0.51449 0.343 0.40070 0.49367    
0.344 0.40187 0.51449 0.344 0.40187 0.49367    
0.345 0.40304 0.51449 0.345 0.40304 0.49367    
0.346 0.40421 0.51449 0.346 0.40421 0.49367    
0.347 0.40537 0.51449 0.347 0.40537 0.49367    
0.348 0.40654 0.51449 0.348 0.40654 0.49367    
0.349 0.40771 0.51449 0.349 0.40771 0.49367    
0.35 0.40888 0.51449 0.35 0.40888 0.49367    
0.351 0.41005 0.51449 0.351 0.41005 0.49367    
0.352 0.41121 0.51449 0.352 0.41121 0.49367    
0.353 0.41238 0.49275 0.353 0.41238 0.48945    
0.354 0.41355 0.47826 0.354 0.41355 0.48523    
0.355 0.41472 0.47101 0.355 0.41472 0.48523    
0.356 0.41589 0.45652 0.356 0.41589 0.48523    
0.357 0.41706 0.44203 0.357 0.41706 0.48101    
0.358 0.41822 0.42754 0.358 0.41822 0.47257    
0.359 0.41939 0.42029 0.359 0.41939 0.46414    
0.36 0.42056 0.39130 0.36 0.42056 0.41350    
 246 
0.361 0.42173 0.37681 0.361 0.42173 0.35021    
0.362 0.42290 0.36957 0.362 0.42290 0.30380    
0.363 0.42407 0.33333 0.363 0.42407 0.26160    
0.364 0.42523 0.31884 0.364 0.42523 0.25316    
0.365 0.42640 0.31884 0.365 0.42640 0.22363    
0.366 0.42757 0.31884 0.366 0.42757 0.19409    
0.367 0.42874 0.31159 0.367 0.42874 0.18143    
0.368 0.42991 0.28261 0.368 0.42991 0.14346    
0.369 0.43107 0.27536 0.369 0.43107 0.12658    
0.37 0.43224 0.27536 0.37 0.43224 0.09283    
0.371 0.43341 0.26812 0.371 0.43341 0.06329    
0.372 0.43458 0.26812 0.372 0.43458 0.03376    
0.373 0.43575 0.26812 0.373 0.43575 0.01688    
0.374 0.43692 0.26812       
0.375 0.43808 0.26087       
0.376 0.43925 0.26087       
0.377 0.44042 0.25362       
0.378 0.44159 0.24638       
0.379 0.44276 0.24638       
0.38 0.44393 0.21739       
0.381 0.44509 0.21739       
0.382 0.44626 0.21739       
0.383 0.44743 0.21739       
0.384 0.44860 0.19565       
0.385 0.44977 0.18841       
0.386 0.45093 0.17391       
0.387 0.45210 0.16667       
0.388 0.45327 0.14493       
0.389 0.45444 0.14493       
0.39 0.45561 0.13768       
0.391 0.45678 0.13043       
0.392 0.45794 0.10145       
0.393 0.45911 0.09420       
0.394 0.46028 0.08696       
0.395 0.46145 0.05072       
0.396 0.46262 0.05072       
0.397 0.46379 0.03623       




Table G-18. 80/20 Long AML neo-sinus particle tracking results for 5.0 L/min. 

















0 0 1 0 0 1 0 0 1 
0.001 0.00117 1 0.001 0.00117 1 0.001 0.00117 0.99714 
0.002 0.00234 1 0.002 0.00234 1 0.002 0.00234 0.99714 
0.003 0.00350 1 0.003 0.00350 1 0.003 0.00350 0.98000 
0.004 0.00467 1 0.004 0.00467 1 0.004 0.00467 0.96000 
0.005 0.00584 1 0.005 0.00584 1 0.005 0.00584 0.91429 
0.006 0.00701 0.99275 0.006 0.00701 1 0.006 0.00701 0.88286 
0.007 0.00818 0.97101 0.007 0.00818 0.99578 0.007 0.00818 0.86857 
0.008 0.00935 0.96377 0.008 0.00935 0.96624 0.008 0.00935 0.83714 
0.009 0.01051 0.96377 0.009 0.01051 0.95359 0.009 0.01051 0.81714 
0.01 0.01168 0.95652 0.01 0.01168 0.95359 0.01 0.01168 0.78571 
0.011 0.01285 0.93478 0.011 0.01285 0.94515 0.011 0.01285 0.76286 
0.012 0.01402 0.91304 0.012 0.01402 0.91983 0.012 0.01402 0.72286 
0.013 0.01519 0.91304 0.013 0.01519 0.91561 0.013 0.01519 0.66857 
0.014 0.01636 0.87681 0.014 0.01636 0.91139 0.014 0.01636 0.63143 
0.015 0.01752 0.86232 0.015 0.01752 0.90717 0.015 0.01752 0.58000 
0.016 0.01869 0.86232 0.016 0.01869 0.90295 0.016 0.01869 0.55143 
0.017 0.01986 0.86232 0.017 0.01986 0.90295 0.017 0.01986 0.51714 
0.018 0.02103 0.86232 0.018 0.02103 0.90295 0.018 0.02103 0.48857 
0.019 0.02220 0.86232 0.019 0.02220 0.89030 0.019 0.02220 0.46571 
0.02 0.02336 0.86232 0.02 0.02336 0.89030 0.02 0.02336 0.44000 
0.021 0.02453 0.85507 0.021 0.02453 0.89030 0.021 0.02453 0.40571 
0.022 0.02570 0.85507 0.022 0.02570 0.88186 0.022 0.02570 0.37143 
0.023 0.02687 0.85507 0.023 0.02687 0.86920 0.023 0.02687 0.34286 
0.024 0.02804 0.85507 0.024 0.02804 0.86498 0.024 0.02804 0.31429 
0.025 0.02921 0.84783 0.025 0.02921 0.85654 0.025 0.02921 0.29429 
0.026 0.03037 0.84058 0.026 0.03037 0.85232 0.026 0.03037 0.27429 
0.027 0.03154 0.84058 0.027 0.03154 0.84810 0.027 0.03154 0.26000 
0.028 0.03271 0.82609 0.028 0.03271 0.84388 0.028 0.03271 0.24286 
0.029 0.03388 0.82609 0.029 0.03388 0.83966 0.029 0.03388 0.22571 
0.03 0.03505 0.82609 0.03 0.03505 0.83544 0.03 0.03505 0.21714 
0.031 0.03621 0.81159 0.031 0.03621 0.83544 0.031 0.03621 0.19714 
0.032 0.03738 0.81159 0.032 0.03738 0.83544 0.032 0.03738 0.17714 
 248 
0.033 0.03855 0.81159 0.033 0.03855 0.83122 0.033 0.03855 0.16286 
0.034 0.03972 0.81159 0.034 0.03972 0.83122 0.034 0.03972 0.15143 
0.035 0.04089 0.80435 0.035 0.04089 0.82700 0.035 0.04089 0.13429 
0.036 0.04206 0.80435 0.036 0.04206 0.82278 0.036 0.04206 0.12000 
0.037 0.04322 0.80435 0.037 0.04322 0.82278 0.037 0.04322 0.11429 
0.038 0.04439 0.79710 0.038 0.04439 0.82278 0.038 0.04439 0.10286 
0.039 0.04556 0.78986 0.039 0.04556 0.81857 0.039 0.04556 0.09714 
0.04 0.04673 0.78986 0.04 0.04673 0.81013 0.04 0.04673 0.08571 
0.041 0.04790 0.78986 0.041 0.04790 0.80591 0.041 0.04790 0.07143 
0.042 0.04907 0.78261 0.042 0.04907 0.80169 0.042 0.04907 0.06571 
0.043 0.05023 0.77536 0.043 0.05023 0.80169 0.043 0.05023 0.06286 
0.044 0.05140 0.77536 0.044 0.05140 0.79747 0.044 0.05140 0.05429 
0.045 0.05257 0.76812 0.045 0.05257 0.79747 0.045 0.05257 0.04571 
0.046 0.05374 0.76812 0.046 0.05374 0.79747 0.046 0.05374 0.04286 
0.047 0.05491 0.76087 0.047 0.05491 0.78903 0.047 0.05491 0.04000 
0.048 0.05607 0.76087 0.048 0.05607 0.78903 0.048 0.05607 0.03429 
0.049 0.05724 0.75362 0.049 0.05724 0.78903 0.049 0.05724 0.03143 
0.05 0.05841 0.74638 0.05 0.05841 0.78903 0.05 0.05841 0.02857 
0.051 0.05958 0.74638 0.051 0.05958 0.78481 0.051 0.05958 0.02000 
0.052 0.06075 0.73913 0.052 0.06075 0.78059 0.052 0.06075 0.01714 
0.053 0.06192 0.72464 0.053 0.06192 0.77215 0.053 0.06192 0.01429 
0.054 0.06308 0.71014 0.054 0.06308 0.76371 0.054 0.06308 0.00857 
0.055 0.06425 0.70290 0.055 0.06425 0.75527 0.055 0.06425 0.00571 
0.056 0.06542 0.70290 0.056 0.06542 0.75105 0.056 0.06542 0.00286 
0.057 0.06659 0.70290 0.057 0.06659 0.74684 0.057 0.06659 0.00286 
0.058 0.06776 0.70290 0.058 0.06776 0.73418    
0.059 0.06893 0.70290 0.059 0.06893 0.73418    
0.06 0.07009 0.70290 0.06 0.07009 0.73418    
0.061 0.07126 0.70290 0.061 0.07126 0.72574    
0.062 0.07243 0.70290 0.062 0.07243 0.72574    
0.063 0.07360 0.70290 0.063 0.07360 0.72574    
0.064 0.07477 0.70290 0.064 0.07477 0.72574    
0.065 0.07593 0.69565 0.065 0.07593 0.71308    
0.066 0.07710 0.69565 0.066 0.07710 0.71308    
0.067 0.07827 0.69565 0.067 0.07827 0.71308    
0.068 0.07944 0.69565 0.068 0.07944 0.70886    
0.069 0.08061 0.68841 0.069 0.08061 0.70464    
0.07 0.08178 0.68841 0.07 0.08178 0.70464    
0.071 0.08294 0.68841 0.071 0.08294 0.70464    
0.072 0.08411 0.68841 0.072 0.08411 0.70042    
0.073 0.08528 0.68841 0.073 0.08528 0.69198    
 249 
0.074 0.08645 0.68841 0.074 0.08645 0.69198    
0.075 0.08762 0.68841 0.075 0.08762 0.68354    
0.076 0.08879 0.68841 0.076 0.08879 0.67932    
0.077 0.08995 0.68841 0.077 0.08995 0.67932    
0.078 0.09112 0.68841 0.078 0.09112 0.67511    
0.079 0.09229 0.68841 0.079 0.09229 0.67511    
0.08 0.09346 0.68841 0.08 0.09346 0.66667    
0.081 0.09463 0.68841 0.081 0.09463 0.66245    
0.082 0.09579 0.68841 0.082 0.09579 0.65823    
0.083 0.09696 0.68841 0.083 0.09696 0.64979    
0.084 0.09813 0.68841 0.084 0.09813 0.63713    
0.085 0.09930 0.68841 0.085 0.09930 0.63713    
0.086 0.10047 0.68841 0.086 0.10047 0.63291    
0.087 0.10164 0.68841 0.087 0.10164 0.61603    
0.088 0.10280 0.68841 0.088 0.10280 0.61181    
0.089 0.10397 0.68841 0.089 0.10397 0.60338    
0.09 0.10514 0.68841 0.09 0.10514 0.60338    
0.091 0.10631 0.68841 0.091 0.10631 0.59916    
0.092 0.10748 0.68841 0.092 0.10748 0.59072    
0.093 0.10864 0.68841 0.093 0.10864 0.59072    
0.094 0.10981 0.68841 0.094 0.10981 0.58650    
0.095 0.11098 0.68841 0.095 0.11098 0.57806    
0.096 0.11215 0.68841 0.096 0.11215 0.56540    
0.097 0.11332 0.68841 0.097 0.11332 0.55274    
0.098 0.11449 0.68841 0.098 0.11449 0.54852    
0.099 0.11565 0.68841 0.099 0.11565 0.54008    
0.1 0.11682 0.68841 0.1 0.11682 0.53586    
0.101 0.11799 0.68841 0.101 0.11799 0.52321    
0.102 0.11916 0.68841 0.102 0.11916 0.51899    
0.103 0.12033 0.68841 0.103 0.12033 0.51055    
0.104 0.12150 0.68841 0.104 0.12150 0.50633    
0.105 0.12266 0.68841 0.105 0.12266 0.50633    
0.106 0.12383 0.68116 0.106 0.12383 0.50633    
0.107 0.12500 0.68116 0.107 0.12500 0.50211    
0.108 0.12617 0.68116 0.108 0.12617 0.49367    
0.109 0.12734 0.68116 0.109 0.12734 0.48523    
0.11 0.12850 0.68116 0.11 0.12850 0.48523    
0.111 0.12967 0.68116 0.111 0.12967 0.48101    
0.112 0.13084 0.68116 0.112 0.13084 0.48101    
0.113 0.13201 0.68116 0.113 0.13201 0.47679    
0.114 0.13318 0.68116 0.114 0.13318 0.47679    
 250 
0.115 0.13435 0.68116 0.115 0.13435 0.47679    
0.116 0.13551 0.68116 0.116 0.13551 0.47257    
0.117 0.13668 0.68116 0.117 0.13668 0.47257    
0.118 0.13785 0.68116 0.118 0.13785 0.46835    
0.119 0.13902 0.68116 0.119 0.13902 0.46835    
0.12 0.14019 0.68116 0.12 0.14019 0.46414    
0.121 0.14136 0.68116 0.121 0.14136 0.46414    
0.122 0.14252 0.68116 0.122 0.14252 0.45992    
0.123 0.14369 0.67391 0.123 0.14369 0.45570    
0.124 0.14486 0.67391 0.124 0.14486 0.45148    
0.125 0.14603 0.67391 0.125 0.14603 0.44304    
0.126 0.14720 0.67391 0.126 0.14720 0.43038    
0.127 0.14836 0.67391 0.127 0.14836 0.42616    
0.128 0.14953 0.67391 0.128 0.14953 0.42616    
0.129 0.15070 0.66667 0.129 0.15070 0.42616    
0.13 0.15187 0.66667 0.13 0.15187 0.42616    
0.131 0.15304 0.66667 0.131 0.15304 0.42194    
0.132 0.15421 0.66667 0.132 0.15421 0.42194    
0.133 0.15537 0.66667 0.133 0.15537 0.42194    
0.134 0.15654 0.65942 0.134 0.15654 0.42194    
0.135 0.15771 0.65942 0.135 0.15771 0.42194    
0.136 0.15888 0.65942 0.136 0.15888 0.42194    
0.137 0.16005 0.65942 0.137 0.16005 0.42194    
0.138 0.16121 0.65942 0.138 0.16121 0.42194    
0.139 0.16238 0.65942 0.139 0.16238 0.42194    
0.14 0.16355 0.65942 0.14 0.16355 0.41772    
0.141 0.16472 0.65942 0.141 0.16472 0.40928    
0.142 0.16589 0.65942 0.142 0.16589 0.40928    
0.143 0.16706 0.65217 0.143 0.16706 0.40084    
0.144 0.16822 0.65217 0.144 0.16822 0.39662    
0.145 0.16939 0.65217 0.145 0.16939 0.39662    
0.146 0.17056 0.65217 0.146 0.17056 0.39662    
0.147 0.17173 0.65217 0.147 0.17173 0.39241    
0.148 0.17290 0.65217 0.148 0.17290 0.39241    
0.149 0.17407 0.65217 0.149 0.17407 0.38819    
0.15 0.17523 0.65217 0.15 0.17523 0.38819    
0.151 0.17640 0.65217 0.151 0.17640 0.37975    
0.152 0.17757 0.64493 0.152 0.17757 0.37131    
0.153 0.17874 0.64493 0.153 0.17874 0.37131    
0.154 0.17991 0.64493 0.154 0.17991 0.37131    
0.155 0.18107 0.63768 0.155 0.18107 0.37131    
 251 
0.156 0.18224 0.63768 0.156 0.18224 0.35443    
0.157 0.18341 0.63768 0.157 0.18341 0.35443    
0.158 0.18458 0.63043 0.158 0.18458 0.35443    
0.159 0.18575 0.63043 0.159 0.18575 0.35443    
0.16 0.18692 0.63043 0.16 0.18692 0.35443    
0.161 0.18808 0.62319 0.161 0.18808 0.35443    
0.162 0.18925 0.62319 0.162 0.18925 0.35443    
0.163 0.19042 0.62319 0.163 0.19042 0.35443    
0.164 0.19159 0.62319 0.164 0.19159 0.35443    
0.165 0.19276 0.61594 0.165 0.19276 0.35443    
0.166 0.19393 0.61594 0.166 0.19393 0.35443    
0.167 0.19509 0.60870 0.167 0.19509 0.35021    
0.168 0.19626 0.60870 0.168 0.19626 0.35021    
0.169 0.19743 0.60870 0.169 0.19743 0.35021    
0.17 0.19860 0.60870 0.17 0.19860 0.35021    
0.171 0.19977 0.60870 0.171 0.19977 0.34599    
0.172 0.20093 0.60870 0.172 0.20093 0.34599    
0.173 0.20210 0.60870 0.173 0.20210 0.34599    
0.174 0.20327 0.60870 0.174 0.20327 0.34599    
0.175 0.20444 0.60870 0.175 0.20444 0.34599    
0.176 0.20561 0.60870 0.176 0.20561 0.34599    
0.177 0.20678 0.60870 0.177 0.20678 0.34599    
0.178 0.20794 0.60870 0.178 0.20794 0.34177    
0.179 0.20911 0.60870 0.179 0.20911 0.34177    
0.18 0.21028 0.60145 0.18 0.21028 0.34177    
0.181 0.21145 0.60145 0.181 0.21145 0.34177    
0.182 0.21262 0.60145 0.182 0.21262 0.34177    
0.183 0.21379 0.60145 0.183 0.21379 0.34177    
0.184 0.21495 0.60145 0.184 0.21495 0.33755    
0.185 0.21612 0.60145 0.185 0.21612 0.33755    
0.186 0.21729 0.60145 0.186 0.21729 0.33755    
0.187 0.21846 0.60145 0.187 0.21846 0.33755    
0.188 0.21963 0.59420 0.188 0.21963 0.33755    
0.189 0.22079 0.59420 0.189 0.22079 0.33755    
0.19 0.22196 0.59420 0.19 0.22196 0.33333    
0.191 0.22313 0.59420 0.191 0.22313 0.33333    
0.192 0.22430 0.59420 0.192 0.22430 0.33333    
0.193 0.22547 0.59420 0.193 0.22547 0.33333    
0.194 0.22664 0.58696 0.194 0.22664 0.33333    
0.195 0.22780 0.58696 0.195 0.22780 0.33333    
0.196 0.22897 0.58696 0.196 0.22897 0.33333    
 252 
0.197 0.23014 0.56522 0.197 0.23014 0.33333    
0.198 0.23131 0.56522 0.198 0.23131 0.33333    
0.199 0.23248 0.55797 0.199 0.23248 0.33333    
0.2 0.23364 0.55072 0.2 0.23364 0.33333    
0.201 0.23481 0.54348 0.201 0.23481 0.33333    
0.202 0.23598 0.52899 0.202 0.23598 0.33333    
0.203 0.23715 0.51449 0.203 0.23715 0.33333    
0.204 0.23832 0.50000 0.204 0.23832 0.33333    
0.205 0.23949 0.50000 0.205 0.23949 0.33333    
0.206 0.24065 0.49275 0.206 0.24065 0.33333    
0.207 0.24182 0.47101 0.207 0.24182 0.33333    
0.208 0.24299 0.44928 0.208 0.24299 0.33333    
0.209 0.24416 0.44928 0.209 0.24416 0.33333    
0.21 0.24533 0.44203 0.21 0.24533 0.33333    
0.211 0.24650 0.43478 0.211 0.24650 0.33333    
0.212 0.24766 0.43478 0.212 0.24766 0.33333    
0.213 0.24883 0.42754 0.213 0.24883 0.33333    
0.214 0.25000 0.42754 0.214 0.25000 0.33333    
0.215 0.25117 0.42754 0.215 0.25117 0.33333    
0.216 0.25234 0.42754 0.216 0.25234 0.33333    
0.217 0.25350 0.42754 0.217 0.25350 0.33333    
0.218 0.25467 0.42029 0.218 0.25467 0.33333    
0.219 0.25584 0.39855 0.219 0.25584 0.33333    
0.22 0.25701 0.39855 0.22 0.25701 0.33333    
0.221 0.25818 0.39130 0.221 0.25818 0.33333    
0.222 0.25935 0.38406 0.222 0.25935 0.33333    
0.223 0.26051 0.38406 0.223 0.26051 0.33333    
0.224 0.26168 0.37681 0.224 0.26168 0.33333    
0.225 0.26285 0.37681 0.225 0.26285 0.33333    
0.226 0.26402 0.36957 0.226 0.26402 0.33333    
0.227 0.26519 0.36957 0.227 0.26519 0.33333    
0.228 0.26636 0.36957 0.228 0.26636 0.33333    
0.229 0.26752 0.36957 0.229 0.26752 0.33333    
0.23 0.26869 0.36957 0.23 0.26869 0.33333    
0.231 0.26986 0.36957 0.231 0.26986 0.33333    
0.232 0.27103 0.36957 0.232 0.27103 0.33333    
0.233 0.27220 0.36957 0.233 0.27220 0.33333    
0.234 0.27336 0.36957 0.234 0.27336 0.33333    
0.235 0.27453 0.36957 0.235 0.27453 0.33333    
0.236 0.27570 0.36957 0.236 0.27570 0.33333    
0.237 0.27687 0.36957 0.237 0.27687 0.33333    
 253 
0.238 0.27804 0.36957 0.238 0.27804 0.33333    
0.239 0.27921 0.36957 0.239 0.27921 0.33333    
0.24 0.28037 0.36957 0.24 0.28037 0.33333    
0.241 0.28154 0.36957 0.241 0.28154 0.33333    
0.242 0.28271 0.36957 0.242 0.28271 0.33333    
0.243 0.28388 0.36957 0.243 0.28388 0.33333    
0.244 0.28505 0.36957 0.244 0.28505 0.33333    
0.245 0.28621 0.36957 0.245 0.28621 0.33333    
0.246 0.28738 0.36957 0.246 0.28738 0.33333    
0.247 0.28855 0.36957 0.247 0.28855 0.33333    
0.248 0.28972 0.36957 0.248 0.28972 0.33333    
0.249 0.29089 0.36957 0.249 0.29089 0.33333    
0.25 0.29206 0.36957 0.25 0.29206 0.33333    
0.251 0.29322 0.36957 0.251 0.29322 0.33333    
0.252 0.29439 0.36957 0.252 0.29439 0.33333    
0.253 0.29556 0.36957 0.253 0.29556 0.33333    
0.254 0.29673 0.36957 0.254 0.29673 0.33333    
0.255 0.29790 0.36957 0.255 0.29790 0.33333    
0.256 0.29907 0.36957 0.256 0.29907 0.33333    
0.257 0.30023 0.36957 0.257 0.30023 0.33333    
0.258 0.30140 0.36957 0.258 0.30140 0.33333    
0.259 0.30257 0.35507 0.259 0.30257 0.33333    
0.26 0.30374 0.35507 0.26 0.30374 0.33333    
0.261 0.30491 0.33333 0.261 0.30491 0.33333    
0.262 0.30607 0.32609 0.262 0.30607 0.33333    
0.263 0.30724 0.32609 0.263 0.30724 0.33333    
0.264 0.30841 0.31884 0.264 0.30841 0.32911    
0.265 0.30958 0.30435 0.265 0.30958 0.32911    
0.266 0.31075 0.28986 0.266 0.31075 0.32911    
0.267 0.31192 0.28261 0.267 0.31192 0.32911    
0.268 0.31308 0.25362 0.268 0.31308 0.32911    
0.269 0.31425 0.24638 0.269 0.31425 0.32489    
0.27 0.31542 0.23913 0.27 0.31542 0.32489    
0.271 0.31659 0.23913 0.271 0.31659 0.32489    
0.272 0.31776 0.23188 0.272 0.31776 0.32489    
0.273 0.31893 0.21739 0.273 0.31893 0.32489    
0.274 0.32009 0.21014 0.274 0.32009 0.32068    
0.275 0.32126 0.19565 0.275 0.32126 0.31646    
0.276 0.32243 0.18841 0.276 0.32243 0.31224    
0.277 0.32360 0.17391 0.277 0.32360 0.31224    
0.278 0.32477 0.17391 0.278 0.32477 0.30802    
 254 
0.279 0.32593 0.16667 0.279 0.32593 0.30802    
0.28 0.32710 0.15942 0.28 0.32710 0.30802    
0.281 0.32827 0.15942 0.281 0.32827 0.29958    
0.282 0.32944 0.15217 0.282 0.32944 0.28270    
0.283 0.33061 0.14493 0.283 0.33061 0.27848    
0.284 0.33178 0.13043 0.284 0.33178 0.27848    
0.285 0.33294 0.12319 0.285 0.33294 0.27848    
0.286 0.33411 0.12319 0.286 0.33411 0.27004    
0.287 0.33528 0.12319 0.287 0.33528 0.27004    
0.288 0.33645 0.12319 0.288 0.33645 0.27004    
0.289 0.33762 0.12319 0.289 0.33762 0.26160    
0.29 0.33879 0.12319 0.29 0.33879 0.25738    
0.291 0.33995 0.12319 0.291 0.33995 0.25738    
0.292 0.34112 0.12319 0.292 0.34112 0.25738    
0.293 0.34229 0.12319 0.293 0.34229 0.25316    
0.294 0.34346 0.12319 0.294 0.34346 0.25316    
0.295 0.34463 0.12319 0.295 0.34463 0.25316    
0.296 0.34579 0.11594 0.296 0.34579 0.25316    
0.297 0.34696 0.11594 0.297 0.34696 0.25316    
0.298 0.34813 0.11594 0.298 0.34813 0.25316    
0.299 0.34930 0.09420 0.299 0.34930 0.25316    
0.3 0.35047 0.08696 0.3 0.35047 0.25316    
0.301 0.35164 0.08696 0.301 0.35164 0.24895    
0.302 0.35280 0.08696 0.302 0.35280 0.24473    
0.303 0.35397 0.08696 0.303 0.35397 0.24473    
0.304 0.35514 0.08696 0.304 0.35514 0.24051    
0.305 0.35631 0.08696 0.305 0.35631 0.24051    
0.306 0.35748 0.08696 0.306 0.35748 0.24051    
0.307 0.35864 0.08696 0.307 0.35864 0.22785    
0.308 0.35981 0.08696 0.308 0.35981 0.22785    
0.309 0.36098 0.08696 0.309 0.36098 0.22785    
0.31 0.36215 0.07971 0.31 0.36215 0.22785    
0.311 0.36332 0.07246 0.311 0.36332 0.22785    
0.312 0.36449 0.06522 0.312 0.36449 0.22785    
0.313 0.36565 0.05797 0.313 0.36565 0.22785    
0.314 0.36682 0.05072 0.314 0.36682 0.22785    
0.315 0.36799 0.05072 0.315 0.36799 0.22363    
0.316 0.36916 0.05072 0.316 0.36916 0.21941    
0.317 0.37033 0.04348 0.317 0.37033 0.21941    
0.318 0.37150 0.04348 0.318 0.37150 0.21097    
0.319 0.37266 0.04348 0.319 0.37266 0.21097    
 255 
0.32 0.37383 0.02174 0.32 0.37383 0.21097    
0.321 0.37500 0.02174 0.321 0.37500 0.21097    
0.322 0.37617 0.02174 0.322 0.37617 0.21097    
0.323 0.37734 0.02174 0.323 0.37734 0.20675    
0.324 0.37850 0.01449 0.324 0.37850 0.20675    
0.325 0.37967 0.01449 0.325 0.37967 0.20675    
0.326 0.38084 0.00725 0.326 0.38084 0.20675    
0.327 0.38201 0.00725 0.327 0.38201 0.20675    
0.328 0.38318 0.00725 0.328 0.38318 0.20675    
0.329 0.38435 0.00725 0.329 0.38435 0.20253    
   0.33 0.38551 0.19409    
   0.331 0.38668 0.18987    
   0.332 0.38785 0.18987    
   0.333 0.38902 0.18987    
   0.334 0.39019 0.18987    
   0.335 0.39136 0.18987    
   0.336 0.39252 0.18565    
   0.337 0.39369 0.17722    
   0.338 0.39486 0.17722    
   0.339 0.39603 0.17300    
   0.34 0.39720 0.16456    
   0.341 0.39836 0.16034    
   0.342 0.39953 0.16034    
   0.343 0.40070 0.15190    
   0.344 0.40187 0.14768    
   0.345 0.40304 0.14346    
   0.346 0.40421 0.14346    
   0.347 0.40537 0.13924    
   0.348 0.40654 0.13502    
   0.349 0.40771 0.12658    
   0.35 0.40888 0.11392    
   0.351 0.41005 0.09283    
   0.352 0.41121 0.08439    
   0.353 0.41238 0.07595    
   0.354 0.41355 0.06751    
   0.355 0.41472 0.06329    
   0.356 0.41589 0.06329    
   0.357 0.41706 0.05907    
   0.358 0.41822 0.05063    
   0.359 0.41939 0.04641    
   0.36 0.42056 0.03797    
 256 
   0.361 0.42173 0.02532    
   0.362 0.42290 0.01688    
   0.363 0.42407 0.00844    
   0.364 0.42523 0.00422    
   0.365 0.42640 0.00422    
 
 
Table G-19. 80/20 Long AML neo-sinus particle tracking results for 6.5 L/min. 






















0 0 1 0 0 1 0 0 1 
0.001 0.00117 1 0.001 0.00117 1 0.001 0.00117 1 
0.002 0.00234 1 0.002 0.00234 1 0.002 0.00234 1 
0.003 0.00350 1 0.003 0.00350 1 0.003 0.00350 0.97429 
0.004 0.00467 1 0.004 0.00467 1 0.004 0.00467 0.95429 
0.005 0.00584 0.97101 0.005 0.00584 1 0.005 0.00584 0.92571 
0.006 0.00701 0.95652 0.006 0.00701 1 0.006 0.00701 0.90857 
0.007 0.00818 0.94928 0.007 0.00818 0.99578 0.007 0.00818 0.88857 
0.008 0.00935 0.94203 0.008 0.00935 0.97890 0.008 0.00935 0.84000 
0.009 0.01051 0.93478 0.009 0.01051 0.96624 0.009 0.01051 0.82000 
0.01 0.01168 0.93478 0.01 0.01168 0.95781 0.01 0.01168 0.78571 
0.011 0.01285 0.92754 0.011 0.01285 0.94937 0.011 0.01285 0.74000 
0.012 0.01402 0.92029 0.012 0.01402 0.93671 0.012 0.01402 0.72000 
0.013 0.01519 0.91304 0.013 0.01519 0.92827 0.013 0.01519 0.68571 
0.014 0.01636 0.89855 0.014 0.01636 0.91983 0.014 0.01636 0.63429 
0.015 0.01752 0.89130 0.015 0.01752 0.91139 0.015 0.01752 0.60000 
0.016 0.01869 0.89130 0.016 0.01869 0.90717 0.016 0.01869 0.57714 
0.017 0.01986 0.89130 0.017 0.01986 0.90295 0.017 0.01986 0.53429 
0.018 0.02103 0.88406 0.018 0.02103 0.89873 0.018 0.02103 0.48571 
0.019 0.02220 0.87681 0.019 0.02220 0.88608 0.019 0.02220 0.45714 
0.02 0.02336 0.87681 0.02 0.02336 0.87342 0.02 0.02336 0.40857 
0.021 0.02453 0.87681 0.021 0.02453 0.87342 0.021 0.02453 0.35429 
0.022 0.02570 0.86957 0.022 0.02570 0.86920 0.022 0.02570 0.31429 
0.023 0.02687 0.86232 0.023 0.02687 0.85232 0.023 0.02687 0.26857 
 257 
0.024 0.02804 0.86232 0.024 0.02804 0.85232 0.024 0.02804 0.22286 
0.025 0.02921 0.85507 0.025 0.02921 0.84810 0.025 0.02921 0.19429 
0.026 0.03037 0.84783 0.026 0.03037 0.84810 0.026 0.03037 0.15429 
0.027 0.03154 0.84058 0.027 0.03154 0.83966 0.027 0.03154 0.11714 
0.028 0.03271 0.83333 0.028 0.03271 0.83966 0.028 0.03271 0.09714 
0.029 0.03388 0.82609 0.029 0.03388 0.83966 0.029 0.03388 0.07143 
0.03 0.03505 0.82609 0.03 0.03505 0.83544 0.03 0.03505 0.06286 
0.031 0.03621 0.81159 0.031 0.03621 0.82700 0.031 0.03621 0.05143 
0.032 0.03738 0.81159 0.032 0.03738 0.82278 0.032 0.03738 0.03429 
0.033 0.03855 0.81159 0.033 0.03855 0.80591 0.033 0.03855 0.03429 
0.034 0.03972 0.81159 0.034 0.03972 0.80591 0.034 0.03972 0.02571 
0.035 0.04089 0.79710 0.035 0.04089 0.80169 0.035 0.04089 0.01714 
0.036 0.04206 0.79710 0.036 0.04206 0.80169 0.036 0.04206 0.01429 
0.037 0.04322 0.79710 0.037 0.04322 0.79325 0.037 0.04322 0.01143 
0.038 0.04439 0.79710 0.038 0.04439 0.78481 0.038 0.04439 0.01143 
0.039 0.04556 0.79710 0.039 0.04556 0.77637 0.039 0.04556 0.00571 
0.04 0.04673 0.77536 0.04 0.04673 0.76793 0.04 0.04673 0.00286 
0.041 0.04790 0.76087 0.041 0.04790 0.75949 0.041 0.04790 0.00286 
0.042 0.04907 0.75362 0.042 0.04907 0.75949 0.042 0.04907 0.00286 
0.043 0.05023 0.75362 0.043 0.05023 0.75527    
0.044 0.05140 0.74638 0.044 0.05140 0.75105    
0.045 0.05257 0.74638 0.045 0.05257 0.75105    
0.046 0.05374 0.74638 0.046 0.05374 0.75105    
0.047 0.05491 0.74638 0.047 0.05491 0.75105    
0.048 0.05607 0.73913 0.048 0.05607 0.74684    
0.049 0.05724 0.73188 0.049 0.05724 0.74684    
0.05 0.05841 0.73188 0.05 0.05841 0.74684    
0.051 0.05958 0.73188 0.051 0.05958 0.74684    
0.052 0.06075 0.73188 0.052 0.06075 0.73840    
0.053 0.06192 0.73188 0.053 0.06192 0.72996    
0.054 0.06308 0.72464 0.054 0.06308 0.72574    
0.055 0.06425 0.71739 0.055 0.06425 0.72152    
0.056 0.06542 0.71014 0.056 0.06542 0.72152    
0.057 0.06659 0.71014 0.057 0.06659 0.71308    
0.058 0.06776 0.71014 0.058 0.06776 0.71308    
0.059 0.06893 0.71014 0.059 0.06893 0.71308    
0.06 0.07009 0.71014 0.06 0.07009 0.71308    
0.061 0.07126 0.69565 0.061 0.07126 0.70886    
0.062 0.07243 0.68841 0.062 0.07243 0.70886    
0.063 0.07360 0.68841 0.063 0.07360 0.70464    
0.064 0.07477 0.68841 0.064 0.07477 0.70042    
 258 
0.065 0.07593 0.67391 0.065 0.07593 0.69620    
0.066 0.07710 0.65942 0.066 0.07710 0.68776    
0.067 0.07827 0.65942 0.067 0.07827 0.68354    
0.068 0.07944 0.65942 0.068 0.07944 0.68354    
0.069 0.08061 0.64493 0.069 0.08061 0.67932    
0.07 0.08178 0.63768 0.07 0.08178 0.67932    
0.071 0.08294 0.63043 0.071 0.08294 0.67932    
0.072 0.08411 0.63043 0.072 0.08411 0.67089    
0.073 0.08528 0.62319 0.073 0.08528 0.67089    
0.074 0.08645 0.60870 0.074 0.08645 0.66245    
0.075 0.08762 0.58696 0.075 0.08762 0.64979    
0.076 0.08879 0.57971 0.076 0.08879 0.64557    
0.077 0.08995 0.57246 0.077 0.08995 0.64557    
0.078 0.09112 0.55072 0.078 0.09112 0.64135    
0.079 0.09229 0.53623 0.079 0.09229 0.63713    
0.08 0.09346 0.52174 0.08 0.09346 0.63713    
0.081 0.09463 0.50000 0.081 0.09463 0.63291    
0.082 0.09579 0.50000 0.082 0.09579 0.63291    
0.083 0.09696 0.47101 0.083 0.09696 0.63291    
0.084 0.09813 0.45652 0.084 0.09813 0.62869    
0.085 0.09930 0.45652 0.085 0.09930 0.62869    
0.086 0.10047 0.42029 0.086 0.10047 0.62869    
0.087 0.10164 0.41304 0.087 0.10164 0.62447    
0.088 0.10280 0.39855 0.088 0.10280 0.62447    
0.089 0.10397 0.37681 0.089 0.10397 0.62447    
0.09 0.10514 0.35507 0.09 0.10514 0.62447    
0.091 0.10631 0.34783 0.091 0.10631 0.62025    
0.092 0.10748 0.32609 0.092 0.10748 0.61603    
0.093 0.10864 0.31159 0.093 0.10864 0.61181    
0.094 0.10981 0.29710 0.094 0.10981 0.61181    
0.095 0.11098 0.28986 0.095 0.11098 0.59072    
0.096 0.11215 0.28986 0.096 0.11215 0.57384    
0.097 0.11332 0.27536 0.097 0.11332 0.56962    
0.098 0.11449 0.26087 0.098 0.11449 0.56540    
0.099 0.11565 0.26087 0.099 0.11565 0.56118    
0.1 0.11682 0.25362 0.1 0.11682 0.56118    
0.101 0.11799 0.23913 0.101 0.11799 0.55696    
0.102 0.11916 0.23913 0.102 0.11916 0.55696    
0.103 0.12033 0.23913 0.103 0.12033 0.55696    
0.104 0.12150 0.23188 0.104 0.12150 0.55696    
0.105 0.12266 0.22464 0.105 0.12266 0.55696    
 259 
0.106 0.12383 0.22464 0.106 0.12383 0.55696    
0.107 0.12500 0.21739 0.107 0.12500 0.55274    
0.108 0.12617 0.21739 0.108 0.12617 0.54852    
0.109 0.12734 0.21739 0.109 0.12734 0.54852    
0.11 0.12850 0.21739 0.11 0.12850 0.54430    
0.111 0.12967 0.21014 0.111 0.12967 0.53165    
0.112 0.13084 0.19565 0.112 0.13084 0.53165    
0.113 0.13201 0.19565 0.113 0.13201 0.52321    
0.114 0.13318 0.19565 0.114 0.13318 0.52321    
0.115 0.13435 0.18841 0.115 0.13435 0.51477    
0.116 0.13551 0.18116 0.116 0.13551 0.51055    
0.117 0.13668 0.18116 0.117 0.13668 0.51055    
0.118 0.13785 0.18116 0.118 0.13785 0.51055    
0.119 0.13902 0.18116 0.119 0.13902 0.51055    
0.12 0.14019 0.18116 0.12 0.14019 0.51055    
0.121 0.14136 0.18116 0.121 0.14136 0.50633    
0.122 0.14252 0.17391 0.122 0.14252 0.50633    
0.123 0.14369 0.17391 0.123 0.14369 0.50211    
0.124 0.14486 0.16667 0.124 0.14486 0.49789    
0.125 0.14603 0.15942 0.125 0.14603 0.49367    
0.126 0.14720 0.15942 0.126 0.14720 0.49367    
0.127 0.14836 0.15217 0.127 0.14836 0.48945    
0.128 0.14953 0.15217 0.128 0.14953 0.48523    
0.129 0.15070 0.13768 0.129 0.15070 0.48523    
0.13 0.15187 0.13043 0.13 0.15187 0.47257    
0.131 0.15304 0.13043 0.131 0.15304 0.47257    
0.132 0.15421 0.13043 0.132 0.15421 0.46835    
0.133 0.15537 0.13043 0.133 0.15537 0.46414    
0.134 0.15654 0.12319 0.134 0.15654 0.46414    
0.135 0.15771 0.12319 0.135 0.15771 0.45992    
0.136 0.15888 0.12319 0.136 0.15888 0.45992    
0.137 0.16005 0.12319 0.137 0.16005 0.45992    
0.138 0.16121 0.12319 0.138 0.16121 0.45992    
0.139 0.16238 0.12319 0.139 0.16238 0.45570    
0.14 0.16355 0.12319 0.14 0.16355 0.45148    
0.141 0.16472 0.12319 0.141 0.16472 0.45148    
0.142 0.16589 0.12319 0.142 0.16589 0.45148    
0.143 0.16706 0.12319 0.143 0.16706 0.44304    
0.144 0.16822 0.12319 0.144 0.16822 0.44304    
0.145 0.16939 0.12319 0.145 0.16939 0.43460    
0.146 0.17056 0.11594 0.146 0.17056 0.41772    
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0.147 0.17173 0.11594 0.147 0.17173 0.39241    
0.148 0.17290 0.10145 0.148 0.17290 0.38397    
0.149 0.17407 0.09420 0.149 0.17407 0.38397    
0.15 0.17523 0.09420 0.15 0.17523 0.37975    
0.151 0.17640 0.09420 0.151 0.17640 0.37553    
0.152 0.17757 0.09420 0.152 0.17757 0.37553    
0.153 0.17874 0.09420 0.153 0.17874 0.37553    
0.154 0.17991 0.09420 0.154 0.17991 0.37553    
0.155 0.18107 0.09420 0.155 0.18107 0.37553    
0.156 0.18224 0.08696 0.156 0.18224 0.37553    
0.157 0.18341 0.08696 0.157 0.18341 0.37131    
0.158 0.18458 0.08696 0.158 0.18458 0.37131    
0.159 0.18575 0.08696 0.159 0.18575 0.37131    
0.16 0.18692 0.08696 0.16 0.18692 0.36709    
0.161 0.18808 0.08696 0.161 0.18808 0.36287    
0.162 0.18925 0.08696 0.162 0.18925 0.36287    
0.163 0.19042 0.08696 0.163 0.19042 0.36287    
0.164 0.19159 0.08696 0.164 0.19159 0.35865    
0.165 0.19276 0.08696 0.165 0.19276 0.35865    
0.166 0.19393 0.07971 0.166 0.19393 0.35865    
0.167 0.19509 0.07971 0.167 0.19509 0.35021    
0.168 0.19626 0.07971 0.168 0.19626 0.34599    
0.169 0.19743 0.07971 0.169 0.19743 0.34599    
0.17 0.19860 0.07971 0.17 0.19860 0.34177    
0.171 0.19977 0.07971 0.171 0.19977 0.33333    
0.172 0.20093 0.07971 0.172 0.20093 0.33333    
0.173 0.20210 0.07971 0.173 0.20210 0.32489    
0.174 0.20327 0.07971 0.174 0.20327 0.32068    
0.175 0.20444 0.07971 0.175 0.20444 0.31224    
0.176 0.20561 0.07971 0.176 0.20561 0.31224    
0.177 0.20678 0.07971 0.177 0.20678 0.31224    
0.178 0.20794 0.07246 0.178 0.20794 0.31224    
0.179 0.20911 0.07246 0.179 0.20911 0.30802    
0.18 0.21028 0.07246 0.18 0.21028 0.30802    
0.181 0.21145 0.07246 0.181 0.21145 0.30802    
0.182 0.21262 0.07246 0.182 0.21262 0.30802    
0.183 0.21379 0.07246 0.183 0.21379 0.30380    
0.184 0.21495 0.07246 0.184 0.21495 0.30380    
0.185 0.21612 0.07246 0.185 0.21612 0.29958    
0.186 0.21729 0.06522 0.186 0.21729 0.29536    
0.187 0.21846 0.06522 0.187 0.21846 0.29536    
 261 
0.188 0.21963 0.06522 0.188 0.21963 0.29536    
0.189 0.22079 0.05797 0.189 0.22079 0.29536    
0.19 0.22196 0.05072 0.19 0.22196 0.29536    
0.191 0.22313 0.05072 0.191 0.22313 0.29114    
0.192 0.22430 0.05072 0.192 0.22430 0.28692    
0.193 0.22547 0.05072 0.193 0.22547 0.28692    
0.194 0.22664 0.03623 0.194 0.22664 0.28270    
0.195 0.22780 0.03623 0.195 0.22780 0.27004    
0.196 0.22897 0.03623 0.196 0.22897 0.26582    
0.197 0.23014 0.03623 0.197 0.23014 0.26582    
0.198 0.23131 0.03623 0.198 0.23131 0.26582    
0.199 0.23248 0.03623 0.199 0.23248 0.26582    
0.2 0.23364 0.03623 0.2 0.23364 0.26160    
0.201 0.23481 0.03623 0.201 0.23481 0.26160    
0.202 0.23598 0.03623 0.202 0.23598 0.26160    
0.203 0.23715 0.03623 0.203 0.23715 0.25738    
0.204 0.23832 0.03623 0.204 0.23832 0.25738    
0.205 0.23949 0.02899 0.205 0.23949 0.25738    
0.206 0.24065 0.01449 0.206 0.24065 0.25738    
0.207 0.24182 0.01449 0.207 0.24182 0.25738    
0.208 0.24299 0.01449 0.208 0.24299 0.25738    
0.209 0.24416 0.01449 0.209 0.24416 0.25316    
0.21 0.24533 0.01449 0.21 0.24533 0.25316    
0.211 0.24650 0.01449 0.211 0.24650 0.25316    
0.212 0.24766 0.01449 0.212 0.24766 0.25316    
0.213 0.24883 0.01449 0.213 0.24883 0.25316    
0.214 0.25000 0.01449 0.214 0.25000 0.25316    
0.215 0.25117 0.01449 0.215 0.25117 0.25316    
0.216 0.25234 0.01449 0.216 0.25234 0.25316    
0.217 0.25350 0.01449 0.217 0.25350 0.25316    
0.218 0.25467 0.01449 0.218 0.25467 0.25316    
0.219 0.25584 0.01449 0.219 0.25584 0.25316    
0.22 0.25701 0.00725 0.22 0.25701 0.25316    
0.221 0.25818 0.00725 0.221 0.25818 0.25316    
0.222 0.25935 0.00725 0.222 0.25935 0.25316    
   0.223 0.26051 0.25316    
   0.224 0.26168 0.25316    
   0.225 0.26285 0.25316    
   0.226 0.26402 0.25316    
   0.227 0.26519 0.25316    
   0.228 0.26636 0.25316    
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   0.229 0.26752 0.25316    
   0.23 0.26869 0.25316    
   0.231 0.26986 0.25316    
   0.232 0.27103 0.25316    
   0.233 0.27220 0.25316    
   0.234 0.27336 0.25316    
   0.235 0.27453 0.25316    
   0.236 0.27570 0.25316    
   0.237 0.27687 0.25316    
   0.238 0.27804 0.25316    
   0.239 0.27921 0.25316    
   0.24 0.28037 0.25316    
   0.241 0.28154 0.25316    
   0.242 0.28271 0.25316    
   0.243 0.28388 0.25316    
   0.244 0.28505 0.25316    
   0.245 0.28621 0.25316    
   0.246 0.28738 0.25316    
   0.247 0.28855 0.25316    
   0.248 0.28972 0.25316    
   0.249 0.29089 0.25316    
   0.25 0.29206 0.25316    
   0.251 0.29322 0.25316    
   0.252 0.29439 0.25316    
   0.253 0.29556 0.25316    
   0.254 0.29673 0.25316    
   0.255 0.29790 0.25316    
   0.256 0.29907 0.25316    
   0.257 0.30023 0.25316    
   0.258 0.30140 0.25316    
   0.259 0.30257 0.25316    
   0.26 0.30374 0.25316    
   0.261 0.30491 0.25316    
   0.262 0.30607 0.25316    
   0.263 0.30724 0.25316    
   0.264 0.30841 0.25316    
   0.265 0.30958 0.25316    
   0.266 0.31075 0.25316    
   0.267 0.31192 0.25316    
   0.268 0.31308 0.25316    
   0.269 0.31425 0.25316    
 263 
   0.27 0.31542 0.25316    
   0.271 0.31659 0.25316    
   0.272 0.31776 0.25316    
   0.273 0.31893 0.25316    
   0.274 0.32009 0.25316    
   0.275 0.32126 0.25316    
   0.276 0.32243 0.25316    
   0.277 0.32360 0.25316    
   0.278 0.32477 0.25316    
   0.279 0.32593 0.25316    
   0.28 0.32710 0.25316    
   0.281 0.32827 0.25316    
   0.282 0.32944 0.25316    
   0.283 0.33061 0.25316    
   0.284 0.33178 0.25316    
   0.285 0.33294 0.25316    
   0.286 0.33411 0.25316    
   0.287 0.33528 0.25316    
   0.288 0.33645 0.25316    
   0.289 0.33762 0.25316    
   0.29 0.33879 0.24895    
   0.291 0.33995 0.24895    
   0.292 0.34112 0.24895    
   0.293 0.34229 0.24895    
   0.294 0.34346 0.24895    
   0.295 0.34463 0.24895    
   0.296 0.34579 0.24895    
   0.297 0.34696 0.24895    
   0.298 0.34813 0.24895    
   0.299 0.34930 0.24895    
   0.3 0.35047 0.24895    
   0.301 0.35164 0.24895    
   0.302 0.35280 0.24895    
   0.303 0.35397 0.24895    
   0.304 0.35514 0.24895    
   0.305 0.35631 0.24895    
   0.306 0.35748 0.24895    
   0.307 0.35864 0.24895    
   0.308 0.35981 0.24895    
   0.309 0.36098 0.24895    
   0.31 0.36215 0.24895    
 264 
   0.311 0.36332 0.24895    
   0.312 0.36449 0.24895    
   0.313 0.36565 0.24895    
   0.314 0.36682 0.24895    
   0.315 0.36799 0.24895    
   0.316 0.36916 0.24895    
   0.317 0.37033 0.24895    
   0.318 0.37150 0.24895    
   0.319 0.37266 0.24895    
   0.32 0.37383 0.24895    
   0.321 0.37500 0.24895    
   0.322 0.37617 0.24895    
   0.323 0.37734 0.24895    
   0.324 0.37850 0.24473    
   0.325 0.37967 0.24473    
   0.326 0.38084 0.24473    
   0.327 0.38201 0.24473    
   0.328 0.38318 0.24473    
   0.329 0.38435 0.24473    
   0.33 0.38551 0.24473    
   0.331 0.38668 0.24473    
   0.332 0.38785 0.24473    
   0.333 0.38902 0.24473    
   0.334 0.39019 0.24051    
   0.335 0.39136 0.23629    
   0.336 0.39252 0.23629    
   0.337 0.39369 0.23629    
   0.338 0.39486 0.22785    
   0.339 0.39603 0.22785    
   0.34 0.39720 0.22785    
   0.341 0.39836 0.22785    
   0.342 0.39953 0.22363    
   0.343 0.40070 0.21941    
   0.344 0.40187 0.21941    
   0.345 0.40304 0.21941    
   0.346 0.40421 0.21941    
   0.347 0.40537 0.21941    
   0.348 0.40654 0.21941    
   0.349 0.40771 0.21941    
   0.35 0.40888 0.21519    
   0.351 0.41005 0.21097    
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   0.352 0.41121 0.21097    
   0.353 0.41238 0.21097    
   0.354 0.41355 0.21097    
   0.355 0.41472 0.20675    
   0.356 0.41589 0.20675    
   0.357 0.41706 0.20675    
   0.358 0.41822 0.19409    
   0.359 0.41939 0.18565    
   0.36 0.42056 0.18143    
   0.361 0.42173 0.17722    
   0.362 0.42290 0.17300    
   0.363 0.42407 0.16456    
   0.364 0.42523 0.16456    
   0.365 0.42640 0.16034    
   0.366 0.42757 0.16034    
   0.367 0.42874 0.14768    
   0.368 0.42991 0.13080    
   0.369 0.43107 0.10970    
   0.37 0.43224 0.10127    
   0.371 0.43341 0.09283    
   0.372 0.43458 0.08017    
   0.373 0.43575 0.05907    
   0.374 0.43692 0.05063    
   0.375 0.43808 0.05063    
   0.376 0.43925 0.05063    
   0.377 0.44042 0.05063    
   0.378 0.44159 0.05063    
   0.379 0.44276 0.04219    
   0.38 0.44393 0.04219    
   0.381 0.44509 0.04219    
   0.382 0.44626 0.03376    
   0.383 0.44743 0.02954    
   0.384 0.44860 0.02954    
   0.385 0.44977 0.02110    
   0.386 0.45093 0.02110    
   0.387 0.45210 0.01688    
   0.388 0.45327 0.01688    
   0.389 0.45444 0.01266    
   0.39 0.45561 0.00844    
   0.391 0.45678 0.00422    






APPENDIX H. DRAWINGS AND PARTS – SPECIFIC AIM 1 
H.1 Specific Aim 1 – Experiment A 
Table H-1. List of parts to make dynamically contracting annulus (DCA) for the 
box left heart chamber. 
Item Vendor Item# Description 
Wire McMaster 3461T63 Used for the contraction; 
embedded in the annulus cuff 
Cam Lever  McMaster 5720K17 Used to hold wires in place 
on motors 
Spring McMaster 9663K16 Embedded in the annulus cuff 
to provide relaxation 
Screws McMaster 99477A620 Secures top plate onto bottom 
plate of DCA 
Nylon McMaster  Shell of annulus cuff 





Figure H-1. Drawing of the top plate of the dynamically contracting annulus 
(DCA) for the box left heart chamber. 
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Figure H-2. Drawing of the bottom plate of the dynamically contracting annulus 
(DCA) for the box left heart chamber. 
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Figure H-3. Motor block for attaching the wire via a cam lever. 
 
H.2 Specific Aim 2 – Experiment B 
 271 
Table H-2. List of parts to make dynamically contracting annulus (DCA) for the 
cylindrical left heart chamber. 
Item Vendor Item# Description 
Screws 
 
McMaster 92185A992 Secures top plate onto bottom 
plate of DCA 
Gasket McMaster 4061T14 Put between top and bottom 
plates to increase seal 
Spring McMaster 9663K16 Embedded in the annulus cuff to 
provide relaxation 
Nylon McMaster  Shell of annulus cuff 




Figure H-4. Drawing of the top plate of the dynamically contracting annulus 




Figure H-5. Drawing of the bottom plate of the dynamically contracting annulus 
(DCA) for the cylinder left heart chamber. 
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APPENDIX I. DRAWINGS AND PARTS – SPECIFIC AIM 2 
I.1 Left Ventricle Box Chamber 
Table I-1. List of parts to make left ventricle box chamber. 
Item Vendor Item# Description 




Chamber material: LV Box Parts 
1 and 2; Parts 10 and 11; Parts 5, 
5-2, 6, 7, and 8; Parts 3 and 4, 
respectively 
Tap Inserts McMaster 99362A700 
99362A600 












Figure I-1. Part 1-a drawing. 
 276 
 




Figure I-3. Part 1-c drawing. 
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Figure I-4. Part 1-d drawing. 
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Figure I-5. Part 2-a drawing. 
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Figure I-7. Part 2-c drawing. 
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Figure I-8. Part 3-a drawing. 
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Figure I-9. Part 3-b drawing. 
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Figure I-10. Part 3-c drawing. 
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Figure I-11. Part 4-a drawing. 
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Figure I-12. Part 4-b drawing. 
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Figure I-13. Part 4-c drawing. 
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Figure I-14. Part 5-a drawing. 
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Figure I-15. Part 5-b drawing. 
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Figure I-16. Part 5-2a drawing. 
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Figure I-17. Part 5-2b drawing. 
 292 
 
Figure I-18. Part 6 drawing. 
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Figure I-19. Part 7 drawing. 
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Figure I-20. Part 8 drawing. 
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Figure I-21. Part 10 drawing. 
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Figure I-22. Part 11 drawing. 
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I.2 Left Ventricle Aorto-Mitral Insert 
 298 
 
Figure I-23. LV Insert 1a drawing. 
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Figure I-24. LV Insert 1b drawing. 
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Figure I-25. LV Insert 2 drawing. 
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I.3 Georgia Tech – Transcatheter Aortic Valve 
 
Figure I-26. 29 mm GT-TAV stent frame drawing. 
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APPENDIX J. LABVIEW CODES – SPECIFIC AIM 1 
J.1 Dynamically Contracting Annulus.vi 
 303 
 
Figure J-1. Initial State of DCA LabVIEW code. 
 304 
 
Figure J-2. Run State of DCA LabVIEW code. 
 305 
 
Figure J-3.  Blocks within the Run State of DCA LabVIEW code. 
 306 
 
Figure J-4. Save and Stop state of the DCA LabVIEW code. 
 307 







%Read in the file in gray scale with pixel information 
img = imread('W:\Work\Work - Graduate\Work - Contracting Annulus\Input 
Graphs\Gorman\Annular Area.PNG'); 
info = imfinfo('W:\Work\Work - Graduate\Work - Contracting 






%Input image axis' scale difference 
X = 100;                                %X-scale difference 
Y = 0.30;                               %Y-scale difference 
  
%Input points of interest from image using mouse 
%MATLAB reads (0,0) as the top left corner for pixels 
%Click Order: xmin, xmax, ymax, ymin 
[xl,y1] = ginput(2)                %Inputting x-scale 
[x2,y2] = ginput(2)                %Inputting y-scale 
a = 0;                             %Graph value for x1(1) 
b = 0.9;                           %Graph value for y2(1) 
c = xl(1)                          %x-axis pixel offset 
d = y2(1)                          %y-axis pixel offset 
x = X/(xl(2)-xl(1))                %cycle/pixel 
y = Y/(y2(2)-y2(1))                %(cm/s)/pixel 
[Px,Py] = ginput();                %Inputting graph data points 
Dx = (Px*x)-(c*x)+a;                 
Dy = (d*y)-(Py*y)+b+Y;            
Data = [Dx,Dy];                    %Snatched data 
n = size(Dx) 
xx = Dx(1):((Dx(n)-Dx(1))/40):Dx(n); 
yy = spline(Dx,Dy,xx); 






%Export data array "Data" to excel spreadsheet 










APPENDIX L. MATLAB CODES – SPECIFIC AIM 2 
L.1 BinAVG.m 
% This code bins each cardiac cycle into 5-frame bins 
% Updated by Thomas Easley on 2018/12/03 to bin average data for 20 





% File containing list of input files for processing 
infile = 'input.txt'; 
fid_inp = fopen(infile,'r'); 
  
TrueImagesPerCycle = 602; 
NumCyclesAcquired = 20; 
BinWidth = 5; 
ImagesPerCycle = floor(TrueImagesPerCycle/BinWidth)*BinWidth; 
  
CardiacCycleLength = 0.856; 
TimeStep = CardiacCycleLength/(ImagesPerCycle/BinWidth); 
  
while ~feof(fid_inp) 
    folder0 = fgetl(fid_inp); 
%    folder1 = fgetl(fid_inp); 
%    folder2 = fgetl(fid_inp); 
%    folder3 = fgetl(fid_inp); 
     
     
    cd(folder0) 
    %%% Seperate 20 cycles individually. Since one cycle is 600 frames, 
    %%% cycle 1= the first 600 vc7 files, the cycle two is the next and 
so 
    %%% forth 
    VelField1 = loadvec(sprintf('B[%d:%d]*.vc7', 1, ImagesPerCycle)); 
    VelField2 = loadvec(sprintf('B[%d:%d]*.vc7', 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
    VelField3 = loadvec(sprintf('B[%d:%d]*.vc7', 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField4 = loadvec(sprintf('B[%d:%d]*.vc7', 
(3*TrueImagesPerCycle+1), (3*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField5 = loadvec(sprintf('B[%d:%d]*.vc7', 
(4*TrueImagesPerCycle+1), (4*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField6 = loadvec(sprintf('B[%d:%d]*.vc7', 
(5*TrueImagesPerCycle+1), (5*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField7 = loadvec(sprintf('B[%d:%d]*.vc7', 
(6*TrueImagesPerCycle+1), (6*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField8 = loadvec(sprintf('B[%d:%d]*.vc7', 
(7*TrueImagesPerCycle+1), (7*TrueImagesPerCycle)+ImagesPerCycle)); 
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    VelField9 = loadvec(sprintf('B[%d:%d]*.vc7', 
(8*TrueImagesPerCycle+1), (8*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField10 = loadvec(sprintf('B[%d:%d]*.vc7', 
(9*TrueImagesPerCycle+1), (9*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField11 = loadvec(sprintf('B[%d:%d]*.vc7', 
(10*TrueImagesPerCycle+1), (10*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField12 = loadvec(sprintf('B[%d:%d]*.vc7', 
(11*TrueImagesPerCycle+1), (11*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField13 = loadvec(sprintf('B[%d:%d]*.vc7', 
(12*TrueImagesPerCycle+1), (12*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField14 = loadvec(sprintf('B[%d:%d]*.vc7', 
(13*TrueImagesPerCycle+1), (13*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField15 = loadvec(sprintf('B[%d:%d]*.vc7', 
(14*TrueImagesPerCycle+1), (14*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField16 = loadvec(sprintf('B[%d:%d]*.vc7', 
(15*TrueImagesPerCycle+1), (15*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField17 = loadvec(sprintf('B[%d:%d]*.vc7', 
(16*TrueImagesPerCycle+1), (16*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField18 = loadvec(sprintf('B[%d:%d]*.vc7', 
(17*TrueImagesPerCycle+1), (17*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField19 = loadvec(sprintf('B[%d:%d]*.vc7', 
(18*TrueImagesPerCycle+1), (18*TrueImagesPerCycle)+ImagesPerCycle)); 
    VelField20 = loadvec(sprintf('B[%d:%d]*.vc7', 
(19*TrueImagesPerCycle+1), (19*TrueImagesPerCycle)+ImagesPerCycle)); 
     
%     cd(folder2) 
%     VelField4 = loadvec(sprintf('B[%d:%d]*.vc7', 1, ImagesPerCycle)); 
%     VelField5 = loadvec(sprintf('B[%d:%d]*.vc7', 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
%     VelField6 = loadvec(sprintf('B[%d:%d]*.vc7', 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
%     
%     cd(folder3) 
%     VelField7 = loadvec(sprintf('B[%d:%d]*.vc7', 1, ImagesPerCycle)); 
%     VelField8 = loadvec(sprintf('B[%d:%d]*.vc7', 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
%     VelField9 = loadvec(sprintf('B[%d:%d]*.vc7', 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
     
%     VelField1 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder1, 1, 
ImagesPerCycle)); 
%     VelField2 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder1, 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
%     VelField3 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder1, 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
%     VelField4 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder2, 1, 
ImagesPerCycle)); 
%     VelField5 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder2, 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
%     VelField6 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder2, 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
%     VelField7 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder3, 1, 
ImagesPerCycle)); 
%     VelField8 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder3, 
(TrueImagesPerCycle+1), TrueImagesPerCycle+ImagesPerCycle)); 
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%     VelField9 = loadvec(sprintf('%s/B[%d:%d]*.vc7',folder3, 
(2*TrueImagesPerCycle+1), (2*TrueImagesPerCycle)+ImagesPerCycle)); 
%      
    NumBins = length(VelField1)/BinWidth; 
    NumBins20 = length(VelField20)/BinWidth; 
     
    %Initializing BinAvg Fields 
    BinAvg1 = VelField1(1:NumBins); 
    BinAvg2 = VelField2(1:NumBins); 
    BinAvg3 = VelField3(1:NumBins); 
    BinAvg4 = VelField4(1:NumBins); 
    BinAvg5 = VelField5(1:NumBins); 
    BinAvg6 = VelField6(1:NumBins); 
    BinAvg7 = VelField7(1:NumBins); 
    BinAvg8 = VelField8(1:NumBins); 
    BinAvg9 = VelField9(1:NumBins); 
    BinAvg10 = VelField10(1:NumBins); 
    BinAvg11 = VelField11(1:NumBins); 
    BinAvg12 = VelField12(1:NumBins); 
    BinAvg13 = VelField13(1:NumBins); 
    BinAvg14 = VelField14(1:NumBins); 
    BinAvg15 = VelField15(1:NumBins); 
    BinAvg16 = VelField16(1:NumBins); 
    BinAvg17 = VelField17(1:NumBins); 
    BinAvg18 = VelField18(1:NumBins); 
    BinAvg19 = VelField19(1:NumBins); 
    BinAvg20 = VelField20(1:NumBins); 
    
    %Initializing PhaseAvg matrix 
     
    for i = 1:NumBins 
        BinAvg1(i) = averf(VelField1(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg2(i) = averf(VelField2(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg3(i) = averf(VelField3(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg4(i) = averf(VelField4(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg5(i) = averf(VelField5(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg6(i) = averf(VelField6(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg7(i) = averf(VelField7(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg8(i) = averf(VelField8(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg9(i) = averf(VelField9(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg10(i) = averf(VelField10(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg11(i) = averf(VelField11(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg12(i) = averf(VelField12(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
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        BinAvg13(i) = averf(VelField13(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg14(i) = averf(VelField14(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg15(i) = averf(VelField15(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg16(i) = averf(VelField16(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg17(i) = averf(VelField17(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg18(i) = averf(VelField18(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg19(i) = averf(VelField19(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
        BinAvg20(i) = averf(VelField20(((BinWidth*i-(BinWidth-
1)):(BinWidth*i)))); 
         
    end 
     
    TotBinAvg = [BinAvg1, BinAvg2, BinAvg3, BinAvg4, BinAvg5, BinAvg6, 
BinAvg7, BinAvg8, BinAvg9, BinAvg10, BinAvg11, BinAvg12, BinAvg13, 
BinAvg14, BinAvg15, BinAvg16, BinAvg17, BinAvg18, BinAvg19, BinAvg20]; 
     
     
    [m,n] = size(TotBinAvg(1).vx); 
    sz = m*n; 
    DatExportX = zeros(sz,1); 
    DatExportY = zeros(sz,1); 
    DatExportVX = zeros(sz,1); 
    DatExportVY = zeros(sz,1); 
     
     
    %% EXPORT BIN AVERAGED DATA TO DAT 
     
    h = waitbar(0); 
    tic 
     
    for t = 1:length(TotBinAvg) 
        counter = 1; 
        for j = 1:n 
            for i = 1:m 
                DatExportX(counter) = TotBinAvg(t).x(i); 
                DatExportY(counter) = TotBinAvg(t).y(j); 
                DatExportVX(counter) = TotBinAvg(t).vx(i,j); 
                DatExportVY(counter) = TotBinAvg(t).vy(i,j); 
                counter = counter + 1; 
            end 
        end 
         
        %Export DatExport from (t*NumBins-NumBins+1):(t*NumBins) 
        if isempty(dir(sprintf('%s/BinAVG',folder0)))         %if the 
directory doesn't exist, make it 
            mkdir(sprintf('%s/BinAVG',folder0)); 
        end 
         
 313 
        fid2 = fopen(sprintf('%s/BinAVG\\T=%04d.dat',folder0,t),'w'); 
        fprintf(fid2,'%s %s %s\n','TITLE = "T = 
',sprintf('%04d',t),'"'); 
        fprintf(fid2,'%s\n','VARIABLES = "X (m)", "Y (m)", "U (m/s)", 
"V (m/s)"'); 
        fprintf(fid2,'%s %s %s %d %s %d\n','ZONE T="T = 
',sprintf('%04d',t),'", I=',m, 'J=',n); 
        tot = m*n; 
        for l = 1:tot 
            fprintf(fid2,'%8.6f %8.6f %8.6f 
%8.6f\n',DatExportX(l)/1000,DatExportY(l)/1000,DatExportVX(l),DatExport
VY(l)); 
        end 
        fclose(fid2); 
        progress = (t/(length(TotBinAvg))); 
        time_elapsed = toc; 
        time_remaining = (1-progress)*(time_elapsed/progress)/60; 
        waitbar(progress, h,['Time Remaining: ', 
num2str(time_remaining),'min'], 'Name', num2str(progress*100)); 
    end 

















    ;                                           %folder containing PIV 
data 
outputfolder = '%s/Scaled';                     %folder containing 
output folders 
outputfolderroot = 'Scaled';                    %folder containing 
output data 
inroot = 'T=';                                  %input filename prefix 
outroot = 'Ts=';                                %output filename prefix 
numformat = '%04d';                             %total digits in 
numbering 
fileextension = '.dat';                         %file type 
firstf = 1;                                     %first file number 
lastf = 2400;                                   %last file number 
 314 
incrementf = 1;                                 %increments between 
files 
%xfactor = 0.9541985;                                    %0x-axis 
scaling factor 
%yfactor = 1.0087719;                                    %0y-axis 
scaling factor 
xfactor = 0.7668712;                                    %50x-axis 
scaling factor 
yfactor = 0.858209;                                     %50y-axis 
scaling factor 
%xfactor = 0.8081897;                                    %100x-axis 
scaling factor 




myfolder = sprintf(outputfolder,datafolder); 
if isempty(dir(myfolder))         %if the directory doesn't exist, make 
it 
   mkdir(myfolder); 
end 
  
NumHeaderLines = 3;                              %number of headerlines 
to skip 
NumCols = 4; 
initialize = 1; 
lengthf = (lastf-firstf+1)/incrementf; 
  
h = waitbar(0); 
    tic  
  
for FileNum = firstf:incrementf:lastf 
    u = sprintf(numformat,FileNum); 
    infilenumformat = strcat(inroot,u,fileextension); 
    outfilenumformat = 
strcat(outputfolderroot,'\\',outroot,u,fileextension); 
     
    %open .dat file 
    fid = fopen(infilenumformat,'r'); 
     
    InputText = textscan(fid,'%s',NumHeaderLines,'delimiter','\n'); 
     
    if initialize == 1; 
        temp = InputText{1}; 
        RowThree = temp(3); 
        SplitRow = strsplit(RowThree{1}); 
        m = str2num(SplitRow{7}); 
        n = str2num(SplitRow{9}); 
        DataLength = m*n; 
        RawData = zeros(DataLength,NumCols); 
        ScaledData = zeros(DataLength,NumCols); 
        initialize = 0; 
    end 
     
    %Create format string based on parameter 
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    FormatString = repmat('%f',1,NumCols); 
     
    %Read Original Data 
    RawData(:,:) = 
cell2mat(textscan(fid,FormatString,'delimiter',',')); 
     
    fclose(fid); 
     
    %Scaled Data 
    ScaledData(:,1) = RawData(:,1)*xfactor; %X 
    ScaledData(:,2) = RawData(:,2)*yfactor; %Y 
    ScaledData(:,3) = RawData(:,3)*xfactor; %VX 
    ScaledData(:,4) = RawData(:,4)*yfactor; %VY 
     
     
    %EXPORT TO DAT 
    DatExportX = ScaledData(:,1); 
    DatExportY = ScaledData(:,2); 
    DatExportVX = ScaledData(:,3); 
    DatExportVY = ScaledData(:,4); 
  
    fid2 = fopen(outfilenumformat,'w'); 
    fprintf(fid2,'%s %s %s\n','TITLE = "T = 
',sprintf('%04d',FileNum),'"'); 
    fprintf(fid2,'%s\n','VARIABLES = "X (m)", "Y (m)", "U (m/s)", "V 
(m/s)"'); 
    fprintf(fid2,'%s %s %s %d %s %d\n','ZONE T="T = 
',sprintf('%04d',FileNum),'", I=',m, 'J=',n); 
    for L = 1:DataLength 
        fprintf(fid2,'%8.6f %8.6f %8.6f 
%8.6f\n',DatExportX(L),DatExportY(L),DatExportVX(L),DatExportVY(L)); 
    end 
    fclose(fid2); 
     
    %progress bar 
    progress = (FileNum/lengthf); 
    time_elapsed = toc; 
    time_remaining = (1-progress)*(time_elapsed/progress)/60; 
    waitbar(progress, h,['Time Remaining: ', 






%% Input files for this script must be bin averaged .dat files 





%% input parameters 
NumCycles = 20; 
TotalBins = 2400; 
  
%% Read Bin Averaged Data 
NumBins = TotalBins/NumCycles; 
NumHeaderLines = 3; 
NumCols = 4; 
initialize = 1; 
  
for FileNum = 1:TotalBins 
    fid = fopen(strcat('Ts=',sprintf('%04d',FileNum),'.dat'),'r'); 
    InputText = textscan(fid,'%s',NumHeaderLines,'delimiter','\n'); 
     
    if initialize == 1; 
        temp = InputText{1}; 
        RowThree = temp(3); 
        SplitRow = strsplit(RowThree{1}); 
        m = str2num(SplitRow{7}); 
        n = str2num(SplitRow{9}); 
        DataLength = m*n; 
        BinnedData = zeros(DataLength, 4, TotalBins); 
        PhaseAvgData = zeros(DataLength,4, NumBins); 
        initialize = 0; 
    end 
     
    % Create format string based on parameter 
    FormatString = repmat('%f',1,NumCols); 
     
    % Read data block 
    BinnedData(:,:,FileNum) = 
cell2mat(textscan(fid,FormatString,'delimiter',',')); 
     
    % Close the file 
    fclose(fid); 
end 
  
%% Phase Average Binned Data 
for count = 1:NumBins 
    for cycle = 1:NumCycles 
        PhaseAvgData(:,:,count) = PhaseAvgData(:,:,count) + 
BinnedData(:,:,(NumBins*(cycle-1))+count); 
    end 
end 
  
PhaseAvgData(:,:,:) = PhaseAvgData(:,:,:)/NumCycles; 
  
%% EXPORT TO DAT 
  
DatExportX = zeros(DataLength); 
DatExportY = zeros(DataLength); 
DatExportVX = zeros(DataLength); 
DatExportVY = zeros(DataLength); 
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for t = 1:NumBins 
    DatExportX = PhaseAvgData(:,1,t); 
    DatExportY = PhaseAvgData(:,2,t); 
    DatExportVX = PhaseAvgData(:,3,t); 
    DatExportVY = PhaseAvgData(:,4,t); 
     
    if isempty(dir(sprintf('%s/BinPhaseAVG',pwd))) 
        mkdir(sprintf('%s/BinPhaseAVG',pwd)); 
    end 
     
    fid2 = fopen(sprintf('BinPhaseAVG\\T=%04d.dat',t),'w'); 
    fprintf(fid2,'%s %s %s\n','TITLE = "T = ',sprintf('%04d',t),'"'); 
    fprintf(fid2,'%s\n','VARIABLES = "X (m)", "Y (m)", "U (m/s)", "V 
(m/s)"'); 
    fprintf(fid2,'%s %s %s %d %s %d\n','ZONE T="T = 
',sprintf('%04d',t),'", I=',m, 'J=',n); 
    tot = m*n; 
    for l = 1:tot 
        fprintf(fid2,'%8.6f %8.6f %8.6f 
%8.6f\n',DatExportX(l),DatExportY(l),DatExportVX(l),DatExportVY(l)); 
    end 
    fclose(fid2); 
end 
  
% Notify Me When Done By Playing Song 
%load handel; 








%**************CHANGE FILE PATH FOR EACH EXPERIMENT!******************* 




znam = '8020F_neo_0Per_6.5minmaxavg'; 
timepoints = 120; 
sz = [112 118 timepoints]; %get from dat file header 
%                                                                     * 
%********************************************************************** 
  
listing = dir(file_path); 
filenames = {listing.name}; 
dat1 = []; 
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for i  = 3:length(filenames) %loop through all time points 
    file_1 = char(cellstr(filenames(i))); 
    file = sprintf('%s\\%s',file_path,file_1); 
     
  
    fid1 = fopen(file,'r'); 
    head = fgetl(fid1); 
    fgetl(fid1); 
    tem = fgetl(fid1); 
    sz2 = sscanf(tem,['ZONE T="Frame 0", I=','%d',', J=','%d'],[1 
Inf]); 
    dat1(:,:,i-2) = fscanf(fid1,'%f %f %f %f\n',[4 inf]); 
    fclose(fid1); 
     
end 
  
vel_mag = sqrt(dat1(3,:,:).^2+dat1(4,:,:).^2); 
vel = reshape(vel_mag,sz(1)*sz(2),1,sz(3)); 
tpts = 0:((1/timepoints)*0.856):0.856; 
  
% Initialize minimum array 
minim = ones(sz(1)*sz(2),1)*1000; 
maxim = zeros(sz(1)*sz(2),1); 
min_ind = zeros(sz(1)*sz(2),1); 
max_ind = zeros(sz(1)*sz(2),1); 
add = zeros(sz(1)*sz(2),1); 
  
for i = 1:(timepoints) 
    minim = min(minim,vel(:,:,i)); 
    min_ind = 
plus(times(tpts(i),ge(minim,vel(:,:,i))),times(min_ind,lt(minim,vel(:,:
,i)))); 
    maxim = max(maxim,vel(:,:,i)); 
    max_ind = 
plus(times(tpts(i),le(maxim,vel(:,:,i))),times(max_ind,gt(maxim,vel(:,:
,i)))); 
    add = plus(add,vel(:,:,i)); 
end 
  
avg = add/timepoints; 
  
% Write out minimum and maximum fields 
fid2 = fopen(strcat(file_path,'\',znam,'.dat'),'w'); 
fprintf(fid2,'%s\n',strcat('TITLE = "',znam,'"')); 
fprintf(fid2,'%s\n','VARIABLES = "X (m)", "Y (m)", "Min (m/s)", "Min 
Time (ms)", "Max (m/s)", "Max Time (ms)", "Average (m/s)"'); 
fprintf(fid2,'%s %s %s %d %s %d\n','ZONE T="',znam,' ", I=',sz(1), 
'J=',sz(2)); 
for j=1:sz(1)*sz(2) 


















datafolder = 'Z:\Work\Work - Graduate\Work - SA2\SA2b 
Processed\Flail8020rescaled\50Per\6.5L_2\Cycle Averaged'... 
    ;                                           %folder containing PIV 
data 
outputfolder = '%s/Reordered_200ms';            %folder containing 
output folders 
inroot = 'T=';                                  %input filename prefix 
outroot = 'T=';                                 %output filename prefix 
numformat = '%04d';                             %total digits in 
numbering 
fileextension = '.dat';                         %file type 
firstf = 1;                                     %number of old first 
file 
lastf = 120;                                    %number of old last 
file 
incrementf = 1;                                 %increments between 
files 
firstfin = 29;                                  %start number of old 
file 






myfolder = sprintf(outputfolder,datafolder); 
if isempty(dir(myfolder))         %if the directory doesn't exist, make 
it 
   mkdir(myfolder); 
end 
length = ((lastf-firstf)+1)/incrementf; 
h = waitbar(0); 
    tic  
  
for m = firstf:incrementf:lastf 
    if m >= firstfin 
        k = (m-firstfin)+1; 
    elseif m < firstfin 
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        k = (m-firstfin)+1+lastf; 
    end 
    t = sprintf(numformat,m);               %input file number 
    u = sprintf(numformat,k); 
    infilenumformat = strcat(inroot,t,fileextension); 
    outfilenumformat = 
strcat(outputfolder,'\\',outroot,u,fileextension); 
    copyfile(infilenumformat,sprintf(outfilenumformat,datafolder)); 
%copies and renames file 
  
    %progress bar 
    progress = (m/length); 
    time_elapsed = toc; 
    time_remaining = (1-progress)*(time_elapsed/progress)/60; 
    waitbar(progress, h,['Time Remaining: ', 















    ;                                           %folder containing PIV 
data 
outputfolder = '%s/Frames';                     %folder containing 
output folders 
outputfolderroot = 'Frame';                     %folder containing 
output data 
inroot = 'T=';                                  %input filename prefix 
outroot = 'Tr=';                                %output filename prefix 
numformat = '%04d';                             %total digits in 
numbering 
fileextension = '.dat';                         %file type 
firstf = 1;                                     %first frame number of 
cycle 
lastf = 120;                                    %last frame number of 
cycle 
incrementf = 1;                                 %increments between 
frames 
lengthc = 120;                                  %number of frames in a 
cycle 
firstc = 1;                                     %first cycle number 
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lastc = 20;                                     %last cycle number 
incrementc = 1;                                 %increments between 
cycles 
cyclelength = 856;                              %(ms) length of cardiac 
cycle 
PIVoutfolder = 'Frames';                        %for syntax in PIV file 
(same as outputfolder) 
PIVfilename = 'PIVinput.txt';                   %list of folders used 
for PIV processing 




dt = cyclelength/lengthc; 
  
cd(datafolder) 
myfolder = sprintf(outputfolder,datafolder); 
if isempty(dir(myfolder))         %if the directory doesn't exist, make 
it 
   mkdir(myfolder); 
end 
  
FileArray = strings(lengthc,1); 
FileArray2 = zeros(1,lengthc); 
dirfilename = strcat(outputfolder,'\\',PIVfilename); 
dtfilename = strcat(outputfolder,'\\',deltatfilename); 
  
h = waitbar(0); 
    tic  
  
for m = firstf:incrementf:lastf 
    %make folder for frame m 
    s = sprintf(numformat,m);                   %folder number 
    outputfolders = strcat(outputfolder,'\\',outputfolderroot,s); 
    if isempty(dir(sprintf(outputfolders,datafolder)))         %if the 
directory doesn't exist, make it 
        mkdir(sprintf(outputfolders,datafolder)); 
    end 
    %copy files to folder and renames to cycle n 
    for n = firstc:incrementc:lastc 
        k = (n-1)*lengthc+m; 
        t = sprintf(numformat,k);               %input file number 
        u = sprintf(numformat,n); 
        infilenumformat = strcat(inroot,t,fileextension); 
        outfilenumformat = 
strcat(outputfolders,'\\',outroot,u,fileextension); 
        copyfile(infilenumformat,sprintf(outfilenumformat,datafolder)); 
%copies and renames file 
    end 
     
    %Export folder names to .txt file 
    diroutfolder = strcat(PIVoutfolder,'\',outputfolderroot,s); 
    FileArray(m,1) = string(strcat(datafolder,'\',diroutfolder)); 
    fid2 = fopen(sprintf(dirfilename,datafolder),'w'); 
    fprintf(fid2,'%s\n',FileArray(:)); 
    fclose(fid2); 
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    %Export dt to .txt file 
    diroutfolder = strcat(PIVoutfolder,'\',outputfolderroot,s); 
    FileArray2(1,m) = dt*(m-1); 
    fid3 = fopen(sprintf(dtfilename,datafolder),'w'); 
    fprintf(fid3,'%8.6f ',FileArray2(:)); 
    fclose(fid3); 
     
    %progress bar 
    progress = (m/lengthc); 
    time_elapsed = toc; 
    time_remaining = (1-progress)*(time_elapsed/progress)/60; 
    waitbar(progress, h,['Time Remaining: ', 















% MASTER PROGRAM FOR PIV PROCESSING 
% CURRENT AS OF 06/02/2019 
% ASSUME NUMBER OF FILES IS NFILE 
% THIS PROGRAM CREATES TWO FILES: 
% 1. B00001-NFILE.DAT 
% 2. MEAN FILES CREATING FROM THE AVERAGING PROGRAM 
% THE INPUT FILE FOR THIS PROGRAM IS input.txt 
% input.txt - List of data folders, exported from Davis 
% THIS PROGRAM ASSUMES THAT THE DATAFILES ARE STORED AS B*****.DAT, 
WHERE 
% ***** RANGES FROM 1-NFILE. 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
flow = 6.5; %lpm 
plane = 'c'; 






% % % % create input file 
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%     fidi = fopen('F:\BSCI_23mm_dat files\plan_a_5lpm - 
Copy/input.txt','w'); 
%     for i=1:length(tp) 
%         fprintf(fidi,'F:\BSCI_23mm_dat files\plan_a_5lpm - 
Copy/T1=%d/\n',tp(i)); 
%     end 









tProc\BinAVG_904Hz\Frames\' num2str(flow) 'lpm_' plane '/']; 
% Number of data files 
nfile = 16; 
% Size of data array in one file 
sz = [96 70]; 
% Density of solution in kg/m3 
rho = 1091; 
% Kinematic viscosity in m2/s 
nu = 3.5E-6; 
% z-location of plane of interest; 
% For BAV, z=5.0 for pl1, z=0.0 for pl2 and z=2.5 for pl3 
% For Normal, z=2.5 for pl1, z=0.0 for pl2 and z=5.0 for pl3 
z = 0.0; 
% Flag for coordinates 
% Flag = 1, write out coordinates, use only for pl2 of all datasets 
% Flag = 2, read coordinates 
flag = 1; 
% Path of coordinates file 
coordfile = strcat(outdir,'coordfile.dat'); 
% Length of string for output files 
lencur = 6; 
% flag_del = 1 deletes the file named B00001-NFILE.DAT. 
% Any other value keeps the file in the folder 
flag_del = 0; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
% Total number of elements 
tot = sz(1)*sz(2); 
  
% Open the file containing the list of dt value 
fid0 = fopen(dt,'r'); 
tp = cell2mat(textscan(fid0,'%f','Delimiter','')); 
tp = tp.'; 
fclose(fid0); 
  
% Open the file containing the list of data directories 
fid1 = fopen(inpf,'r'); 
dirs = textscan(fid1,'%s','Delimiter','\n'); 




% Create file for writing time points of measurements 
A = exist(strcat(outdir,'Mean')); 
if (A~=7)  
    mkdir(outdir,'Mean'); 
end 
outf = strcat(outdir,'Mean/tpts.txt'); 
fid5 = fopen(outf,'w'); 
  
h = waitbar(0); 
    tic  
lengthc = size(dirs,1); 
% Scan through the list of directories 
for i=1:size(dirs,1) 
    curr = char(dirs(i)); 
    mean_term = zeros(8,tot); 
     
    if (nfile>99) 
        nfile_nam = num2str(nfile,'%3d'); 
    else if (nfile>9) 
            nfile_nam = num2str(nfile,'%2d'); 
        else 
            nfile_nam = num2str(nfile,'%1d'); 
        end 
    end 
% Create the output file name for writing     
    outf = strcat(curr,'_Tr=0001-',nfile_nam,'.dat'); 
    fid3 = fopen(outf,'w'); 
    fprintf('%s%s\n','Writing file: ',outf); 
     
    for l=1:nfile 
        fprintf('%s%s\n','Processing file: 
',strcat(curr,'\Tr=',sprintf('%04d\n',l),'.dat')); 
%   CREATE FILENAME     
        fnam = strcat(curr,'\Tr=',sprintf('%04d\n',l),'.dat'); 
%   OPEN FILE 
        fid2 = fopen(fnam,'r'); 
%   READ HEADER 
        head = fgetl(fid2);  
        fgetl(fid2); 
        tem = fgetl(fid2); 
        %sz = sscanf(tem,['ZONE T="T= 0001", I=','%d','J=','%d'],[1 
Inf]); 
%   READ DATA     
        dat = fscanf(fid2,'%f %f %f %f\n',[4 inf]); 
        fclose(fid2); 
  
%   VELOCITY MAGNITUDE 
        vel_mag = sqrt(dat(3,:).^2+dat(4,:).^2); 
         
%   RESHAPING DATA 
        X = reshape(dat(1,:),sz(1),sz(2)); 
        Y = reshape(dat(2,:),sz(1),sz(2)); 
        U = reshape(dat(3,:),sz(1),sz(2)); 
        V = reshape(dat(4,:),sz(1),sz(2)); 
         
%   VECTOR SPACING 
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        dx = (X(2,1)-X(1,1)); 
        dy = (Y(1,1)-Y(1,2)); 
         
        dUdx = zeros(sz(1),sz(2)); 
        dUdy = zeros(sz(1),sz(2)); 
        dVdx = zeros(sz(1),sz(2)); 
        dVdy = zeros(sz(1),sz(2)); 
        tau_sumxy = zeros(sz(1),sz(2)); 
      
%   CALCULATING GRADIENTS AND WALL-NORMAL GRADIENTS 
        for j=2:sz(1)-1 
            for k=2:sz(2)-1 
                dUdx(j,k) = (U(j+1,k)-U(j-1,k))/(X(j+1,k)-X(j-1,k)); 
                dUdy(j,k) = (U(j,k+1)-U(j,k-1))/(Y(j,k+1)-Y(j,k-1)); 
                dVdx(j,k) = (V(j+1,k)-V(j-1,k))/(X(j+1,k)-X(j-1,k)); 
                dVdy(j,k) = (V(j,k+1)-V(j,k-1))/(Y(j,k+1)-Y(j,k-1)); 
                tau_sumxy(j,k) = dUdy(j,k)+dVdx(j,k); 
            end 
        end 
         
        dUdx = reshape(dUdx,1,tot); 
        dUdy = reshape(dUdy,1,tot); 
        dVdx = reshape(dVdx,1,tot); 
        dVdy = reshape(dVdy,1,tot); 
        tau_sumxy = reshape(tau_sumxy,1,tot); 
  
% If it is the first file, write the common header, else only write 
zone 
% header 
        if (l==1) 
            fprintf(fid3,'%s\n',head); 
            fprintf(fid3,'%s\n','VARIABLES = "X (m)", "Y (m)", "U 
(m/s)", "V (m/s)", "Vel (m/s)", "dUdX", "dUdY", "dVdX", "dVdY", 
"dUdy+dVdx"'); 
        end 
        fprintf(fid3,'%s%s%s%d%s%d%s\n','ZONE 
T="',strcat('B',sprintf('%05d\n',i),'.dat'),'", I=',sz(1),' 
J=',sz(2),',DATAPACKING=POINT'); 
        for j=1:tot 




        end 
% Calculate mean quantities for the N files         
        mean_term(1,:) = mean_term(1,:) + dat(3,:)/double(nfile); 
        mean_term(2,:) = mean_term(2,:) + dat(4,:)/double(nfile); 
        mean_term(3,:) = mean_term(3,:) + vel_mag/double(nfile); 
        mean_term(4,:) = mean_term(4,:) + dUdx/double(nfile); 
        mean_term(5,:) = mean_term(5,:) + dUdy/double(nfile); 
        mean_term(6,:) = mean_term(6,:) + dVdx/double(nfile); 
        mean_term(7,:) = mean_term(7,:) + dVdy/double(nfile); 
        mean_term(8,:) = mean_term(8,:) + tau_sumxy/double(nfile); 
    end 
% Conversion of units from m/s/mm to 1/s 
%     for j=4:8 
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%         mean_term(j,:) = mean_term(j,:)*1000; 
%     end 
    fclose(fid3); 
     
% Open the newly created file for further calculations     
    fid3 = fopen(outf,'r'); 
    fprintf('%s%s\n','Reading file for mean calculations: ',outf); 
%   READ HEADER 
    for l=1:2 
        head = fgetl(fid3); 
    end 
     
    uu = zeros(1,tot); 
    vv = zeros(1,tot); 
    uv = zeros(1,tot); 
    TKE = zeros(1,tot); 
    pRSS = zeros(1,tot); 
    VSS = zeros(1,tot); 
     
% Calculation of quantities     
    for l=1:nfile 
        head = fgetl(fid3); 
        dat = fscanf(fid3,'%f %f %f %f %f %f %f %f %f %f\n',[10,tot]); 
        for j=1:tot 
            uu(1,j) = uu(1,j) + (dat(3,j)-
mean_term(1,j))^2/double(nfile); 
            vv(1,j) = vv(1,j) + (dat(4,j)-
mean_term(2,j))^2/double(nfile); 
            uv(1,j) = uv(1,j) + (dat(4,j)-mean_term(2,j))*(dat(3,j)-
mean_term(1,j))/double(nfile); 
        end 
    end 
% Calculation of TKE, Principle RSS, and VSS scalar shear components 
    for j=1:tot 
        TKE(1,j) = 0.5*(uu(1,j)+vv(1,j)); 
        pRSS(1,j) = rho*sqrt(((uu(1,j)-vv(1,j))/2)^2+(uv(1,j))^2); 
        VSS(1,j) = nu*rho*mean_term(8,j); 
    end 
    fclose(fid3); 
  
% Read or write coordinates file depending on flag     
    if (flag==1) 
        fid4 = fopen(coordfile,'w'); 
        for j=1:tot 
            fprintf(fid4,'%8.4f %8.4f\n',dat(1,j),dat(2,j)); 
        end 
        flag = 2; 
        fclose(fid4); 
    else 
        fid4 = fopen(coordfile,'r'); 
        tem = fscanf(fid4,'%f %f\n',[1 inf]); 
        fclose(fid4); 
        dat(1,:) = tem(1:2:tot*2); 
        dat(2,:) = tem(2:2:tot*2); 
    end 
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% Write results of mean calculations 
    slash = find(curr=='\'); 
    fnam = strcat(outdir,'Mean/T= ',sprintf('%f',tp(i)),'.dat'); 
    fid6 = fopen(fnam,'w'); 
    fprintf(fid5,'%s%s%s\n','T=',sprintf('%f',tp(i)),'.dat'); 
    fprintf('%s%s\n','Writing file: ',fnam); 
  
    fprintf(fid6,'%s %s %s\n','TITLE = "T = 
',sprintf('%f',tp(i)),'ms"'); 
    fprintf(fid6,'%s\n','VARIABLES = "X (m)", "Y (m)", "Z (m)", "U 
(m/s)", "V (m/s)", "Vel (m/s)", "dU/dx (s<sup>-1</sup>)", "dU/dy 
(s<sup>-1</sup>)", "dV/dx (s<sup>-1</sup>)", "dV/dy (s<sup>-1</sup>)", 
"<b><greek>w</greek><sub>z</sub> (s<sup>-1</sup>)</b>", 
"<greek>r</greek>u\''u\'' (N/m<sup>2</sup>)", "<greek>r</greek>v\''v\'' 
(N/m<sup>2</sup>)", "<greek>r</greek>u\''v\'' (N/m<sup>2</sup>)", "TKE 
(m<sup>2</sup>/s<sup>2</sup>)", "RSS (N/m<sup>2</sup>)", "VSS 
(N/m<sup>2</sup>)"'); 
    fprintf(fid6,'%s %s %s %d %s %d\n','ZONE T=" T = 
',sprintf('%f',tp(i)),'ms", I=',sz(1), 'J=',sz(2)); 
    for j=1:tot 
        fprintf(fid6,'%8.4f %8.4f %8.4f %8.4f %8.4f %8.4f %8.4f %8.4f 




    end 
    fclose(fid6); 
    if (flag_del==1) 
        delete(outf); 
    end 
    %progress bar 
    progress = (i/lengthc); 
    time_elapsed = toc; 
    time_remaining = (1-progress)*(time_elapsed/progress)/60; 
    waitbar(progress, h,['Time Remaining: ', 











% Input your file name WITHOUT FILE EXTENSION! 
%[filename, pathname] = uigetfile({'*.txt*'},'Select Particle Path Text 
File'); 
filename = '8020F_0Per_6.5pt_aa'; 
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pathname = 'Z:\Work\Work - Graduate\Work - SA2\SA2a 
Processed\Flail8020\0Per\6.5L\Cycle Averaged'; 
chdir(pathname); 
%neo sinus axes 
%user_axis = [-.011,.011,-.01,.01];  %0Per_neo 8020F 
%user_axis = [-.01,.012,-.01,.01];  %50Per_neo 8020F 
%user_axis = [-.017,.005,-.012,.008];  %100Per_neo 8020F 
%LV axes 
user_axis = [-.07,.03,-.05,.03];  %0Per 8020F 
%user_axis = [-.01,.012,-.01,.01];  %50Per 8020F 
%user_axis = [-.075,.025,-.055,.025];  %100Per 8020F 
  
% Open text file 
fid = fopen(strcat(filename,'.txt'),'r'); 
  
% Number of Header Lines 
NumHeaderLines = 1; 
  
%Read strings delimited by a carriage return 
InputText = textscan(fid,'%s',NumHeaderLines,'delimiter','\n'); 
  
FileHeader = InputText{1}; 
%disp(FileHeader); 
  
% Number of INTERNAL Header Lines 
NumInternalHeaderLines = 1; 
  
% Initialize block index 
NumParticles = 1;   
  
% Number of Columns of Data (X,Y,Z,etc)   
NumCols = 2; 
  
% For each block: 
while (~feof(fid))                                      
    
   % Display block number 
   % disp(cellstr(['Particle ' num2str(NumParticles)])); 
    
   % Read header lines 
   InputText = 
textscan(fid,'%s',NumInternalHeaderLines,'delimiter','\n'); 
   HeaderLines{NumParticles,1} = InputText{1}; 
   % disp(HeaderLines{NumParticles}); 
     
   % Create format string based on parameter 
   FormatString = repmat('%f',1,NumCols); 
    
   % Read data block 
   InputText = textscan(fid,FormatString,'delimiter',','); 
  
   % Convert to numerical array from cell 
   ParticlePaths{NumParticles,1} = cell2mat(InputText); 
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   % Size of table 
   [NumRows,NumCols] = size(ParticlePaths{NumParticles});              
   % disp(cellstr(['Table data size: ' num2str(NumRows) ' x ' 
num2str(NumCols)])); 
    
   % New line 
   % disp('*****');      
    
   % Increment block index 
   NumParticles = NumParticles+1; 
end 
  
NumParticles = NumParticles - 1; 
  






%     LPP = length(ParticlePaths{i}); 
%     for j=1:LPP 
%         if ParticlePaths{i}(j,1) == ParticlePaths{i}(LPP,1) 
%             if ParticlePaths{i}(j,2) == ParticlePaths{i}(LPP,2) 
%                 ParticlePaths{i}(j:end,:) = [];                 
%                 %break 
%             end 
%         end 
%     end 
    r = length(ParticlePaths{i}(:,1)); 
    FormatForExcel(1:r,2*i-1:2*i) = [ParticlePaths{i}(:,1), 
ParticlePaths{i}(:,2)]; 
end 





% Make directory for video frames 
% if isempty(dir(sprintf('ParticleTrackingFrames')))  
%     mkdir(sprintf('ParticleTrackingFrames')); 
% end 
  
v = VideoWriter(strcat(filename,'_particle_tracking.avi')); 
v.FrameRate = 10; 
v.Quality = 100; 
open(v); 
  
[m,n] = size(FormatForExcel); 
h = waitbar(0); 
tic 
for t=1:10:m 
    name = sprintf('ParticleTrackingFrames\\t=%04i',t); 
    figure('Visible','off') 
    for i=1:NumParticles 
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        plot(FormatForExcel(t,2*i-1),FormatForExcel(t,2*i),'.r'); 
        axis(user_axis) 
        hold on 
    end 
    hold off 
    F = getframe; 
    writeVideo(v,F); 
    %print(name,'-deps');  % writes EPS file 
    close; 
    clc; 
    progress = (t/m); 
    time_elapsed = toc; 
    time_remaining = (1-progress)*(time_elapsed/progress)/60; 
    waitbar(progress, h,['Time Remaining: ', 







%Clear Workspace except for Particle Paths (not necessary) 
clear ans fid FileHeader FormatString HeaderLines InputText ... 
    NumHeaderLines NumInternalHeaderLines NumRows NumCols ... 
    i r FormatForExcel; 
 
L.9 ParticleTrackingWashout.m 
%%[filename, pathname] = uigetfile({'*.csv*'},'Select Particle Path 
Text File'); 
%%^had to comment out for Word 
chdir(pathname); 
  
A = importdata(filename); 
  
[len, num] = size(A); 
  
WashoutCurve = zeros(len,1); 
  
for i = 1:2:num 
    Var = A(:,i); 
    Var(isnan(Var(:,1)),:)=[]; 
    Var(:)=1; 
    dim = numel(Var); 
    WashoutCurve(1:dim) = WashoutCurve(1:dim) + Var; 
end 
  
WashoutCurve = WashoutCurve/max(WashoutCurve); 
Time = [0:0.001:(numel(WashoutCurve)-1)*0.001]'; 





data = [Time CardiacCycles WashoutCurve]; 
header = {'Time(s)','Cardiac Cycles', 'Particles Remaining (%)'}; 





APPENDIX M. TECPLOT CODES – SPECIFIC AIM 2 
M.1 neo_mma.m 
#!MC 1410 
$!FieldLayers ShowShade = No 
$!FieldLayers ShowContour = Yes 
$!ContourLevels New 
  ContourGroup = 1 

















  Var = 5 
  ContourGroup = 2 
  LevelInitMode = ResetToNice 
$!ContourLevels New 
  ContourGroup = 2 

















  Var = 7 
  ContourGroup = 3 
  LevelInitMode = ResetToNice 
$!ContourLevels New 
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  ContourGroup = 3 
















$!GlobalContour 3  ColorMapName = 'Small Rainbow' 
$!GlobalContour 3  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 3  ColorMapFilter{ContinuousColor{CMax = 
0.26000000000000001}} 
$!GlobalContour 2  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 2  ColorMapFilter{ContinuousColor{CMax = 
0.26000000000000001}} 
$!GlobalContour 1  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 1  ColorMapFilter{ContinuousColor{CMax = 
0.26000000000000001}} 
$!GlobalContour 1  ColorMapName = 'Small Rainbow' 
$!GlobalContour 2  ColorMapName = 'Small Rainbow' 
$!Blanking Value{Constraint 1 {VarA = 7}} 
$!Blanking Value{Constraint 1 {Include = Yes}} 
$!Blanking Value{Include = Yes} 
$!Blanking Value{Constraint 2 {VarA = 1}} 
$!Blanking Value{Constraint 2 {VarA = 2}} 
$!Blanking Value{Constraint 2 {RelOp = GreaterThanOrEqual}} 
$!Blanking Value{Constraint 2 {ValueCutoff = 0.0050000000000000001}} 
$!Blanking Value{Constraint 2 {Include = Yes}} 
$!TwoDAxis YDetail{RangeMin = -0.01} 
$!TwoDAxis YDetail{RangeMax = 0.01} 
$!FrameLayout ShowBorder = No 





$!FieldLayers ShowShade = No 
$!GlobalRGB RedChannelVar = 3 
$!GlobalRGB GreenChannelVar = 3 
$!GlobalRGB BlueChannelVar = 3 
$!SetContourVar  
  Var = 3 
  ContourGroup = 1 
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  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 4 
  ContourGroup = 2 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 3 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 4 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 5 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 6 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 7 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 3 
  ContourGroup = 8 
  LevelInitMode = ResetToNice 
$!FieldLayers ShowContour = Yes 
$!ExtendedCommand  
  CommandProcessorID = 'CFDAnalyzer4' 
  Command = 'SetFieldVariables ConvectionVarsAreMomentum=\'F\' UVar=3 
VVar=4 WVar=0 ID1=\'NotUsed\' Variable1=0 ID2=\'NotUsed\' Variable2=0' 
$!ExtendedCommand  
  CommandProcessorID = 'CFDAnalyzer4' 




  Var = 5 
  ContourGroup = 1 
  LevelInitMode = ResetToNice 
$!ContourLevels New 
  ContourGroup = 1 

















$!GlobalContour 1  ColorMapName = 'Small Rainbow' 
$!GlobalContour 1  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 1  ColorMapFilter{ContinuousColor{CMin = 0}} 
$!GlobalContour 1  ColorMapFilter{ContinuousColor{CMax = 
0.26000000000000001}} 
$!RedrawAll  
$!Blanking Value{Constraint 2 {Include = Yes}} 
$!Blanking Value{Constraint 2 {VarA = 5}} 
$!Blanking Value{Include = Yes} 
$!Blanking Value{Constraint 1 {VarA = 1}} 
$!Blanking Value{Constraint 1 {VarA = 2}} 
$!Blanking Value{Constraint 1 {RelOp = GreaterThanOrEqual}} 
$!Blanking Value{Constraint 1 {ValueCutoff = 0.0050000000000000001}} 
$!Blanking Value{Constraint 1 {Include = Yes}} 
$!TwoDAxis YDetail{RangeMin = -0.01} 
$!TwoDAxis YDetail{RangeMax = 0.01} 





$!FieldLayers ShowShade = No 
$!GlobalRGB RedChannelVar = 17 
$!GlobalRGB GreenChannelVar = 3 
$!GlobalRGB BlueChannelVar = 3 
$!SetContourVar  
  Var = 3 
  ContourGroup = 1 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 4 
  ContourGroup = 2 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 5 
  ContourGroup = 3 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 6 
  ContourGroup = 4 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 7 
  ContourGroup = 5 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 8 
  ContourGroup = 6 
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  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 9 
  ContourGroup = 7 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 10 
  ContourGroup = 8 
  LevelInitMode = ResetToNice 
$!FieldLayers ShowContour = Yes 
$!SetContourVar  
  Var = 6 
  ContourGroup = 1 
  LevelInitMode = ResetToNice 
$!ContourLevels New 
  ContourGroup = 1 
















$!GlobalContour 1  ColorMapName = 'Small Rainbow' 
$!GlobalContour 1  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 1  ColorMapFilter{ContinuousColor{CMax = 
0.25999999999999995}} 
$!GlobalContour 2  ColorMapName = 'Small Rainbow' 
$!GlobalContour 2  ColorMapFilter{ColorMapDistribution = Continuous} 
$!SetContourVar  
  Var = 12 
  ContourGroup = 2 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 17 
  ContourGroup = 3 
  LevelInitMode = ResetToNice 
$!SetContourVar  
  Var = 16 
  ContourGroup = 4 
  LevelInitMode = ResetToNice 
$!GlobalContour 3  ColorMapName = 'Small Rainbow' 
$!GlobalContour 3  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 4  ColorMapName = 'Small Rainbow' 
$!GlobalContour 4  ColorMapFilter{ColorMapDistribution = Continuous} 
$!GlobalContour 2  ColorMapFilter{ContinuousColor{CMin = -2}} 
$!GlobalContour 2  ColorMapFilter{ContinuousColor{CMax = 3.5}} 
$!GlobalContour 3  ColorMapFilter{ContinuousColor{CMin = 1}} 
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$!GlobalContour 3  ColorMapFilter{ContinuousColor{CMax = 13}} 
$!GlobalContour 4  ColorMapFilter{ContinuousColor{CMin = 2}} 
$!GlobalContour 4  ColorMapFilter{ContinuousColor{CMax = 26}} 
$!TwoDAxis YDetail{RangeMin = -0.01} 
$!TwoDAxis YDetail{RangeMax = 0.01} 
$!Blanking Value{Constraint 1 {VarA = 2}} 
$!Blanking Value{Constraint 1 {RelOp = GreaterThanOrEqual}} 
$!Blanking Value{Constraint 1 {ValueCutoff = 0.0050000000000000001}} 
$!Blanking Value{Constraint 1 {Include = Yes}} 
$!Blanking Value{Include = Yes} 
$!Blanking Value{Constraint 2 {VarA = 1}} 
$!Blanking Value{Constraint 2 {VarA = 6}} 
$!Blanking Value{Constraint 2 {Include = Yes}} 
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